Design and development of magnetic resonance imaging (MRI) compatible tissue mimicking phantoms for evaluating focused ultrasound thermal protocols by Menikou, G.
              
City, University of London Institutional Repository
Citation: Menikou, G. (2017). Design and development of magnetic resonance imaging 
(MRI) compatible tissue mimicking phantoms for evaluating focused ultrasound thermal 
protocols. (Unpublished Doctoral thesis, City, University of London) 
This is the accepted version of the paper. 
This version of the publication may differ from the final published 
version. 
Permanent repository link:  http://openaccess.city.ac.uk/19247/
Link to published version: 
Copyright and reuse: City Research Online aims to make research 
outputs of City, University of London available to a wider audience. 
Copyright and Moral Rights remain with the author(s) and/or copyright 
holders. URLs from City Research Online may be freely distributed and 
linked to.
City Research Online:            http://openaccess.city.ac.uk/            publications@city.ac.uk
City Research Online
   
  
 
 
Design and development of magnetic resonance 
imaging (MRI) compatible tissue mimicking 
phantoms for evaluating focused ultrasound 
thermal protocols. 
 
 
 
 
A thesis submitted to the graduate faculty in partial fulfilment of the requirements for 
the Degree of Doctor of Philosophy in Biomedical Engineering 
 
 
 
Georgios Menikou 
 
 
 
Electrical, Electronic Engineering 
School of Mathematics, Computer Science and Engineering 
 
City, University of London 
June 2017 
Acknowledgements 
 
I would like to express my gratitude to my supervisors, Dr. Christakis Damianou and Dr. 
Panayiotis Kyriacou whose support, expertise and insight added considerably to my 
research goals. Also a very special thanks goes out to Christos Yiallouras and 
MarinosYiannakou for their scientific assistance. 
 
I would like to thank my beloved parents Menikos and Sotiroulla for supporting me 
emotionally, spiritually and financially throughout my life.  
 
Finally and most importantly, I would like to thank my wife Alexandra for her continuous 
support, encouragement and quiet patience that undoubtedly contributed towards the 
completion of this thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
  
i 
 
Abstract 
 Animal models are often used to test the efficacy and safety of clinical 
applications employing focused ultrasound that range in various stages of research, 
development and commercialization. The animals are usually subjected to conditions that 
cause pain, distress and euthanasia. Access to cadaveric models is not easy and affordable 
for all research institutions, whereas conservation and changes of their physical properties 
over time can be a delimiting factor for translational research.  The above set the 
motivation for this project, which its primary objective is to design and develop 
appropriate tissue mimicking phantoms using a simplistic and cost effective 
methodology. These phantoms are expected to contribute in reducing the need for animal 
testing and allow researchers to get hands experience with tools that will promote and 
accelerate testing in focused ultrasound thermal protocols. The main requirements for 
these phantoms are to be geometrically accurate, compatible with magnetic resonance 
imaging (MRI) and to be composed of materials that approximate the acoustic and 
thermal properties of the replicated tissues.  
 Throughout the duration of the project three ultrasonic composite phantoms (head, 
femur bone-muscle and breast-rib) were developed. The acoustic properties of candidate 
materials were assessed using pulse-echo immersion and through transmission 
techniques. The thermal properties were estimated by observing the rate of heat diffusion 
following a sonication in the soft tissue parts with MR thermometry. Acrylonitrile 
butadiene styrene (ABS) was used to replicate bone tissue, where its acoustic attenuation 
coefficient was found to be 16.01 ± 6.18 dB/cm at 1 MHz and the speed of sound at 2048 
± 79 m/s. Soft tissue parts consisted out of agar-based gels doped with varying 
concentrations of additives that controlled the relative contribution of acoustic absorption 
(evaporated milk) and scatter (silica dioxide) to total attenuation independently. Brain 
tissue phantom (2 % w/v agar - 1.2 % w/v SiO2 - 25 % v/v evaporated milk) matched an 
attenuation coefficient of 0.59 ± 0.05 dB/cm-MHz whereas muscle and breast mimicking 
phantom (2 % w/v agar - 2 % w/v SiO2 - 40 % v/v evaporated milk) were estimated of 
inducing  an attenuation coefficient of the order of 0.99 ±0.08 dB/cm-MHz. The speed of 
sound for the brain and muscle/breast recipe were estimated at 1485 ± 12 m/s and 1529 ± 
13 m/s respectively. The thermal conductivity of the brain phantom was estimated to be 
0.52 ± 0.06 W/mº-C and 0.57 ± 0.10 W/mº-C for the muscle/breast phantom. The acoustic 
and thermal properties of candidate materials were within range of the replicated tissues 
extracted from literature, except the speed of sound in ABS compared which was lower 
compared to bone (~3000 m/s).  
 Three dimensional models of bone parts (skull, femur, rib) were reconstructed in 
Standard Tessellation Language (STL) format by segmenting bony tissue of interest from 
adult human computed tomography (CT) images. The STL bone models were 3D printed 
in ABS using a fused deposition modelling (FDM) machine. The final composite 
phantoms were fabricated by molding the agar based soft tissue phantoms inside/around 
the ABS bone phantoms. The functionality of all three composite phantoms was assessed 
with focused ultrasound sonications applied by a 1 MHz single element transducer while 
temperature was monitored with 1.5 Tesla MRI scanner. A spoiled gradient recalled 
(SPGR) pulse sequence was used to produce phase images that were analyzed using a 
custom coded software developed in Matlab that employed proton-resonance frequency 
shift (PRFS) thermometry.  
 
Keywords: Focused ultrasound, MRI, phantoms, PRFS thermometry, skull, brain, breast, 
rib, bone.  
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1 Introduction 
1.1 Motivation behind the project 
 Currently there is a large and growing number of clinical applications employing 
high intensity focused ultrasound (HIFU) that ranges in various stages of research, 
development and commercialization. Nearly in all stages of research and development, 
animal models are used to mimic the clinical setting of the tested applications. The 
animals are usually subjected to conditions that cause pain, distress or euthanasia.  This 
ethical dilemma sets the motivation for this project, which its primary objective is to 
design and develop appropriate phantoms that will contribute in reducing animal testing 
in the area of focused ultrasound.  
 The preliminary results from various studies assessing the efficacy and safety of 
the modality clearly show that HIFU can be a disruptive technology for treating patients 
that would normally require an invasive approach or the use of treatments that are 
accompanied with high risks of toxicity. Consequently it is very important to accelerate 
research in the field in order to overcome the remaining obstacles that retain HIFU from 
becoming a standard treatment option. Therefore it is very important that the cost of 
fabricating these phantoms is low enough to allow researchers worldwide with limited 
resources to get hands on such tools.  
1.2 History and Background of Ultrasound 
Ultrasound technology was initially used in sonars during World War II and as a non-
destructive testing tool for detecting material corrosion. It was only in the late 60’s when 
the first commercial systems capable of producing 2D grayscale real time images of 
ultrasound echoes where used in diagnostic radiology. Nowadays diagnostic ultrasound 
imaging is an indispensable modality for any radiology department. It offers a quick and 
safe way of visualizing internal body structures in the search of disease or excluding 
pathology. The basic principle of diagnostic systems is to send ultrasound waves through 
the body of a patient and an image is formed by recording the intensity and travel time of 
echoes reflected at tissue interfaces. Ultrasound medical imaging technology has 
progressed significantly and modern systems can process ultrasound echoes accordingly 
to fuse anatomical images with quantitative maps of blood flow, tissue displacement, 
tissue stiffness, etc. Increased computing and processing power has also made 3D and 4D 
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ultrasound imaging possible. It is therefore not surprising that ultrasound imaging is the 
primary choice in diagnosing cardiovascular disease and obstetrics.  
 The use of ultrasound in medicine is not limited in diagnosis but it is also met in 
therapeutic applications. High Intensity Focused Ultrasound (HIFU) uses acoustic energy 
to non-invasively heat and destroy pathological tissues. Extracorporeal shock wave 
lithotripsy is an effective way of non-invasively fragmenting gallbladder or liver stones. 
Ultrasound is also used as a hyperthermic modality in physiotherapy sessions for 
accelerating bone healing and reducing inflammation caused by rheumatism, tendinitis or 
joint injuries.  
 
1.3 Definition of High Intensity Focused Ultrasound (HIFU) 
 HIFU also referred as Focused Ultrasound Surgery (FUS), is an application that 
focuses a high intensity acoustic beam over a small region.  Focusing leads to beam 
intensity amplification at a particular distance away from the HIFU transducer known as 
the focal length which occurs as a result of constructive interference. It is used for a 
number of clinical applications that are currently in different stages of research, 
development and commercialization [1]. For the majority of applications, HIFU can be 
delivered non-invasively making it a very attractive alternative to conventional therapies. 
1.4 HIFU induced thermotherapy 
 HIFU can be justifiably categorized as a thermal treatment method. The focused 
ultrasonic beam raises locally the temperature of the targeted region by acoustic 
absorption and under certain conditions this can be sufficient enough to cause cellular 
necrosis, while adjacent tissue is sustained at sub lethal heat levels.  It is worth mentioning 
that cellular death in HIFU is not only a result of thermal injury. Cellular apoptosis has 
been observed in in vivo experiments [2] even at sub-lethal thermal doses as a result of 
HIFU induced mechanical effects like cavitation, micro-streaming, and radiation force.  
Open surgery, radiotherapy and chemotherapy were the gold standard until recently for 
treating solid tumours and metastatic disease.  HIFU tries to offer a new solution to 
modern medicine that reduces the risk to patient’s health associated with the conventional 
treatment modalities mentioned above [2]. HIFU is a completely non-invasive procedure, 
free of incisions and blood transfusions. The risk from pre and postoperative 
complications like infections, internal organ injury and severe haemorrhage is limited. 
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There is usually no need for a general anaesthesia in HIFU applications. The patient is 
usually fully conscious or can be lightly sedated or under light general anaesthesia and is 
subjected to minimum discomfort and pain. Another advantage is that there is no limit in 
the number of HIFU treatment sessions that a patient can receive in case of a malignant 
disease recurrence, unlike radiotherapy and chemotherapy. These advantages can 
potentially contribute overall to a reduction in recovery time and hospital stay along with 
an improvement in quality of life for the treated patients. 
 HIFU is prone to some limitations like all other treatment modalities [3]. All 
ultrasound specific artifacts that appear in diagnostic imaging system pose limitations to 
safety and efficiency in FUS systems. Targets that lie deeply in relation to bones like liver 
lesions are difficult to treat because of the heavy scattering and attenuation effects. Gas 
filled tissues like bowels and lungs reflect the beam backwards and the reflected high 
acoustic energy is absorbed by tissues located between the target and the transducer. 
Rarefaction artifacts are also known to divert the beam and deposit heat in tissue adjacent 
to the target. Fibrotic and fatty tissues attenuate and absorb the acoustic energy differently 
from soft tissue leading to unpredictable distributions of cell death. Focal sizes in HIFU 
are in the millimetre range and therefore treatment of large targets is time consuming. 
HIFU is not the only thermal treatment available. Some of the major alternative 
thermotherapies are listed below [4]: 
 Radiofrequency ablation (RFA) is the most common local thermal treatment [5], 
[6]. A needle like electrode is seeded inside the region of interest and an RF alternating 
current is passed through a closed loop circuit (RF generator- RF electrode – patient 
grounding pads). The current agitates ions that lie in surrounding tissue which is ablated 
by the induced frictional heat. 
 Microwave ablation is a technique where microwave antennae are positioned 
usually percutaneously under image guidance near the region of interest [7], [8]. 
Microwave radiation produced is absorbed from water content in tissue which sets the 
water molecules in oscillatory motion. Heat produced by frictional losses is sufficient to 
lead to coagulative necrosis. 
 Laser ablation is achieved by positioning a cannula interstitially and guide through 
it laser fibres. Laser radiation is emitted in tissue specific wavelengths to optimize optical 
absorption. The absorption of the laser energy translates to heat which conducts to the 
surrounding tissue [9], [10]. 
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 Cryoablation is a therapeutic modality that involves the percutaneous insertion of 
a needle-like applicator (cryoprobe) to the target site under imaging guidance (CT or 
ultrasound (US))[11], [12]. The cryoprobe is a hollow tube that allows the circulation of 
liquid nitrogen or argon gas cryogens. The tip of the cryoprobe creates extremely cold 
temperatures and destroys the surrounding tissue through multiple freeze-thaw cycles. 
1.5 Physics of ultrasound. 
 Ultrasound belongs to the family of sound waves that corresponds to the transfer 
of energy via the propagation of a pressure wave in a medium. The prefix term Ultra 
indicates the fact that these pressure waves vibrate at frequencies higher than the audible 
human range (> 20 kHz). Waves produced by piston like ultrasound transducers cycle 
periodically in a sequence of compressions and rarefactions. The distance travelled by an 
ultrasound pressure wave in one cycle is known as the wavelength (λ) and it is interrelated 
with the velocity (v) of the wave and the frequency (f): 
 Unlike electromagnetic waves that can travel in vacuum, sound waves require an 
elastic medium to propagate its mechanical disturbance. Elastic mediums refer to any 
material that will not be permanently deform from its original structural state when 
disturbed and they can generally be liquids or solids. Another major difference with 
electromagnetic waves is that the medium’s particles oscillate parallel to the direction of 
propagation of the wave (longitudinal wave). The source of the mechanical disturbance 
in the medium sets the molecules of the medium in to vibration and the pressure wave 
travels through. The exerted pressure creates periodic compressions and rarefactions of 
the medium’s density which travel at the speed of the wave. 
1.6 Definition of ultrasound transducers. 
 In general terms a transducer is any device that can convert one form of energy to 
another. Ultrasound transducers convert electrical energy to mechanical energy and vice 
versa. Ultrasound transducers are made out of piezoelectric crystals. 
1.6.1  Piezoelectric effect. 
 Piezoelectricity refers to the property possessed by some crystalline materials. 
These crystals polarize and develop a potential difference across their faces when they 
are under a mechanical stress. The amplitude of the induced voltage is proportional to the 
 
 
𝒗 = 𝒇 ×  𝝀 (1.1) 
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force/pressure exerted. The phenomenon works reversely since the application of a 
radiofrequency voltage across the faces of the crystal induces a periodic displacement of 
the faces at the same frequency. The piezoelectric effect is sustained below a temperature 
that is characteristic to each type of crystal and it is better known as the Curie point. 
1.6.2 Piezoelectric materials used in medical ultrasound systems. 
 Ultrasound probes in diagnostic and therapeutic applications use solely 
piezoelectric materials. Usually the materials used for clinical purposes are man-made 
ferroelectrics like barium titanate, lead metaniobate, and lead zirconate titanate (PZT). 
These artificially made materials can be manufactured to be superior from naturally 
occurring crystals since they can possess a much higher electromechanical coupling 
coefficient. The electromechanical coefficient correlates to the efficiency of a crystal in 
converting electrical energy to mechanical and vice versa.  The basic properties of 
selected piezoelectric crystals are showed in Table 1-1. 
 
Table 1-1:  Properties of Piezoelectric Materials used in Medical Ultrasound [13]. 
Materials 
Electromechanical 
Coupling Coefficient (Kc) 
Curie Point 
(ºC) 
Quartz 0.11 550 
Rochelle salt 0.78 45 
Barium titanate 0.30 120 
PZT-4 0.70 328 
PZT-5 0.70 365 
 
Modern ultrasound technologies employ composite piezoelectric materials that have a 
lower acoustic impedance from monolithic equivalents. The acoustic coupling of 
composite crystals with biological tissue is improved. Additionally, unwanted lateral 
propagation modes are suppressed by the inhomogeneous microstructure of the composite 
material. 
1.7  Instrumentation of an ultrasound transducer. 
 The active element of an ultrasound transducer is made out of piezoelectric 
materials described in the previous section. The vibrations are induced by electrodes 
connected at its front and back surfaces.  Maximum conversion from electrical to acoustic 
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energy is achieved when the active element is driven at its resonance frequency. The 
resonance frequency of the crystal depends on its thickness.  When the thickness is equal 
to half wavelength (λ/2) of its resonance frequency, compression waves moving towards 
the crystal’s centre are in phase with the next cycle of expansion-contraction and interfere 
constructively. This principle stands for thicknesses equal to odd multiples of λ/2 but one 
has to consider that the extra thickness will attenuate the wave further. The back surface 
is covered with a backing material that is highly attenuative. By choosing a backing 
material with acoustic impedance closely matched to the active element’s impedance, the 
emitted sound from the back surface is absorbed and no reflections propagate in the 
forward direction. A thin wear plate (matching layer) covers the front place of the crystal 
and its purpose is to acoustically match the active element with the medium.  The 
selection of its thickness is crucial to bring in to phase the wave generated by the active 
element in the forward direction with the wave internally reflected at the faces of the 
matching layer. The two waves are back in phase when they exit, if the thickness of the 
matching layer is set to λ/4. A diagram of an ultrasonic transducer with its main 
components is shown in Figure 1.1. 
.  
Figure 1.1:  Components diagram of an ultrasonic transducer. 
 
The active element is driven by an RF digital pulse generator. The generator allows for 
manual selection of frequency, waveform and voltage and can operate in continuous or 
pulsed wave mode. The output signal is fed to an amplifier for power amplification before 
reaching the active element. The amplified signal reaches the crystal through a matching 
λ/4 
λ/2 
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reaches the crystal through a matching circuit that matches the electrical impedance of 
the transducer to the amplifier. Signal conversion and transmission is optimized by 
observing the forward and reflected power. The output power of the transducer can be 
calculated by calibrating the net electric power versus acoustic power. 
1.7.1 Focused Ultrasound Transducers. 
 Hyperthermia systems that use the thermal effects of ultrasound, employ focused 
transducers. Focusing the beam, amplifies the intensity at the focus compared to regions 
that fall outside the focal zone, making it possible to reach ablative temperatures. The 
effect of focusing is possible by manufacturing piezoelectric crystals with spherical 
geometry or through an assembly of a crystal coupled with an acoustic lens [14]. Focusing 
is also feasible through arrays of small transducers, which their phase and amplitude can 
be controlled simultaneously and independently [2]. Focusing is not the only function of 
phased arrays since they can steer the beam anywhere in front of the array and virtually 
at any depth. Phased arrays are the method of choice for the majority of clinical 
applications because of the obvious offered versatility along with the possibility of 
distortion correction of waves propagating through bone.  
 Each element of the phased array transducer is connected through an impedance 
matching circuit to a channel of the power generator/amplifier for controlling 
independently the phase and amplitude of the driving signal. The complexity of putting 
together the required hardware increases the cost and size of the phased array. In large 
phased array systems, the inter-element distance is a limiting factor that governs steering 
capabilities and the formation of grating lobes that deposit acoustic energy in unwanted 
directions [15]. 
1.8 Speed of ultrasound 
 The speed at which the disturbance propagates through any medium is strongly 
dependent on the medium’s physical properties. Typical propagation speeds of ultrasound 
in biological tissue are shown in Table 1-2. 
 
Table 1-2 Typical propagation speeds in biological tissue [16], [17]. 
Tissue Temp 
 (C) 
Speed of ultrasound 
(m/s) 
 Human Soft Tissues 
Brain 22 - 40 1460 - 1580 
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Skeletal Muscle 24 - 37, in vivo 1500 - 1610 
Breast (pre-menopausal) in vivo 1450 - 1570 
Breast (post-menopausal) in vivo 1430 - 1520 
Liver 37, in vivo 1522 - 1607 
Spleen 37, in vivo 1567 
Kidney 37 1560 
Human Bone Tissues 
Skull bone, whole 37 2590 - 2960 
Skeletal long bones, whole in vivo 3190 - 3406 
Cortical bone  23 1630 - 4040 
Trabecular bone - 1688 - 2084 
 
Gaseous media are made of molecules sparsely distributed and loosely bound that need 
to travel a long distance before they influence their neighbouring molecule in the direction 
of propagation. In reverse analogy, solids are densely populated with a constrained 
molecular structure that favours a very fast propagation.  In biological tissues ultrasound 
propagates in a wide range of velocities. The two extremes consist of the lungs rich in 
atmospheric air where sound travels slowly and bones where propagation is relatively 
fast. In soft tissues, ultrasound propagates in intermediate speeds which are relatively 
constant. Velocity changes at tissue interfaces do not affect the frequency of the acoustic 
wave, but alter its wavelength according to Equation (1.1). Additionally reflection, 
refraction and transmission, which are all properties of ultrasound, are characteristic of 
the propagation’s velocity.  
1.9 Reflection of ultrasound at interfaces 
 Propagation of ultrasound involves transmitting through interfaces of different 
tissues. The amount of the incident acoustic energy that manages to pass the interface is 
highly dependent on the media properties. More specifically the matching of the acoustic 
impedances of the adjacent media governs the amount acoustic energy reflected. 
 Acoustic impedance (Z) refers to the intrinsic property of any material or tissue in 
opposing the disturbance from a longitudinal wave propagation. Typical impedance 
values expressed in Rayl units for different biological tissues and materials are 
demonstrated in Table 1-3. 
 
Table 1-3: Acoustic impedances for different Biological Tissues [18], [19]. 
Biological Tissue Acoustic Impedance (MRayl) 
Water 1.48 
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Brain 1.60 
Breast 1.64 
Fat 1.38 
Liver 1.69 
Blood 1.66 
Kidney 1.65 
Skeletal Muscle 1.68 - 1.69 
Bone 5.32 
 
The degree of this material–specific opposition to wave propagation is proportional to the 
medium density (ρ) and the speed of sound (v).  
 
 
𝒁 =  𝝆 × 𝒗 (1.2) 
The fraction of reflected energy (R) at an interface between two materials with 
mismatched impedances is given by the following expression, where Z1 and Z2 refer to 
the impedances of each material. 
 𝑹 =  (
𝒁𝟐 − 𝒁𝟏
𝒁𝟐 + 𝒁𝟏
)
𝟐
 (1.3) 
It is straightforward to deduce that at interfaces with great impedance mismatch like 
air/tissue or tissue/bone the beam will be strongly reflected and very little if at all will be 
transmitted. Strong reflections produced from returning echoes to the transducer will 
define the tissue interface clearly in a diagnostic examination but the overall effect can 
be deleterious for imaging tissue that resides deeper. Similarly in therapeutic applications, 
propagation through acoustic windows that induce strong reflections should be avoided, 
since no energy will be deposited at treatment site. The direction of the reflected wave is 
predictable if the incident wave strikes on a smooth interface (specular reflection). The 
reflection is unidirectional and the angle of reflection equals the angle of incidence. This 
is very important in diagnostic ultrasound where transducers act as receivers. A wide 
angle of incidence will direct the reflected echo to an equally wide angle of reflection and 
therefore very little energy will be detected. In the case of non-specular reflections, where 
the interface is uneven and/or consists of reflective structures which are smaller in size 
from the ultrasound’s wavelength, then the reflected wave scatters randomly in many 
different directions. 
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1.10 Attenuation in biological tissues 
 The term attenuation refers to sum of all loss mechanisms that reduce the intensity 
of the acoustic beam while propagating through tissue. The total attenuation is 
characterized by an exponential drop of the pressure wave’s amplitude with distance 
travelled. Attenuative mechanisms that control the degree of penetration of the beam are 
presented in the following sections. Attenuation coefficients for different biological 
tissues measured at different frequencies are shown in Table 1-4. 
 
Table 1-4: Acoustic attenuation coefficient for different Biological Tissues [16], [17]. 
Tissue Freq 
 (MHz) 
Temp 
 (C) 
Attenuation 
coefficient 
 (dB/cm) 
 Human Soft Tissues 
Brain 1 25 0.6 
Brain 5 25 4.5 
Brain (white matter) 2.2 37 1.05 
Brain (grey matter) 2.2 37 0.625 
Skeletal Muscle (thigh) 4.3 in vivo 4.71 
Breast  1.7 in vivo 0.5 - 1.1 
Breast  7 23,37 9.5 - 12.6 
Liver *(rat) 100 22 130 
Spleen 2, 10 37 1, 11.5 
Kidney*(pig) 2, 10 37 2, 8.5 
Human Bone Tissues 
Skull bone, whole 1, 3 37 22, 78 
Skull bone, outer table 1 37 14.5 
Skull bone, inner table 1 37 18.7 
Skull bone, diploe 1, 3 37 26 - 43, 100 - 140 
Skeletal long bones 1 - 12.5 
Vertebra 1 - 1.5 - 38.2 
Cortical bone* (cow, femur)  1 - 6.9 
Cortical bone* (pig, femur) 1 32 8.4 
Trabecular bone 0.5 - 1.9 - 15.7 
 
1.10.1 Acoustic absorption in biological tissues 
 Absorption is recognized by studies results as the dominant process of acoustic 
energy loss [20].  Classical absorption phenomena are induced by the pressure wave in 
biological tissue. Tissues are far from ideal elastic media and due to their characteristic 
viscosity they oppose to any deformation causing lag between pressure and density 
redistribution. Viscous forces between moving particles convert part of the wave energy 
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to heat. Energy is also absorbed by a spectrum of relaxation mechanisms at the 
macromolecular scale of tissue proteins [21]. Tissue absorption coefficient (α) is 
dependent on frequency and tissue type. These observations are formulated in the 
following empirical expression, where α0 is the absorption coefficient per MHz, f is the 
frequency in MHz and n is the characteristic number of tissue type. 
 
 
𝜶 = 𝜶𝟎 (𝒇
𝒏) (1.4) 
Studies proved little difference of the absorption coefficient amongst different 
mammalian species whereas the difference was significant for different tissue types of 
the same species. The constitution of tissues in protein content and lipids seems to 
increase absorption [20]. 
1.10.2 Acoustic scattering in biological tissues 
 As mentioned in Section 1.4, ultrasound waves reflect at interfaces with an 
acoustic impedance mismatch. Biological tissues are “doped” with inhomogeneities that 
have different physical properties like density and elasticity from the surrounding tissue. 
If the inhomogeneity’s size is comparable or smaller from the wavelength of the sound 
wave, this leads to a generation of a secondary scattered wave in different directions. 
Scattering centres found in soft tissues show a small contribution to overall attenuation 
through scattering since their density and elasticity are close to the rest of the tissue. At 
low frequencies, this contribution does not exceed 10-15 % of the total attenuation [22] . 
 Unlike soft tissue, the effect of scattering becomes more important while 
propagating through the cancellous bone part of skeletal tissue. Cancellous bone consists 
of trabeculae which are complex structures of mineralized tissue with bone marrow with 
very different acoustic properties [23]. The solid matrix of the interconnected trabecular 
elements have a mean thickness of 50-150 μm which is much smaller than the wavelength 
of ultrasound in bone and generate secondary scattered waves.  
1.11  Ultrasound bioeffects 
 The interaction of ultrasound with biological tissue can lead to a variety of effects 
that differ in the mechanisms involved and the conditions for initiation. These are usually 
separated in the following thermal and mechanical effects. 
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1.11.1 Thermal bioeffects 
 Propagation of ultrasound through tissue always results in some degree of acoustic 
energy absorption which leads to heat generation.  Thermocoagulation can only occur if 
temperature is elevated for an adequate amount of time. Induced heat disrupts the weak 
hydrogen bonds of proteins by supplying kinetic energy to molecules that vibrate 
violently. The threshold of the thermal dose capable of coagulation is tissue specific. 
Temperature elevation in a tissue depends on the absorption, the acoustic field’s intensity, 
conductivity and the local perfusion rate. Thermal dose is quantified in terms of thermal 
isoeffective dose of  43ºC exposure minutes (CEM - cumulative effective minutes) [24].   
The isoeffective thermal dose in CEM’s can be calculated for any temperature T using 
the following expression. The constant R is derived from in vivo and in vitro studies for 
a variety of mammalian tissue types using the Arrhenius relationship [7–9]. 
The above expression is valid if the average temperature T is constant for the duration t 
of the thermal treatment.  For complex heating profiles where temperature continuously 
changes over time as it is the case in HIFU treatments, then the thermal dose for the entire 
heating is given by: 
 
𝑪𝑬𝑴𝟒𝟑℃,𝑻𝒐𝒕𝒂𝒍 =  ∑  𝒕𝑹
(𝟒𝟑−𝑻) (1.6) 
Arrhenius plots describe the cellular survival rate at different temperatures.  Although the 
selection of the 43⁰C reference temperature is arbitrary, it is almost equal to the “break 
point” temperature for human cells which is around 43.5 ºC [28] . Above the “break point” 
temperature, a shallower slope is observed suggesting that the thermo-tolerance of cells 
is decreased and the rate of cell killing doubles for every degree increase in temperature.  
The response to hyperthermia treatment of different cell lines of humans and rodents is 
shown in Figure 1.2.  
 The break point temperature for humans (43.5 ºC) is slightly higher than rodents 
(43ºC) suggesting a different thermo-tolerance between difference species. Although the 
break point is fairly constant for cell lines of the same species, it is obvious from the data 
above that there is a differentiation in survival rate of different cell lines of the same 
species for the same temperature. 
 
 
𝑪𝑬𝑴𝟒𝟑℃,𝑻 =   𝒕𝑹
(𝟒𝟑−𝑻) (1.5) 
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Figure 1.2:  Arrhenius plots for different cell lines of humans and rodents [11]. 
 
1.11.2 Mechanical bioeffects 
The effects of ultrasound interaction with biological tissue are not limited to thermal. A 
variety of mechanical (non-thermal) effects induced by ultrasound have been recognized 
by researchers and have been studied thoroughly. Some of them are exploited in some 
revolutionary medical applications whilst others raise patient safety risks. 
Cavitation – The term cavitation refers to the phenomenon where the acoustic field 
interacts with cavities filled with gas in a medium. The prerequisite of creating such 
bubbles in tissue is that the tissue is a host of microscopic gaseous nuclei and the intensity 
of the acoustic field is large enough to diffuse dissolved gas from the tissue during every 
compression-rarefaction cycle. Gas bubbles can also be formed as a result of tissue 
boiling during HIFU treatments.  Calculations from early studies have shown that 
microsecond pulses of ultrasound with peak intensities as low as 10–30 W/cm2 can 
generate transient cavitation in water [29]. This threshold is well below typical intensities 
used in focused ultrasound applications. 
 At low acoustic field intensities, gas bubbles in tissue will oscillate with relatively 
small amplitude in reference with a stable radius. The expansion and contraction of the 
gas bubbles is out of phase with the compression-rarefaction cycle of the wave. When the 
pressure field is in the compression phase the bubbles contract in size and during 
rarefaction they expand. Through a process called rectified diffusion, bubbles can enlarge 
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until they reach their resonance size after a considerable number of cycles. This type of 
cavitation is better known as stable or non-inertial cavitation. Bubbles in stable cavitation 
scatter the acoustic wave in all directions (assuming that during the oscillations the bubble 
retains its spherical shape) and can induce an effect of fluid rapid movement known as 
micro streaming. If the event is near a tissue boundary, it can produce high shear forces 
that can disrupt cell membranes.  This effect is used in HIFU applications for increasing 
transport of drugs or genes through impermeable cell membranes [13-14]. 
 Inertial cavitation occurs at higher field intensities where bubbles experience a 
rapid growth in size after very few cycles and gain inertia. When the compression cycle 
arrives, the supersized bubbles cannot absorb any more energy and collapse violently.  
The implosion results in a shock wave of equivalent acoustic pressure of several 
thousands of atmospheres and high temperatures of thousands of degrees. The 
accompanied bioeffects of inertial cavitation include the formation of water free radicals 
which are chemically active and tissue integrity destruction [32]. Additionally in in vitro 
ablation studies, bubbles formed due to boiling of the tissue undergoing inertial 
cavitation,  were found to contribute to thermal effects [33]. 
1.12 HIFU Safety Considerations 
 Patient safety during the delivery of HIFU applications depends on fine 
controlling of the aforementioned thermal and mechanical mechanisms.  
 Accidental thermal damage of critical structures (e.g. nerves) found near the focal 
region is a frequent safety concern that can be avoided by selecting an appropriate beam’s 
pathway. Unwanted thermal damage from excessive heating is by all means possible even 
in regions far from the focus and most importantly in tissues adjacent to interfaces.  
Depending on the acoustic impedance mismatch (air/tissue, bone/tissue, etc.) at these 
interfaces, strong reflections can interfere constructively with the incident acoustic field 
and form a standing wave in the post focal region. Hot “spots” formed at the nodes of the 
standing wave are more evident in low frequency sonications used in transcranial 
applications that are not adequately attenuated in the intervening tissue.  Additionally 
bones absorb acoustic energy at larger rate compared to soft tissues and their temperature 
can increase significantly even at mild acoustic pressures outside the focal region. The 
heat can conduct to adjacent soft tissues and induce secondary thermal injuries to critical 
structures. A typical example of the above adverse event is the transfer of heat from the 
conducting skull bone to brain surface or skin which can be avoided by applying external 
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cooling or by increasing the surface of the extracorporeal transducer. Tissue burns, pain 
during the procedure and visceral perforation are typical symptoms originating from 
thermal lesions. 
 Non-thermal or mechanical mechanisms related with cavitation events are always 
present since peak-rarefactional pressure fields used in HIFU can exceed the threshold 
for cavitation activation.  Cavitational activity of gas bodies that pre-exist in the lung or 
intestines can induce local tissue injury, including cell death, rupture and hemorrhage of 
blood vessels. These effects are results of non-inertial cavitation where during the 
collapse of the vibrating gas bubbles present in tissues a shock wave is produced. The 
formation of a shock wave is accompanied with a local increase of temperature by several 
thousand kelvins and a pressure of several hundred atmospheres.  
1.13 Current status of Focused Ultrasound applications. 
According to the State of the Field report published in 2017 by the Focused Ultrasound 
Foundation [34],  the current state of research and regulatory approval per application is 
shown in Figure 1.3. Data was collected by the Foundation from HIFU vendors and 
research sites worldwide demonstrates a very wide range of applications that vary from a 
conceptual to FDA approved stages.  
 
Figure 1.3: State of research and regulatory appoval categorized by indication. 
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The following sections run an overview of MRgFUS (Magnetic Resonance guided 
Focused Ultrasound Surgery) applications related to the developed composite tissue 
mimicking phantoms. 
1.13.1 Brain MRgFUS applications. 
 The ‘holy grail’ for researchers and manufacturers in MRgFUS field is of course 
the application and optimization of the technology in treating brain disorders [35]. The 
potential of performing noninvasive transcranial surgery to treat disorders of the central 
nervous system has many advantages and numerous attractive applications. Noninvasive 
thermocoagulation of brain tumors using focused ultrasound offers an alternative option 
to traditional surgery, radiotherapy and chemotherapy. Early attempts involved 
transcranial in vivo animal studies prepared with craniotomy that tested the feasibility of 
detecting temperature elevations with MRI at sub ablative temperatures [36].  
 With the introduction of phased array systems, animal brain models in ex vivo 
human skulls were monitored with MR thermometry and focal lesions were correlated 
with histology [37]. Skull induced phase aberrations were compensated using a time 
reversal mirror technique, which involved field amplitude corrections calculated by using 
implantable hydrophones through excised human skull [15] and sheep skulls [38]. 
Transcranial MRgFUS through intact skulls of primates demonstrated temperature 
distribution in critical structures like skin, skull and brain surface while thermally ablating 
brain tissue [39]–[41]. 
 Recently, in a phase I clinical trial patients with recurrent glioblastoma were 
treated with transcranial MRgFUS and the ultrasound focus was confirmed with MR 
temperature imaging [42]. Thermal coagulation of the tumor was not reached due to 
power limitation at the time of study, but extrapolation of the available data proved that 
ablation was possible with some device modifications while avoiding overheating the 
brain surface. Several studies have demonstrated that MRgFUS can be the future of 
functional neurosurgery. Essential tremor [43], [44] and Parkinson’s patients [45], [46] 
have been treated safely and effectively with MRgFUS thalamotomy. The improvement 
in some of the patients was immediate and tremor symptoms were suppressed even after 
the first year follow up. Following the completion of a randomized, double-blind, multi-
center clinical study designed for evaluating the safety and efficacy of MRgFUS 
thalamotomy by Elias et al.[47], FDA approved in 2016 the Exablate Neuro system for 
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the non-invasive treatment of essential tremor (ET) in patients who have not responded 
to medication. Patients with chronic neuropathic pain have also been treated and 
benefitted with considerable pain relief  [48]. Cadaveric models have been used to explore 
the feasibility of treating trigeminal neuropathic pain along with an in vitro gel phantom 
encased in a human skull fitted with multiple thermocouples to examine the temperature 
changes in skull base while targeting the trigeminal nerve region [49]. 
 MRgFUS has also been tested in the temporal disruption of the blood brain barrier 
(BBB) in animal models [50]–[52]. In vivo small animal and non-human primates studies 
showed that the disruption was possible in a range of frequencies allowing deep brain 
penetration and focus formation with minor adverse effects to cerebral tissue (minor 
extravasation) and without functional deficits [52], [53]. FUS has been applied in an 
attempt to treat efficiently Alzheimer’s neurodegenerative disease in mouse models [54], 
[55] by temporarily disrupting the BBB and allowing large molecules of diagnostic and 
therapeutic agents to extravasate in the brain parenchyma. The introduction of ultrasound 
microbubbles agent during low intensity sonication proved in histological assessments to 
reduce the number of subjects experiencing petechiae compared to subjects treated at 
higher peak negative pressure fields [54]. The opening of the barrier was monitored with 
MRI and was confirmed in vivo with gadolinium-based, contrast enhanced MR 
sequences. 
 Sonothrombolysis is another application of therapeutic ultrasound that receives 
interest. In vitro studies of human blood clots treated with pulsed FUS in combination 
with a thrombolytic agent known as recombinant tissue plasminogen activator (rtPA) 
proved to enhance thrombolysis rate compared to rtPA treatment alone [56]. Similarly in 
another in vitro study, enhanced lytic treatment efficacy for both tPA and liposome- 
loaded tPA with the parallel application of a 120 kHz unfocused ultrasound has been 
demonstrated [57]. The possibility of destructing transcranially an in vitro human clot 
using a hemispheric phased array FUS transducer in the absence of a thrombolytic agent, 
has been demonstrated [58]. In an in vivo rabbit aorta [59] and rabbit ear marginal vein 
[60] model studies, clots were treated with pulsed ultrasound with the synergy of rtPA 
whereas in other similar in vivo studies safe temperature limits and efficacy of treatment 
protocols was investigated [61], [62]. Currently clinical trials using sonothrombolysis are 
underway such as the CLOTBUST (Combined Lysis of Thrombus in Brain ischemia 
using transcranial Ultrasound and Systemic Recombinant Tissue-Type Plasminogen 
Activator rt-PA) [63], the interventional management of treating stroke patients (IMS) 
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[64] and the transcranial low-frequency ultrasound- mediated thrombolysis in brain 
ischemia (TRUMBI) [65]. The TRUMBI trial that uses non-focused, low-frequency (300 
kHz) ultrasound showed an increased hemorrhage risk as compared to tPA alone. A recent 
simulation study [66] demonstrated that the low frequency used in this trial possibly 
resulted to unwanted standing waves with pressure that exceeds the threshold of inertial 
cavitation. This not only could possibly lead to increased hemorrhage risk, but also to 
elevated temperatures in the brain. Finally a randomized, placebo-controlled study with 
continuous transcranial 2 MHz Doppler ultrasound and perflutren-lipid microspheres was 
performed [67]. Table 1-5 summarizes the most important transcranial MRgFUS brain 
ablation studies. 
 
Table 1-5 : Summary table of important transcranial MRgFUS brain ablation studies. 
Study type No.  Purpose Results and Adverse 
events 
Animal study (rabbit thigh and 
brain tissue) and soft tissue 
phantom with intervening ex 
vivo human skull [37]. 
4 To test a prototype MRI-compatible 
focused ultrasound phased array (500-
elements operated at 0.7-.8 MHz) 
system for transcranial brain tissue 
ablation 
Results: Sharp temperature 
elevations were produced. High-
power sonications (600 –1080 W) 
produced peak temperatures up to 
55°C and focal lesions were 
consistent with thermal tissue 
damage. Lesion size increased with 
increasing peak temperature. 
 
Adverse events: Skin burns 
 
Animal study (rhesus monkeys) 
with intact skull [68]. 
3 To determine the amount of skull heating 
in an animal model with a head shape 
similar to that of a human. 
Results:   Skin and skull surface 
was protected by applying surface 
cooling. MRI thermometry was 
shown to be useful in detecting the 
tissue temperature distribution next 
to the bone, and it should be used to 
monitor the brain surface 
temperature. Acoustic intensity (20 
s sonications) were adequate for 
ablating human brain provided that 
surface cooling is used. 
 
Adverse events: Brain surface 
heating 
 
Clinical study for treating 
transcranially glioblastoma 
patients [69]. 
3 To assess the feasibility of transcranial 
magnetic resonance imaging-guided 
focused ultrasound surgery in 
glioblastoma patients. 
Results:  Thermal coagulation of the 
target was not achieved due to 
device power limitation. 
Extrapolation of the results 
suggested that ablation will be 
possible without overheating the 
skull. 
 
Adverse events: Sonication-related 
pain in one patient from heating of 
the dura, suggested that the 
targetable regions of the brain may 
be limited to deep, central locations 
in the brain. 
 
Randomized controlled clinical 
trial for patients with moderate-
to-severe tremor that hat had 
not responded to at least two 
trials of medical therapy [47] . 
76(3:1) MRI-guided focused ultrasound unilateral 
thalamotomy applied transcranially for the 
treatment of medication-refractory 
essential tremor. 
Results: Hand-tremor scores 
improved more after focused 
ultrasound thalamotomy (from 18.1 
points at baseline to 9.6 at 3 
months) than after the sham 
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procedure (from 16.0 to 15.8 
points); the between-group 
difference in the mean change was 
8.3 points (95% confidence interval 
[CI], 5.9 to 10.7; P<0.001).  
 
Adverse events: In the thalamotomy 
group reported gait disturbance in 
36% of patients and paresthesias or 
numbness in 38%; these adverse 
events persisted at 12 months in 9% 
and 14% of patients, respectively. 
Intra-procedural sensations 
described as pain in the form of 
‘heat’ or ‘pressure’ were resolved 
within seconds after the delivery of 
acoustic energy. 
 
Uncontrolled clinical trial of 
patients chronic therapy-
resistant neuropathic pain [48]. 
12 To apply the new transcranial magnetic 
resonance imaging-guided focused 
ultrasound (tcMRgFUS) technology to 
perform noninvasive central lateral 
thalamotomies (CLTs) as a treatment for 
chronic neuropathic pain. 
Results: tcMRgFUS represents a 
noninvasive, precise, and radiation-
free neurosurgical technique for the 
treatment of neuropathic pain. The 
procedure avoids mechanical brain 
tissue shift and eliminates the risk 
of infection. The possibility of 
applying sonication thermal spots 
free from trajectory restrictions 
should allow one to optimize target 
coverage. The real-time continuous 
MR imaging and MR thermometry 
monitoring of targeting accuracy 
and thermal effects are major 
factors in optimizing precision, 
safety, and efficacy in an outpatient 
context. 
 
Adverse events: Bleeding in the 
target with ischemia in the motor 
thalamus that occurred in one 
patient possibly attributed to 
cavitation effects or excessive 
heating. Study recommended 
maintaining sonication temperatures 
below 60 ºC. 
 
1.13.2 Bone MRgFUS applications. 
 Bone metastases are a frequent complication observed in patients suffering from 
advanced stages of cancer [70], [71]. More than 60 % of advanced breast and prostate 
cancers, which are the most common malignancies in adults, metastasize in skeletal sites 
[72], [73]. Metastases in bones from other types of primary solid tumors like lung, 
kidneys, thyroid, bladder and melanoma also occur, but at a lower prevalence.  
Pain is the most common and distressing symptom associated with bone metastases [74]. 
About 83 % of patients with bone metastases complain of pain at some point with wide 
variation in pattern and severity [75]. Therefore a lot of effort has been made in 
developing strategies to manage pain of patients with bone metastases and improve life 
quality.   
 For cases where there is a multifocal spread of the disease in the skeleton, pain 
palliation is controlled, but not limited to, by systemic therapies like hemi body irradiation 
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[76], [77], administration of bone-seeking radiopharmaceuticals [78]–[80], analgesic 
drugs and  bisphosphonates [81], [82]. The gold standard though for controlling localized 
metastatic bone pain is external beam radiotherapy (EBRT).  The mechanism underlying 
the analgesic effect of radiation in bone pain is not completely understood, but recent 
animal studies suggested that palliation is a result of reduced cancer burden and reduced 
osteolysis [83]. The increasing number of patients with painful bone metastases that are 
insufficiently palliated by radiation therapy alone, indicate the need for additional 
palliative localized treatments to maintain quality of life for the patients [84], [85]. 
 Thermal ablation techniques have been extensively used as alternatives to 
radiotherapy for the curative and palliative treatment of primary or secondary bone 
tumors. The most commonly used techniques are radiofrequency ablation [86], 
microwave ablation [87] and laser ablation [88]. These techniques induce thermal 
coagulation necrosis by delivering high temperatures above 50 ºC to the target. A 
hypothermia technique known as cryoablation is also used by inducing cryogenic 
temperatures to the targeted tissue lower than -40 ºC [89].  A common characteristic of 
these techniques is that all require an invasive approach for implanting their delivery 
probes near the targeted tissue. The emerging application of FUS for the treatment and 
palliation of bone tumors, recently receives a lot of research interest [90]. Combined with 
MRI, FUS offers a completely non-invasive, and safe treatment option with excellent 
monitoring of the procedure. The low thermal conductivity in the periosteum and bone 
cortex confines the thermal damage in proximity to the treated site protecting the 
surrounding tissue. Additionally, the high ultrasonic absorption in bones reduces the 
energy levels required to induce the same thermal effect compared to soft tissues.  
 The major therapeutic goal of FUS applications in palliating pain from bone 
metastases is the denervation of the periosteum which contains pain-reporting nerve 
fibers through thermal coagulation necrosis [90]. The study by Catane et al. [91], was the 
first attempt to assess the safety and initial efficacy of MRI guided FUS (MRgFUS) for 
the palliation of pain caused by bone metastases. The treated targets involved lesions in 
the humerus, iliac bone, femur bone, ischium bone, sacrum and sacro-iliac joints. Pain 
relief was noted in the majority of patients from first assessment and prolonged 
improvement in pain score and reduction of analgesics dosage was reported throughout 
the follow up period. No severe adverse events were reported with exemption a slight 
increase of pain for few patients in the immediate post-procedural period that disappeared 
before first follow up. More clinical work in the same area were reported by Gianfelice 
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et al. [92], Napoli et al. [93], Liberman et al. [94],  Hurwitz et al. [95] and Huisman et al. 
[96]. In a recent report by Joo et al. [97], the safety and effectiveness of the ExAblate 
Conformal Bone system for treating painful bone metastases was tested. Compared to the 
original MRgFUS systems where the transducer is fixed in the MR table, this new design 
has its transducer strapped on the patient with external connections. The obvious 
advantage of such configuration is that it enables easy and comfortable access to multiple 
anatomical locations. The patient position is more comfortable because lying on a painful 
body site is avoided, thereby decreasing discomfort experienced during treatment. Table 
1-6 summarizes the most important MRgFUS bone ablation studies. 
Table 1-6: Summary table of important MRgFUS bone ablation studies. 
Study type No.  Purpose Results and Adverse 
events 
MR-guided focused ultrasound 
surgery for the palliation of 
pain in patients with bone 
metastases--preliminary 
clinical experience [91]. 
13 To evaluate the safety and initial 
efficacy of MRgFUS for the palliation 
of pain caused by bone metastases, in 
patients for whom other treatments are 
either not effective or not feasible. 
Results: Patients reported prolonged 
improvement in pain score and/or 
reduced analgesic dosage. 
 
Adverse events: No device-related 
severe adverse events were 
recorded. One patient was unable to 
tolerate the sonication-related pain 
and the treatment was stopped. 
 
A multicenter study using 
MRgFUS for palliation of bone 
metastases pain [94]. 
31 To evaluate the safety and efficacy of 
MRgFUS palliative treatment of bone 
metastases was conducted in patients 
suffering from painful metastatic bone 
lesions for which other treatments were 
either ineffective or not feasible. 
Results: The results suggest that 
MRgFUS has the ability to provide 
an accurate, effective, and safe 
noninvasive palliative treatment for 
patients with bone metastases. 
 
Adverse events: None 
 
Multicenter phase III controlled 
clinical trial of treating patients 
with painful bone metastases 
with MRgFUS [98]. 
147(3:1) This study assessed the safety and 
efficacy of magnetic resonance-guided 
focused ultrasound surgery (MRgFUS), 
a noninvasive method of thermal tissue 
ablation for palliation of pain due to 
bone metastases. 
Results: MRgFUS is a safe and 
effective, noninvasive treatment for 
alleviating pain resulting from bone 
metastases in patients that have 
failed standard treatments. 
 
Adverse events: The most common 
treatment-related adverse event 
(AE) was sonication pain, which 
occurred in 32.1% of MRgFUS 
patients. Two patients had 
pathological fractures, one patient 
had third-degree skin burn, and one 
patient suffered from neuropathy. 
Observational cohort study for 
feasibility of volumetric MRI-
guided high intensity focused 
ultrasound (MR-HIFU) for 
painful bone metastases [96]. 
11 The first experience with volumetric 
MR-HIFU for palliative treatment of 
painful bone metastases and evaluate the 
technique on three levels: technical 
feasibility, safety, and initial 
effectiveness. 
Results: At 3 days after volumetric 
MR-HIFU ablation, pain scores 
decreased significantly and 
response was observed in a 6/11 
(55%) patients. At 1-month follow-
up, which was available for nine 
patients, pain scores decreased 
significantly compared to baseline 
and 6/9 patients obtained pain 
response (overall response rate 
67%). 
 
Adverse events: No treatment-
related major adverse events were 
observed 
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1.13.3 Breast MRgFUS applications 
 In 2012 about 1.7 million new cases of breast-cancer were diagnosed worldwide 
according to the World Cancer Research Fund international [99]. Breast cancer is the 
most common malignant disease in women [100]. Radical mastectomy is considered the 
gold standard therapy [101], [102]. Another key option for breast cancer management is 
the breast conserving therapy (BCT) which is a less invasive therapy that potentially 
improves cosmesis [103]. The option of BCT is offered in combination with adjuvant 
treatment modalities such as radiotherapy, chemotherapy, and hormonal therapy [103]. 
BCT although invasive can be applied in patients with concomitant diseases, or elderly 
patients who are excluded from traditional surgery. 
 By contrast, focused ultrasound surgery (FUS) has the potential to precisely 
deliver coagulation to a specific location in soft tissue with an accuracy of 1 mm through 
the intact skin [104]. FUS can produce temperature elevations of 50 °C to 80 °C at the 
focus with a 10 s sonication. The delivery of this heating instantaneously induces cellular 
death in normal and tumor tissue  [105].  Contrast enhanced MRI is usually the method 
of choice in breast cancer screening since it can reveal lesions that are undetected by 
conventional mammograms and sonograms [106], [107]. Moreover, MRI can 
noninvasively measure the ultrasound-induced temperature [108], [109]. In recent years, 
the technical feasibility of conducting FUS therapy guided by MRI has been demonstrated 
and improved in terms of accurate and fast temperature control in ex vivo tissue and 
animal studies in vivo [108]. This first experience of MRgFUS for human treatment of 
benign breast tumors was reported by Hynynen et al. in 2001 [110]. In this study it was 
reported that breast fibroadenomas in nine patients were treated with FUS. Eight out of 
the 11 lesions treated with FUS demonstrated complete or partial ablation. In 2001 Huber 
et al. [111] treated a 56-year-old patient with breast cancer using FUS. Post procedural 
pathologic examination indicated that FUS induced lethal and sub lethal tumor ablation 
without damage to the surrounding healthy tissue. In a randomized clinical trial by Wu et 
al [112], 48 women with biopsy confirmed breast cancer were randomly separated to two 
groups. The first control group (n=25) received modified radical mastectomy whilst the 
second group (n=23) was first treated with extracorporeal ultrasound guided HIFU 
ablation followed by modified radical mastectomy. The study concluded for the first time 
that US-guided HIFU is an effective, safe, and feasible treatment modality for localised 
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breast cancer with well-demarcated margins. The authors recognised that supplementary 
investigation is needed before considering extracorporeal FUS as a standard treatment 
option for breast cancer.  
 After these initial studies, Gianfelice et al. reported the treatment of 12 patients 
with invasive breast cancer using MRgFUS prior to surgery [113]. Histopathology of 
resected tumor in 9 patients showed that a mean of 88 % cancer tissue was necrosed. 
Residual tumor was observed in all cases at the periphery of the tumor mass, indicating 
the need for safety margins greater than 5 mm. In agreement with these findings, Zippel 
et al. [114] conducted the first phase of a human trial using MRgFUS ablation for breast 
cancer, using the Insightec’s ExAblate 2000 system. Ten patients were treated one week 
prior to lumpectomy. They reported complete necrosis in only two patients (20%), and 
concluded that there were still several issues that needed to be resolved before MRgFUS 
can become a gold standard treatment for breast cancer. Furusawa et al. [115] conducted 
human trials with MRgFUS in 30 patients with breast cancer. All patients followed radical 
mastectomy after FUS treatment. On pathologic examination the mean percentage of 
tumor necrosis was 97 % of tumor volume. In another study Kovatcheva et al. [116] 
conducted clinical trials on 42 women with 51 fibroadenomas using ultrasound-guided 
unilateral or bilateral FUS. Ultrasound-guided FUS was well tolerated by the patients and 
the preliminary results showed that it could be an effective noninvasive alternative to 
surgery for breast fibroadenomas. Table 1-7 summarizes the most important MRgFUS   
breast ablation studies. 
Table 1-7: Summary table of important MRgFUS breast ablation studies. 
Study type No.  Purpose Results and Adverse 
events 
Clinical feasibility study 
treating patients of pathological 
breast tissue with MRgFUS 
[110]. 
9 To test the feasibility of noninvasive 
magnetic resonance (MR) imaging-
guided focused ultrasound surgery 
(FUS) of benign fibroadenomas in the 
breast 
Results: Temperature elevations 
ranging between 12.8 ºC - 49.9 
degrees ºC from the planned 
sonications were measured with 
MR thermometry. 8 of the 11 
lesions treated demonstrated 
complete or partial lack of contrast 
material uptake on post therapy T1-
weighted images. Three lesions 
showed no marked decrease of 
contrast material uptake. This lack 
of effective treatment was most 
likely due to a lower acoustic power 
and/or patient movement that 
caused misregistration. 
 
Averse events: No adverse effects 
were detected, except for one case 
of transient edema in the pectoralis 
muscle 2 days after therapy. 
 
A randomized controlled 
clinical trial of US guided high-
intensity focused ultrasound 
48 (1:1) To explore the possibility of using HIFU 
for the treatment of patients with 
Results: Pathologic findings 
revealed that HIFU-treated tumor 
cells underwent complete 
 24 
 
ablation for the treatment of 
patients with localized breast 
cancer [112]. 
localized breast cancer in a controlled 
clinical trial. 
coagulative necrosis, and tumor 
vascular vessels were severely 
damaged. Immunohistochemical 
indicated that the treated tumor cells 
lost the abilities of proliferation, 
invasion, and metastasis. 
 
Adverse events: No adverse events 
were detected, except for one case 
of transient edema in the pectoralis 
muscle 2 days after therapy. 
 
A preliminary phase I study for 
the use of MR guided focused 
ultrasound in breast cancer 
patients [114]. 
10 To examine the possibility of ablating 
breast carcinoma using MRIgFUS in 
place of lumpectomy. 
Results: Two patients had a 
complete pathological response. 
The remaining 8 patients had 
varying amounts of residual tumor; 
2 had microscopic foci of residual 
carcinoma, 3 had 10% residual 
tumor, and 3 had 10-30% of 
residual tumor. 
 
Adverse events: Procedure related 
pain required additional analgesia 
and sedation. One patient suffered 
from a second degree skin burn 
over the treated area. This adverse 
even suggested a better cooling is 
required whilst the procedure 
should be limited to peripheral 
lesions of at least 1 cm from skin 
and yet not in proximity to chest 
wall. 
 
A multicenter ultrasound-
guided high-intensity focused 
ultrasound treatment of breast 
fibroadenomas [116]. 
42 To assess the clinical outcome and 
safety of ultrasound (US)-guided high-
intensity focused ultrasound (HIFU) in 
patients with breast fibroadenomas 
(FA). 
Results: The FA mean baseline 
volume was 3.89 ml (0.34–19.66 
ml). At 2-month follow-up, the 
mean volume reduction was 
33.2% ± 19.1% and achieved 
significance at 6-month 
(59.2% ± 18.2%) and 12-month 
(72.5% ± 16.7%) follow-up. 
 
Adverse events: Related side effects 
as superficial skin burn with blister-
like aspect in three patients and 
hyperpigmentation over the treated 
area in one patient were transient 
and resolved spontaneously. In one 
patient, asymptomatic subcutaneous 
induration persisted at the end of 
the study. 
 
 
1.14 Potential usefulness of the designed phantoms. 
 The usefulness of developing application specific mimicking phantoms in a quest 
of researching and overcoming patient safety or procedure efficacy limitations recognized 
from the results of a literature overview in the previous section are presented below.    
 The head mimicking phantom can be used to investigate the efficacy of different 
HIFU devices. Literature review indicated that due to power limitations, ablative 
temperatures in deep seated tumours cannot be reached. Precise targeting in transcranial 
applications depends on the algorithm used to correct phase aberrations induced by the 
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human skull. The designed mimicking head phantom can be used to assess the effect of 
targeting accuracy, focal temperature and spatial distribution and using the 
aforementioned as quality criteria to optimize the algorithms. The effectiveness of cooling 
systems in decreasing brain surface temperature and the induced hot spots resulting from 
the development of standing waves near skull base can also be a matter of investigation 
using the head phantom. 
 Although palliative HIFU treatments for painful bone metastases is already an 
FDA approved procedure there is still room for improvement. Due to the great variety of 
bone shapes and accesses to targets, a customizable bone mimicking phantom will be 
valuable for assessing a priori the efficacy and safety of the treatment. The safety and 
efficacy of thermal protocols that employ novel approaches like volumetric sonications 
for increased treatment envelope can also be tested. A suitable bone phantom can be used 
to assess the functionality of newly developed HIFU transducers that provide flexibility 
in the delivery of the treatment to patients that cannot tolerate particular positioning. 
 A breast rib phantom can be used to test improved cooling systems in a search of 
reducing skin burns as observed in clinical studies. These studies were limited to targeted 
breast tissue which was far enough from tissue/air or tissue/chest wall interfaces. This 
was done to avoid excessive heating from intense ultrasound reflections and high acoustic 
absorption of ribs indicating the need to improve the technology to include patients with 
lesions that don’t qualify for these criteria. The designed phantom can be used to test the 
safety and efficacy of new HIFU treatment devices that overcome the aforementioned 
limitations. 
1.15 Aim and Objectives 
The safety and efficacy of various applications that use HIFU as a thermal ablation 
treatment modality, have been extensively assessed through numerous animal studies. 
The results of these studies identified important safety and efficacy related issues and 
suggested that some applications are not ready for treating humans in their current status. 
The need for testing new or improved hardware and software HIFU related features, raises 
the question whether this can be done by using solely phantoms instead of animals. The 
use of suitable phantoms is expected to: a) reduce the number of animal studies, b) 
conduct experiments under controlled conditions and c) reduce the cost, implications and 
complexity associated with animal studies. Overall the use of suitable phantoms for 
testing HIFU thermal protocols will accelerate the development of several HIFU 
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applications and provide clinicians with a new treatment alternative that demonstrates 
important advantages over conventional (open surgery, chemotherapy, radiotherapy, 
other thermally ablative techniques, etc.).  
 
The aim described above is expected to be accomplished by fulfilling the following 
research objectives: 
 
 A literature review will be held to identify procedure related obstacles that halt 
some HIFU applications from becoming a standard treatment option. This 
information will be taken into consideration during phantom designing. The 
phantoms should allow researchers to exploit these defects for different treatment 
protocols.  
 A second literature review will attempt to summarize the current state-of-the-art 
in HIFU phantoms. The knowledge gained from this review will be used as the 
base of designing improved or novel phantoms. 
 Important tissue intrinsic acoustic and thermal properties that govern its 
interaction with ultrasound will be identified. Following a literature review the 
range of values of these tissue specific properties will be extracted.  
 The corresponding properties of candidate phantom materials for replicating soft 
and bone tissue will be assessed through appropriate techniques. This will be done 
in order to check their matching with the values extracted from literature for 
human tissues. Adequate matching is vital for reproducing realistically the 
interaction of ultrasound in phantom materials and translating the results for 
human subjects. 
 A set of three composite phantoms will be fabricated, each representing a different 
anatomy that consists of soft and bone tissue. Each composite phantom will 
correspond to a different application of HIFU ablation. 
 The functionality of the fabricated phantoms for assessing safety and treatment 
efficacy issues will be demonstrated. This will involve exposing each phantom to 
a focused ultrasound field while monitoring the spatial distribution of thermal 
energy in quasi real time. This will be achieved by acquiring appropriate MRI 
images that encode temperature increment to signal phase change using the proton 
resonance frequency shift technique. 
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1.16 Thesis structure 
 This section presents a brief outline of the introductory Chapter 1 and the 
remaining Chapters that follow. 
 Chapter 1 introduces the reader to the main physical concepts of ultrasound that 
includes a short description of its wave-like characteristics. A description of ultrasound 
production process by transducers that exploit the piezoelectric effect,  the different types 
of transducers available and the main features of the instrumentation involved is 
presented. The following sections cover the use of high intensity ultrasound in medicine, 
the interaction types of ultrasound with biological tissue and the induced thermal and 
mechanical bioeffects. The chapter closes with an overview of HIFU applications (brain, 
bone and breast) related to developed phantoms. 
 In Chapter 2 the current state-of-the-art of HIFU phantoms found from literature 
is reported.  The phantoms are subcategorized in groups depending on the gelling agents 
used to replicate soft tissue. Details of the additives used to control the properties of the 
gels is given. Bone phantoms and composite phantoms that combine biological tissue 
with artificial materials to replicate soft and bone tissue are also presented. 
 Candidate materials for replicating soft and bone tissue are presented in Chapter 
3. Moreover agar gels doped with silica dioxide/evaporated milk and ABS polymer were 
tested as mimicking materials of soft and bone tissue respectively. The method for 
characterizing their acoustic properties (attenuation coefficient and speed of sound) using 
pulse immersion techniques is described. A method for deducing the thermal conductivity 
and diffusivity coefficients of the soft tissue mimicking agar gels using numerical 
modelling of MR thermometry data is also presented. 
 In Chapter 4 the composite phantoms fabrication process is described. 
Geometrically accurate replicas of the bone parts are printed in ABS using fusion 
deposition modelling (FDM) technology. The digital 3D bone models were reconstructed 
by segmenting bone tissue from adult human CT images. The formation of three 
composite phantoms is demonstrated (skull-brain, bone-muscle, rib-breast) by molding 
agar gels either inside or around the bone ABS replicas. 
 Chapter 5 introduces the reader to MR thermometry, which is the most popular 
method for monitoring quantitative temperature elevations induced by HIFU sonications 
under MRI guidance. The theory of Proton Resonance Frequency Shift (PRFS), which is 
the primary choice of MR Thermometry techniques due to its wide temperature range 
linearity and independence from tissue type, is explained thoroughly. The next section 
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presents the development and workflow of a custom coded graphic user interface in 
MATLAB that takes MRI images as inputs and produces temperature maps using the 
PRFS technique. Finally the results of relaxometry conducted to characterize the T1 and 
T2 relaxation times of the developed soft tissue mimicking agar gel phantoms are 
reported. 
 Chapter 6 describes a series of functionality tests for each of the developed 
composite phantoms. Each phantom was sonicated with a 1 MHz single element 
spherically focused HIFU transducer with appropriate experimental setups under MRI 
guidance. By observing the temporal evolution and spatial distribution of temperature 
using the aforementioned GUI, the usefulness of the phantoms for testing these thermal 
protocols was proven. More specifically it was possible to observe the heating profile for 
different exposure parameters, the development of “unwanted” hot spots especially at 
tissue/bone interfaces, the effect of beam “starvation” and defocusing from intervening 
bone in transmit-through applications, etc. 
 Chapter 7 describes the work done to assess the compatibility of an MR-
compatible robotic system used to drive the HIFU transducer during the aforementioned 
functionality tests inside the bore of the MRI scanner. The system’s compatibility was 
assessed on the basis of signal to noise ratio drop and visual observation for induced 
image artifacts. 
 The final Chapter 8 summarizes the key findings of the thesis and emphasizes the 
contribution of the work done to current knowledge in the field. The limitations of the 
developed tissue mimicking composite phantoms are commented. Suggestions for 
overcoming these limitations or improving these phantoms are made in the form of future 
work proposals. 
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2 State-of-the art of FUS phantoms 
2.1 Phantom models in Biomedical Research 
 A phantom usually refers to any artificially made object used for testing. In 
biomedical research, phantoms can be manufactured to replicate realistically the subjects 
or conditions of different applications, they can accommodate different tools suitable for 
parametric measurements or can be used in absolute and reference dosimetry studies. The 
development of such phantoms reduces the necessity of using animal models. 
 The use of animals in research has always been the subject of debate between the 
scientific community and animal welfare organizations. The ethical dilemma that much 
of the discussion revolves around is whether the benefits for human kind from research 
counterbalance the exploitation of animal rights. Animal use for research in developed 
countries is controlled by national committees that use targeted regulations to assess 
submitted research proposals. The proposals are usually reviewed based on the value and 
the originality of the potential outcomes and seek for justification of the inability to use 
alternatives.  The principles of testing alternatives better known as the Three R’s (3Rs), 
first described by Russell and  Burch in 1959 [117], are included in national legislation 
worldwide that govern the use of animals in science. According to the National Centre 
for the Replacement, Refinement and Reduction of Animals in Research UK, these 
principles are defined as [118] : 
“Replacement:  Methods that avoid or replace the use of animals defined as 
'protected’ under the Animals (Scientific Procedures) Act 1986, amended 2012 
(ASPA) in an experiment where they would have otherwise been used. Protected animals 
are all living vertebrates (except humans), including some immature forms, and 
cephalopods (e.g. octopus, squid, cuttlefish). Replacement includes the use of: 
1) Human volunteers, tissues and cells. 
2) Mathematical and computer models. 
3) Established animal cell lines, or cells and tissues taken from animals killed solely for 
this purpose (i.e. not having been subject to a regulated procedure) 
4) Immature forms of vertebrates, or invertebrates, such as Drosophila and nematode 
worms. 
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Protected forms are embryonic and fetal forms of mammals, birds and reptiles during the 
last third of their gestation or incubation period, fish and amphibians once they can feed 
independently, and cephalopods at the point they hatch. Embryonic and fetal forms are 
protected from an earlier stage of development if they are going to live beyond the stage 
described above and the procedure is likely to cause them pain, suffering, distress or 
lasting harm after they have developed to that stage. 
Reduction: Methods that minimize the number of animals used per experiment or study, 
either by enabling researchers to obtain comparable levels of information from fewer 
animals, or to obtain more information from the same number of animals, thereby 
avoiding further animal use. Examples include improved experimental design and 
statistical analysis, sharing data and resources (e.g. animals and equipment) between 
research groups and organizations, and the use of technologies, such as imaging, to enable 
longitudinal studies in the same animals. 
Refinement: Methods that minimize the pain, suffering, distress or lasting harm that may 
be experienced by the animals. Refinement applies to all aspects of animal use, from the 
housing and husbandry used to the scientific procedures performed on them. Examples 
of refinement include, using appropriate anaesthetics and analgesics, avoiding stress by 
training animals to cooperate with procedures such as blood sampling, and providing 
animals with appropriate housing that allows the expression of species-specific behaviors, 
such as nesting opportunities for mice.” 
2.2  Transcranial FUS phantom models   
 The potential of treating brain disorders including the revolutionary application of 
blood brain barrier (BBB) disruption using a noninvasive technology like FUS, promises 
to revolutionize current treatment approaches. The access of FUS in deep seeded brain 
targets without harming healthy tissue is intriguing for many research groups around the 
globe. The variety of models expands from purely cadaveric models, ex vivo skulls with 
tissue mimicking phantom gels and tissue mimicking phantom skulls with ex vivo tissue. 
Purely cadaveric models 
 Strong aberrations both in phase and in amplitude were corrected by energy 
adapting focusing on a clinical brain FUS system composed of 512 ultrasonic elements 
in a cadaver head model [119]. Adaptive focusing was optimized using acoustic radiation 
force imaging (ARFI) which encoded tissue displacement. Tissue displacement at focus 
 31 
 
is considered of being linearly dependent to acoustic intensity at focus. This displacement 
power linearity assumption was confirmed in the same study in an in vitro lamb brain 
model. Displacement measurements were directly inverted to correct for the skull induced 
aberrations. The results showed that acoustic intensity at focus was 2.2 times higher than 
the uncorrected beam and 1.5 higher from the beam treated with adaptive focusing 
corrections produced by simulated time-reversed computed tomography data of the skull.   
 The accuracy of FUS targeting the trigeminal nerve in four unpreserved cadaver 
heads under MRI guidance was presented by Monteith et al. [49]. This was a feasibility 
study for testing MR guided FUS as a possible therapeutic method of treating neuropathic 
pain of trigeminal neuralgia.  Significant focal heating in the absence of unwanted skull 
base and surrounding structures heating was made possible by the inclusion of no-pass 
regions through the petrous bone. The work of Chauvet et al. [120] tested the accuracy of 
MR guided FUS in a cadaver head in targeting part of the thalamic nucleus ventralis 
intermedius, which is a brain structure related with essential tremor. Using a 1 MHz FUS 
phased array a millimetric targeting accuracy was possible and temperature elevation at 
the target was detected using the proton resonance frequency shift thermometry. The 
authors commented the limitation of the model due to its lack of vascularization that 
controls thermoregulation. 
2.2.1 Ex vivo skull with tissue mimicking phantom models 
 Eames et al. [121] suggested a model consisting of an ex vivo human skull 
combined with a tissue mimicking hydrogel to replicate brain tissue. The gel was melted 
in a microwave and oven and was molded inside the skull. This model was used to 
investigate the effect of scalp hair in the focal temperature elevation during transcranial 
treatments. The head phantom was covered with human hair wig. Sonications at 220 kHz 
showed no measurable change in focal temperature elevation whereas for a higher 
frequency sonication at 710 kHz a 17 % drop was observed. In a recent publication by 
Eames et al.  [122], it was reported that their previous head model was upgraded by adding 
a layer of skin mimicking material. The skin layer was made from the same tissue 
mimicking hydrogel that the brain was created from. The authors made comparative 
studies between the latest model, the head model in the absence of the skin layer and a 
cadaver. The cadaveric phantom model, gel-filled skull model, and full head phantom 
model had heating efficiencies of 5.3, 4.0, and 3.9 °C/(kW/s), respectively, compared to 
a sample clinical heating efficiency of 2.6 °C/(kW/s). 
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2.2.2 Skull mimicking phantom with ex vivo tissue 
 Damianou et al [123] designed in a computer aided design (CAD) software a skull 
phantom made out of Acrylonitrile Butadiene Styrene (ABS) thermoplastic polymer 
which was printed in a rapid prototyping machine. The ABS material’s attenuation 
coefficient was measured using the transmission-reception method and was found close 
to human skull. The thickness of the phantom was chosen appropriately so as to achieve 
the same attenuation effect as in the case of a human skull. The feasibility of focusing 
ultrasound through skull was tested under MRI guidance in a gel phantom and an ex vivo 
freshly excised tissue using a single element transducer operating at 0.5 MHz or 1 MHz. 
Temperature elevation detected with a fast spoiled gradient recalled (FSPGR) pulse 
sequence was confirmed with the 0.5 MHz beam. 
2.3  Bone mimicking phantoms 
 Clarke et al [124] used liquid epoxy resin in conjunction with a hardener to 
simulate cortical bone. The measured acoustic properties of the developed material were 
3.7 dB/cm at 1 MHz for the attenuation coefficient and 3168 m/s velocity. Ultrasound 
velocity in the bone mimicking material was within range but the attenuation coefficient 
was significantly lower from published value of 8.36 dB/cm at 1 MHz by Tavakoli et 
al[125].In the same study of Clarke et al an attempt to simulate trabecular bone was made 
by mixing in the liquid epoxy resin gelatine cubic granules (1 mm each side) before 
pouring in to moulds and left to harden. The mixture’s acoustic properties were tested for 
different degrees of porosity by varying the concentration of gelatines granules to the total 
volume. The trabecular phantom material demonstrated ultrasonic characteristics similar 
to those of trabecular bone with high dependence in the degree of porosity. The authors 
reported acoustic speeds in the range of 1844 m/s to 3118 m/s and attenuation between 7 
to 17 dB/cm at 0.5 MHz. In a similar study by Tatarinov et al [126] trabecular bone was 
mimicked by mixing 1 mm3 soft rubber  granules in an epoxy resin matrix to control 
porosity. The authors also added particles of natural bone which was first burned and 
grinded to control the mineral content of the phantom.  In a more recent study of 
Tatarinov et al [127] cortical bone was modelled using tubular specimens  of different 
polymers and polymer composites like ebonite, acrylic plastic, fiberglass and carbon fiber 
plastic. The polymers increased in stiffness with measured longitudinal velocity ranging 
from 2200 m/s in ebonite to 4400 m/s in carbon fiber plastic that covered that velocity 
range of poorly mineralize to hypermineralized compact bone. A multi-layered model of 
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compact bone was also presented to simulate increasing porosity between endosteum and 
periosteum. Pores in the layers were manufactured by randomly mixing rubber particles 
of bulk velocity equal to 1500 m/s in a homogeneous solid epoxy matrix with bulk 
velocity of about 2700 m/s. Hodgskinson et al [128] reported the use of Perspex plates as 
a cortical bone mimicking material with reported speed of sound  of 2657 m/s, attenuation 
coefficient of 5.3 dB/cm-MHz and density of 1180 kg/m3.. 
2.4 Soft tissue mimicking gel phantoms for ultrasound applications 
Though there is a broad range of tissue mimicking phantoms available for ultrasound 
imaging, there are few material substitutes made specific for FUS, particularly which 
possess tissue-like properties. Although FUS corresponds to ultrasound propagation 
through a medium, appropriate phantoms should be appropriate for withstanding high 
temperature and pressure regimes involved in FUS. The following sections review the 
main tissue mimicking US gels. 
2.4.1 Gelatin gels 
Several low cost gelatin gel based recipes have been introduced for mimicking accurately 
soft tissue for imaging purposes. These recipes mainly differ between them in the 
selection of the additive materials used for controlling acoustic scattering and speed. The 
Madsen group [129] used gelatin gel with graphite powder and alcohol to control the 
attenuation coefficient and speed of sound respectively. Their measurements reported an 
easily controllable attenuation coefficient range of 0.12 to 1.5 dB/cm-MHz and speeds 
between 1520 and 1650 m/s at room temperature. Cook et al. [130] demonstrated a gelatin 
based gel for photo acoustic imaging doped with silica particles, dye and 
Intralipid® solution additives that controlled the acoustic speed and attenuation and the 
optical absorption and scattering. Measurements correlated the concentration of these 
additives to aforementioned properties. In another study psyllium fibers were introduced 
as a scattering material in a gelatin based gel that resembled the echogenicity of thyroid 
and testicular texture [131]. No information of the acoustic properties of this gel recipe 
was provided. Amongst the reported disadvantages of gelatin gels, the one that makes 
them unsuitable for using in FUS applications is their low melting point (35 ºC). 
Additionally unless treated with preservatives they are susceptible to microbial and 
bacterial invasion and difficult to achieve a uniform distribution of the chosen scattering 
material. 
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2.4.2 Agar gels 
 Agar based gels are the most popular soft tissue substitutes found in literature. 
They are cheap and easy to produce, durable in high temperatures, nontoxic and 
disposable. However they lack long term stability and repeatability of acoustic properties 
measurement over time. Under ideal storage conditions, agar gels can remain stable up to 
two and a half years [132]. Burlew et al. [133] suggested agar gels as a replacement for 
gelatin gels which suffered for temperature dependent structural instability. The 
developed recipe resulted in a speed of sound that ranged between 1498 and 1600 m/s, 
density between 1016 and 1100 kg/m3 and an attenuation coefficient between 0.04 and 
1.40 dB/cm-MHz. A modified agar based tissue mimicking phantom gel available in 
liquid or solid form was presented by Madsen et al. [132]. The authors used a low 
scattering material like evaporated milk to control the attenuation coefficient though pure 
absorption. The produced phantoms were capable of exhibiting attenuation coefficient 
slopes spanning the range 0.1-0.7 dB/cm-MHz. The advantage of this phantom is that the 
absence of scatterers allows the backscatter coefficient to be varied over a considerable 
range. Zell et al. [134] presented measurements of the acoustic properties and density for 
a 2 % weight to volume agar gel. For a 5 MHz frequency acoustic wave, it was found that 
the speed of sound was 1500 m/s, the acoustic impedance was 1.57 MRayl and the 
acoustic attenuation 0.4 dB/cm. Its mass density was found as expected very near to 
water’s at 1040 kg/m3. Tissue-mimicking agar gels were also employed in a study for 
mapping inertial cavitation activity in a HIFU sonication [135]. A study by Partanen et 
al. [136] investigated the feasibility of using an agar-silica phantom for quality assurance 
purposes of MR guided FUS. Silica particles served as scatterers and their concentration 
controlled the overall attenuation coefficient of the final product. The study concluded 
that an agar-silica gel with mass concentrations 2 % and 3 % respectively, mimicked a 
soft tissue with an attenuation coefficient 0.58±0.06 dB/cm-MHz, ultrasound speed 
1490±10 m/s, mass density 1.03±0.01 g/cm3 and acoustic impedance 1.54±0.01 MRayl. 
2.4.3 Polyurethane gels 
 Kondo et al. [137] reported the fabrication of polyurethanes as an alternative to 
tissue substitutes. The molecular design of these gels is rather complex and very difficult 
to standardize. The authors produced a phantom with acoustic properties with an 
attenuation coefficient in the lower range (0.13 dB/cm-MHz), speed of sound of 1468 m/s 
and a mass density of 1130 kg/m3. 
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2.4.4 Polyacrylamide gels  
 The use of polyacrylamide hydrogels has been a popular choice amongst 
researchers in HIFU. The gel itself is optically transparent and its acoustic properties can 
be matched closely to soft tissue, making it suitable for monitoring the therapeutic effects 
of HIFU in simulation studies. Different studies have used slightly different recipes for 
creating these gels. Lafon and colleagues [138] were the first to develop such a phantom 
by crosslinking copolymerization of acrylamide and N,N′-methylene bisacrylamide (bis) 
in an aqueous solution. Gel samples embedded with different concentrations of bovine 
serum albumin (BSA) were made. BSA is a concentrated protein serum derived from 
cows. The purpose of adding BSA was to increase the acoustic absorption of the gel, as a 
result of the energy loss during protein denaturation. The authors examined the acoustic 
and optical properties of the phantom, which were characterized as a function of BSA 
concentration and temperature. The measured attenuation coefficient was found to vary 
linearly over the 1 to 5 MHz frequency range, with the coefficients of 0.009, 0.013, 0.017 
and 0.021 Np/cm-MHz measured for BSA concentrations of 3, 5, 7 and 9 %, respectively. 
The attenuation increased linearly with the increase in the BSA concentration. The 
attenuation coefficient of the phantom was approximately 8 times lower (for 9 % BSA 
concentration) than that for the soft tissues. The difference in attenuation coefficient was 
observed as a reduction in lesion volume compared in lesions created for the same HIFU 
dose in a sample of turkey breast. The speed of sound was found to be dependent on 
temperature, reaching a maximum at 1590 m/s near 60 °C. The phantom was destined to 
be used for HIFU therapies under ultrasound guidance. The authors reported that the 
optically opaque lesion created in the gel, coincided with the hyperechoic region observed 
in B-mode ultrasound imaging.  The hyperechoic region is recognized as a result of 
scattering induced by bubble formation at the focus [139]. 
 A cheaper version of Lafon’s recipe was reported in another study [140]. In this 
study the BSA was replaced with egg white which is also known of being a rich source 
of protein. The variation of the acoustic properties of the gel were tested for different egg 
white concentrations (0-40 %).   It was found that the mass density of the gel remained 
the same for the whole range (1.0 g/cm3) near to water. The sound speed of the gel varied 
from 1537 to 1544 m/s. High speeds were correlated with large egg concentrations. More 
importantly, it was found that there was strong linear correlation of attenuation coefficient 
with egg white concentrations. Even for the highest concentration tested (40 %), the gel 
possessed a lower attenuation coefficient than soft tissue (0.28 dB/cm-MHz). The use of 
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the egg white embedded polyacrylamide gel was demonstrated in an in vivo animal model 
where the fabricated gel was implanted inside a rabbit’s stomach to simulate a gastric 
submucosal tumor. The model was exposed to a 2.2 MHz HIFU beam with electric power 
of 100 W for 10 s. The authors demonstrated formation of a lesion in the gel, whilst the 
gastric mucosa surrounding the gel stayed unaffected. Another study used a 
polyacrylamide gel with egg white to test the effect of embedding nylon fibers to the 
phantom in order to increase heat deposition under HIFU [141].    
 In another study a modified recipe of the standard polyacrylamide gel with 
embedded BSA was proposed [142].  In order to improve the matching of the attenuation 
coefficient of the gel with that of soft tissue, glass beads with diameters of 40-80 μm were 
added. The glass beads served two purposes. They increased the attenuation coefficient 
of the gel by adding scattering effects, which were missing in previous recipes. The final 
product was an optically transparent gel with an acoustic impedance of 1.67 MRayl, a 
speed of sound of 1576 m/s, an attenuation coefficient of 0.52 dB/cm-MHz. The acoustic 
and thermal properties of the gel were very close to liver tissue. The formed lesion volume 
was larger using the new recipe compared to the standard polyacrylamide-BSA gel. This 
was attributed to the increased attenuation coefficient from the glass beads that enhanced 
heat deposition in the gel. 
 Commercially available polyacrylamide gel phantoms manufactured by Onda 
Corp (Sunnyvale, California, USA) are widely used for characterizing transducer 
geometry, frequency and power profiles. The synthetic gel is transparent and when its 
temperature exceeds 70 ºC, white three dimensional lesions are formed, making it easy to 
assess lesion growth, position and shape over time.  They are suitable tools for performing 
quality control tests on HIFU equipment and treatment protocol testing. The manufacturer 
states that these gels have similar acoustic and thermal properties to soft tissue. The 
products have a density of 1060 kg/m3, phase velocity of 1600 m/s, an attenuation 
coefficient of 0.6 dB/cm-MHz, specific heat of 3850 J/kg-K and thermal conductivity 
coefficient of 0.55 W/m-K [143]. Their properties are close to soft tissue and therefore 
they can be considered as a tissue mimicking material. 
2.4.5 N-isopropylacrylamide (NIPAM) gels  
 NIPAM gels have been designed to become opaque above a threshold temperature 
which can be controlled by altering the concentration of acrylic acid (AAc) [144]. By 
testing different concentrations of AAc, NIPAM based gels were fabricated and matched 
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the acoustic and thermal properties of different swine tissues. NIPAM gels are superior 
to polyacrylamide BSA or egg white based phantoms since they are reusable. Unlike these 
phantoms where thermal protein denaturation induces irreversibly opaque lesions, in 
NIPAM gels these lesions gradually disappear and the phantom gel can be reused. 
2.4.6 Polyvinyl Alcohol (PVA) gels 
 A polyvinyl alcohol cryogel (PVA)  tissue mimicking phantom gel was presented 
by Surry et al. [145] suitable for MR and US  imaging. The gel was solidified through a 
freeze-thaw cycle process and was characterized for the speed of sound which was found 
in the range of 1520 to 1540 m/s. The gel’s attenuation coefficients were in the range of 
0.075-0.28 dB/cm-MHz. T1 and T2 relaxation values were estimated between 718-1034 
ms and 108-175 ms respectively. The authors used this gel to develop a brain and breast 
phantom that were used in synergy with ultrasound or MR for segmentation and biopsy. 
Reinertsen et al. [146] designed a multi-layer  phantom made out of PVA gel to 
characterize and correct for brain shift during image guided surgery. Each gel was treated 
with different number of freeze-thaw cycles to control its mechanical and imaging 
characteristics. Brain vessels were simulated using plastic tubes filled with water and 
doped with glass micro-bubbles in order to enhance signal in Doppler ultrasound imaging.  
2.5 Summary 
 The following Table 2-1 summarizes the existing phantoms extracted from 
literature presented in previous sections and denotes their advantages and disadvantages. 
 
Table 2-1: Pros and Cons of existing phantoms extracted from a literature review. 
Phantom type 
Replicated 
tissue 
Pros Cons 
Liquid epoxy resin treated 
with hardener 
Bone - Matched tissue 
ultrasound velocity 
- Low attenuation 
coefficient compared 
to bone. 
- Lack of trabecular 
bone layer. 
- Requires molding. 
Liquid epoxy resin doped 
with gelatin cubic granules 
(1mm) and particles of 
natural bone. 
Trabecular bone - Matched tissue 
ultrasound velocity 
and attenuation 
coefficient. 
- Requires molding. 
 
- Simulated trabeculae 
are too large (1 mm3). 
- Biological tissue. 
Tubular polymer 
composites like ebonite, 
acrylic plastic, fiberglass 
and carbon fiber plastic. 
Cortical bone - Multi-layered model 
simulating increasing 
porosity. 
- Polymers covered a 
velocity range of 
poorly mineralize to 
hypermineralized 
compact bone. 
- Expensive to produce. 
- Complicated 
manufacturing 
procedure. 
- No attenuation 
coefficient data. 
- Requires molding. 
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Perspex plates Cortical bone - Matched tissue 
ultrasound velocity 
and attenuation 
coefficient. 
- Expensive to produce. 
- Complicated 
manufacturing 
procedure. 
- Produced in plates 
therefore no realistic 
anatomical geometry. 
- Fragile. 
Gelatin gels doped with 
graphite and alcohol. 
Soft tissues - Cheap to produce. 
- Easy to produce. 
- Easily controllable 
acoustic properties. 
- Low melting point. 
- Attenuation induced 
primarily with scatter 
agent. 
Gelatin gels doped with 
silica particles and 
Intralipid solution. 
Soft tissues. - Easy to produce. 
- Easily controllable 
acoustic properties. 
- Low melting point. 
- Expensive Intralipid 
solution. 
Gelatin gels doped with 
psyllium fibers. 
Soft tissues. - Cheap to produce. 
- Easy to produce. 
- Resembled the 
echogenicity of 
thyroid and testicular 
texture under US 
imaging. 
 
- Low melting point. 
- Attenuation induced 
primarily with scatter 
agent. 
- No information of the 
acoustic properties of 
this gel recipe was 
provided. 
Agar gels doped with 
graphite. 
Soft tissues - Cheap to produce. 
- Easy to produce. 
- Matched tissue 
ultrasound velocity 
and attenuation 
coefficient. 
- High melting point. 
- Attenuation induced 
primarily with scatter 
agent. 
- Fragile. 
- Visually opaque. 
Agar gels doped with 
evaporated milk. 
Soft tissues - Cheap to produce. 
- Easy to produce. 
- Matched tissue 
ultrasound velocity 
and attenuation 
coefficient. 
- High melting point. 
- Attenuation induced 
primarily with 
absorption agent. 
- Fragile. 
- Visually opaque. 
 
Agar gels doped with silica. Soft tissues. - Cheap to produce. 
- Easy to produce. 
- Matched tissue 
ultrasound velocity 
and attenuation 
coefficient. 
- High melting point. 
- Attenuation induced 
primarily with scatter 
agent. 
- Fragile. 
- Visually opaque. 
 
Polyurethane gels Soft tissues - Acceptable ultrasound 
velocity. 
- Complex molecular 
design and difficult to 
standardize. 
- Low attenuation 
coefficient. 
Polyacrylamide gels doped 
with BSA. 
Soft tissues. - Visually transparent 
matrix with visible 
heated lesions. 
- Linear dependence of 
attenuation coefficient 
with BSA 
concentration. 
-  
- Low attenuation 
coefficient. 
- Expensive to produce. 
- Complex to produce. 
- Possible toxicity 
during preparation. 
- Attenuation induced 
primarily with 
absorption agent. 
Polyacrylamide gels doped 
with egg white. 
Soft tissues. - Visually transparent 
matrix with visible 
heated lesions. 
- Linear dependence of 
attenuation coefficient 
with egg white 
concentration. 
- Low attenuation 
coefficient. 
- Possible toxicity 
during preparation. 
- Complex to produce. 
- Attenuation induced 
primarily with 
absorption agent. 
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Polyacrylamide gels doped 
with egg white, nylon, 
stainless steel and copper 
fibers. 
Soft tissues. - Visually transparent 
matrix with visible 
heated lesions. 
- Volumes of lesions 
formed in phantoms 
similar to control 
lesions. 
- Attenuation induced 
from both scatter and 
absorption agents. 
- Absence of acoustic 
properties 
quantitative data. 
- Complex to produce. 
- Possible toxicity 
during preparation. 
- Use of metallic 
materials can induce 
image artifacts in 
MRI. 
Polyacrylamide gels doped 
with BSA white and glass 
beads. 
Soft tissues. - Visually transparent 
matrix with visible 
heated lesions. 
- Attenuation induced 
from both scatter and 
absorption agents. 
- Matched tissue 
acoustic properties. 
- Expensive to produce. 
- Complex to produce. 
- Possible toxicity 
during preparation. 
Polyacrylamide gel 
phantoms by Onda Corp 
Soft tissues - Matched tissue 
acoustic and thermal 
properties. 
- Expensive to 
purchase. 
- Sold in rectangular 
containers. 
- No information for 
additives. 
N-isopropylacrylamide 
(NIPAM) gels 
Soft tissues - Matched tissue 
acoustic properties. 
- Reusable. 
- Complex to produce. 
- Possible toxicity 
during preparation. 
Polyvinyl Alcohol (PVA) 
cryogel 
Soft tissues - Matched tissue 
ultrasound velocity. 
- Possibility of treated 
with different number 
of freeze-thaw cycles 
to control its 
mechanical and 
imaging 
characteristics. 
- Low attenuation 
coefficient. 
- Long and complex 
preparation through 
multiple freeze-thaw 
cycles. 
 
 Following literature review, it was concluded that soft tissue phantoms are   
predominantly mimicked by a variety of different gels. The gels differ between them in 
the gelling agent used and the preparation method. Gelatin and agar are natural products 
extracted for animal collagen and seaweed polysaccharides respectively, they are not 
toxic and their preparation does not require either special skills or equipment. 
Polyurethane, polyacrylamide and polyvinyl based gels are synthetic polymers that 
present various degrees of toxicity and the preparation can be complex varying from 
freeze-thaw cycles to crosslinking of multiple polymers. In order to match the attenuation 
characteristics of the replicated tissue, gels were doped with different types of scatterers 
in the form of nylon fibers, glass beads, silica particles etc. Other phantom makers chose 
to control the attenuation characteristics their gels with additives high in protein content 
like BSA, evaporated milk, egg white, etc., which induce primarily acoustic absorption. 
No evidence in literature was found for a soft tissue mimicking gel that combined both 
scatter and absorption additives except in the report of Choi et al [142], where glass beads 
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were combined with BSA in a polyacrylamide gel in order to increase the rather low 
attenuation coefficient and induce scattering effects.  
 There were very few examples of bone replicating phantoms with their majority 
being hardened liquid epoxy resin or different polymers and polymer composites like 
ebonite, acrylic plastic, fiberglass and carbon fiber plastic. Attempts of simulating 
trabecular bone structure were made by doping epoxy resins with rubber granules. The 
majority of these phantoms were manufactured in plate samples and no standardized 
methodology of fabricating bone structures with realistic geometry was presented. 
 This review revealed the need of developing composite tissue mimicking 
phantoms with realistic geometry and independently controlled attenuation 
characteristics. There was complete absence of composite phantoms made out of non-
biological material.  Composite phantoms of replicating both soft and bone tissue are 
necessary to assess the possible interactions of ultrasound with tissue residing inside and 
outside the acoustic field. Unwanted thermal spots rising from increased absorption and 
reflection at interfaces, field intensity amplification from standing waves and the 
absorption of scattered waves using the proposed phantoms can be examined thoroughly. 
The phantoms preparation method should be easy without any expertise needed. The cost 
of the materials used should be affordable and any technology used for their fabrication 
should be widely available. The remaining of the thesis will present a methodology of 
developing phantoms for three major focused ultrasound applications that will allow 
researchers to explore the extent of thermal effects. 
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3  Selection and testing of phantom materials 
3.1 Introduction 
 The following chapters describe the fabrication and characterization of three 
phantoms suitable for testing thermal exposures using HIFU guided by MRI. All 
phantoms were composed by two homogenous materials, one for replicating soft tissue 
and the second one for bone tissue. The selection process of the candidate materials used 
was considered prior to fabrication. The requirements tested for assessing the materials 
suitability are presented in the following sections. 
3.2 Agar gels for mimicking soft tissue phantoms 
 Agar is a gelling agent extracted from red algae which consists of a complex 
mixture of polysaccharides. Gels can be formed by dissolving agar in boiling water that 
set once cooled down. During the jellification process, agar demonstrates a hysteresis 
phenomenon where the melting temperature (>85 ºC) is considerably higher from the 
temperature range that solidification takes place (32-45 ⁰C). The final product is a 
homogeneous opaque gel that can be easily molded to form well-shaped volumes with 
clear margins.  
 Agar based gels are a frequent selection for constructing soft tissue mimicking gel 
phantoms in ultrasound applications since they are non-toxic, low cost, easy to make and 
do not require special equipment to be prepared [134], [147], [148]. The high melting 
temperature of agar gels makes them ideal for testing HIFU applications since they can 
maintain their structural integrity for a considerably wide range of ablative temperatures 
(60 ⁰C< θ<85 ⁰C).  The concentration of agar in water expressed in weight (grams of 
agar) per volume of water percentage (w/v %) affects the gel’s stiffness and consequently 
controls its elasticity. By varying the concentration of agar, the stiffness of the gel can be 
modified to match the replicated tissue’s bulk mechanical characteristics.  
3.3 Silica dioxide (SiO2) for controlling acoustic scattering in an agar 
matrix 
 The process of scattering is a significant energy loss mechanism produced in the 
vicinity of biological tissue inhomogeneities. Although scattering does not contribute 
directly to the conversion of acoustic energy to heat, it increases the overall attenuation 
and thus needs to be considered when designing a realistic tissue mimicking phantom. 
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Silica dioxide or silica is commonly added in tissue mimicking phantom gels to enhance 
attenuation through acoustic scattering [130], [136]. 
 Silica is a crystalline compound found abundant in sand. It is insoluble in water 
with a high mass density ( 2.6 g/cm3) while its melting temperature exceeds 1600 ⁰C.  
Due to the large acoustic impedance mismatching at interfaces of dense silica particles 
embedded in a tissue mimicking gel, ultrasound is reflected. Since silica dioxide crystals 
in powdered form are usually amorphous and with dimensions comparable or smaller to 
the acoustic wave’s wavelength, the wave is reflected in all directions through the process 
of Rayleigh scattering.  The degree of scattering is correlated with the population of 
scatterers per unit volume and their size. Scatterers can enhance secondary absorption by 
increasing the effective path length of the wave but for simplicity it will be assumed that 
attenuation in gels doped with silica is purely a result of scattering. 
3.4 Evaporated milk for controlling acoustic absorption in an agar 
matrix 
 The effectiveness of HIFU induced hyperthermia and ablation applications 
depend on the thermal dose deposited at the targeted tissue throughout the treatment 
period. This loss mechanism is characterized by the associated tissue’s absorption 
coefficient. Evaporated milk induces low scattering and has been used in various studies 
as an additive in gel phantoms to primarily control attenuation independently from 
scattering [132], [149], [150]. Acoustic energy is converted to heat via viscous frictions 
inside the phantom. When the temperature is raised above a threshold, heat energy is 
sufficient to disrupt irreversibly hydrogen bonds that retain milk proteins in a folded state. 
This irreversible effect is known as thermal protein denaturation and it is the primary 
mechanism of biological tissue necrosis under HIFU ablation. The addition of evaporated 
milk was tested on the hypothesis that acoustic absorption and thus attenuation is 
correlated to the concentration of milk in the final gel, expressed in a volume to volume 
percentage (v/v %). 
3.5 Acrylonitrile Butadiene Styrene (ABS) for replicating bone tissue 
 Attenuation and loss of the acoustic wave’s phase coherence distort the quality of 
the focusing pattern in transcranial applications. Researchers have developed various 
adaptive focusing techniques to overcome these skull induced amplitude and phase 
aberrations. These techniques involve solving back projected acoustic linear wave 
equations and calculating the required amplitude and time shifts for every element of the 
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array that converges the beam at focus. In order to solve these differential equations, the 
skull thickness, density and the speed of sound in the skull for each acoustic pathway 
needs to be calculated. Unintended heating from bone/tissue interfaces in the near or far 
field pose major safety and treatment efficacy problems in some HIFU applications that 
need to be addressed in phantom studies. 
 For bone modelling it was decided to test ABS as a possible candidate material. 
ABS is a thermoplastic polymer commonly used as a raw material in Fused Deposition 
Modelling (FDM). FDM is just one of the many available techniques for prototyping 3D 
models. During printing operation, raw ABS is heated by a filament to reach melting 
temperature and then it is forced through a fine nozzle to build 3D models. While fusing 
layer upon layer, the final product is built to a geometrically accurate representation of 
the model, which is important for inducing analogous acoustic field distortions to human 
bones. 
 ABS products are durable, heat resistant and chemically inert under normal 
conditions and therefore reusable. This is also another advantage since ABS will be used 
as a bone phantom for a range of different conditions without having to worry for changes 
to its physical properties. Being a plastic is also not expected to produce any severe 
artifacts while monitoring focused ultrasound exposures with MRI. 
3.6 Estimation of materials acoustic properties using immersion 
techniques 
 In order to assess the suitability of the materials used to construct the phantoms,   
a methodology for assessing their acoustic properties is needed. The most relevant 
acoustic properties for phantoms designed for HIFU is the attenuation coefficient and the 
propagation speed. The first property controls the degree of acoustic energy to heat 
conversion and therefore a close matching with the attenuation coefficient of the 
replicated tissue is desirable. Acoustic speed and mass density set the reflection 
coefficient at interfaces and consequently the actual fraction of incident acoustic energy 
propagating through the phantom depends on it.  Pulse-echo and transmission methods 
are broadly used for characterizing the attenuation coefficient and acoustic speed of 
ultrasound. They involve submerging the specimen under examination in a tank filled 
with degassed water. All measurements are performed with immersion unfocused 
ultrasonic transducers. These methods differ in experimental configuration, the 
assumptions taken, the type of signals measured and their advantages. 
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3.6.1 Methods for estimating acoustic attenuation coefficient 
Transmission through method for measuring acoustic attenuation coefficient 
This technique compares the transmitted signals through material specimens of different 
thicknesses [151]. It uses two immersion planar transducers, one for transmitting and one 
for receiving the signal (Figure 3.1). 
 
Figure 3.1: Variable thickness technique for measuring attenuation coefficient of the 
tested material [9]. 
 
The two transducers operate at the same central frequency and gain to ensure an identical 
response. The specimen is positioned between the two transducers and preferably beyond 
the far field of the transmitting transducer, where constructive interference of waves 
produced at the face of the transducer create a uniform front that decays smoothly with 
distance.  
 The advantage of the variable thickness method is that there is no need to calculate 
the reflection or transmission coefficients of the material. First a thinner specimen with 
thickness d1 is positioned between the two transducers. The peak-to-peak voltage at the 
receiver side is measured (Vd1) on an oscilloscope. The thicker specimen with thickness 
d2 is positioned at exactly the same distance from the transmitter. For strictly correct 
measurements the receiver in the second measurement must be moved by a d2-d1 distance 
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in order to keep the length of the immersion liquid constant between the two 
measurements. If water is used as the immersion liquid and the thickness difference 
between the two specimens is small, we can neglect this correction since water does not 
attenuate the beam significantly. The peak-to-peak voltage of the thicker specimen is also 
measured (Vd2). The voltage measured at the receiver is directly proportional to the 
pressure exerted by the acoustic wave. It is then safe to deduce that the square of the 
voltage measured is proportional to the sound wave’s intensity. If we follow some 
mathematical analysis to calculate the sound intensity at the receiver’s end for both 
thicknesses we end up with Equation (3.1) for calculating the characteristic attenuation 
coefficient (α) of the material in units of  dB/cm. 
The expression above contains no reflection or transmission coefficient. The coefficients 
cancel each other out when we calculate the ratio of intensities as a function of the 
measured voltages for the two different thicknesses. 
Pulse echo method for measuring acoustic attenuation coefficient 
The method introduced by Youssef and Gobran [152], follows a different approach from 
the variable thickness technique. The main difference is that measurements are performed 
using reflected echoes at a single transducer (T) working in transmit and receive mode 
(Figure 3.2). 
 
Figure 3.2:  Single transducer pulse echo method [10]. 
 
𝛼 =  
20
𝑑2 − 𝑑1
(𝑙𝑜𝑔10
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) 
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 The authors described equations of the acoustic intensity arriving at the transducer 
face for two different scenarios. First the transducer (T) is immersed in a tank of fixed 
dimensions and on the opposite side of the tank a perfect reflector is placed. The reflector 
can be any flat and smooth material with a high acoustic impedance like aluminum or 
plastic. The transducer measures the signal intensity (Iw) arriving in the absence of a 
specimen in the path of the beam. The intensity of the signal depends only on the 
attenuation coefficient of the immersion liquid and the distance travelled.  
 In the second scenario, a specimen of thickness L is positioned in the pathway of 
the beam. The transducer records echoes rising from reflections produced by every 
interface met along the wave’s pathway. The echo returning from the front face of the 
specimen and travelling a distance 2x1 is denoted as intensity I3 , while the signal with 
intensity I12 travels the full pathway of distance 2( x1+L+x2). A system of equations 
describing the reflected echoes intensities at every interface (I1 to I12) is solved and by 
using multiple substitutions we end up in a simple system of two equations containing 
two unknown variables. 
 Iw and I3 are directly measured from the transducer whereas the term r
2 is equal to 
the reflection coefficient of the liquid/specimen interface. The term α1 stands for the 
attenuation coefficient of the immersion liquid. If degassed water is used as the immersion 
liquid it can be safely assumed that the attenuation of ultrasound is negligible and 
therefore the exponent approximates unity, which leads to a very simple expression 
described by: 
 
The second equation of the system after all substitutions is given by Equation 3.3, where 
α2 refers to the attenuation coefficient of the specimen.  
 
Once again I12 and Iw are deduced from the transducer’s voltage signals whereas r2 is 
calculated from Equation (3.2). The attenuation coefficient α2 is calculated using 
Equation (3.3).  The single transducer method is valid if the reflection and transmission 
 
𝐼𝑤
𝐼3
= (
1
𝑟2
) 𝑒[−4𝑎1(𝑥2+𝐿)]    =  (
1
𝑟2
) , 𝑓𝑜𝑟 𝑎1 ≈ 0 
(3.2) 
 
 𝐼12
𝐼𝑤
=  (1 − 𝑟2)4 𝑒[−4(𝑎2−𝑎1)𝐿] =  (1 − 𝑟2)4 𝑒(−4𝑎2𝐿) , 𝑓𝑜𝑟 𝑎1 ≈ 0 (3.3) 
  
 47 
coefficients at both faces of the specimen are equal. For a homogeneous material at 
constant temperature, this seems to be a logical assumption. 
3.6.2 Estimation of attenuation coefficient variation for agar gels doped with 
different concentrations of SiO2 using transmission through technique. 
Materials and Methods 
Agar gels (granulated form, microbiology grade-Merck Millipore, Darmstadt, Germany) 
of a 2 % w/v of water concentration were used in order to produce gels of intermediate 
stiffness and flexible enough to withstand manual handling and high intensity ultrasound 
compressional forces without cracking. This selection is within the range of 
concentrations (2 %-2.7 %) of agar based HIFU soft tissue mimicking phantoms found in 
bibliography [153]–[155]. Agar gel specimens were doped with silica dioxide powder of 
different concentrations (0 %, 1 %, 2 %, 3 % w/v). The silica particles size ranged between 
0.5-10 μm (Silica Dioxide, Sigma-Aldrich, St. Louis, Missouri , United States). 
 The first step in preparing the gels was to calculate and weigh the quantities 
needed for each of the tested four recipes. The volume of each batch was 100 ml and 
therefore the weights were extracted based on the concentrations previously described. 
Agar and silica powders were weighed using a 0.1 g precision electronic scale. To 
minimize attenuation from gas bubbles trapped inside the gels, 150 ml of distilled and 
degassed water was used. Distilled water is free from impurities that can affect the 
attenuation measurements. The water volume was degassed inside a vacuum chamber. 
Degassing time lasted for as long as we could see bubbles emerging on the surface 
(approximately 20-25 minutes). 
 Agar and silica powders were poured inside a glass beaker containing 100 ml of 
degassed water. The mixture was first stirred using a magnetic stirrer to ensure adequate 
mixing and dissolving of powder granules before boiling. Excessive boiling leads to 
evaporation and desired concentrations can be altered. Following 20 minutes of stirring 
on high revolutions the mixture was then boiled to exceed 85 ⁰C, which is the melting 
temperature of agar. The amount of water evaporated during boiling was replenished to 
reach the initial 100 ml volume and maintain the initial agar and silica concentrations. 
The heater was turned off and the mixture was left to cool down to room temperature. 
Stirring was kept at all times during cooling period, but at lower revolutions, up until the 
mixture started jellifying (35-40 °C) and becoming viscous. This was vital to ensure that 
silica particles distributed evenly within the gel’s matrix. 
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 The variable thickness technique was followed because it does not require 
determination of the reflection coefficient.  For each silica dioxide concentration two 
different thicknesses were prepared (16 mm and 26 mm). The samples were poured in 
plastic 3D printed plastic containers and were left to solidify overnight (Figure 3.3A – 
Figure 3.3B).  Custom made plastic holders were designed and manufactured to 
accommodate the specimen containers of different thicknesses (16 and 26 mm) in 
between the immersion transmitter and receiver (Figure 3.3C). 
 
 
The holder had two cylindrical cavities that could fit tightly the two 10 mm circular 3.5 
MHz transducers (Etalon, ESN-410-SCBI) facing each other while the specimen was 
positioned in between and with side openings perpendicular to the acoustic beam’s 
A 
B 
C 
1st transducer 
2nd transducer 
Agar-silica specimen 
Figure 3.3: A) Agar-silica gel sample moulded inside the 16 mm sample container, B) 
Agar-silica gel sample moulded inside the 26 mm sample container, C) Custom made 
holder for agar gel transmission through measurements. 
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pathway emitted by the transmitting transducer. The transmitter (T/R) and receiver (R) 
were connected via coaxial cables to a Panametrics pulser/receiver (Panametrics 500PR, 
Olympus Corp, Tokyo, Japan). 
 A high pass filter selectable via a rear panel switch was used to change excitation 
pulse recovery time and reject low frequency noise. The pulser/receiver was set to operate 
in transmission through mode. The signal of the receiving transducer was fed to a 20 MHz 
oscilloscope (Hameg HM203-7, HAMEG Instruments GmbH, Mainhausen, Germany) to 
observe voltage over time. The transmitter and receiver gain were kept constant whilst 
the pulse repetition frequency was adjusted (5 kHz) to keep a single cycle of the periodic 
signal for the set time per division (20 μs). The attenuation coefficient in dB/cm was 
calculated using Equation 3.1 for every set of gels. The coefficient for different silica 
concentrations was normalized to more useful units of dB/cm-MHz by dividing with the 
transducer’s frequency (3.5 MHz). This approach assumed a linear dependence of 
attenuation of with frequency of the prescribed heterogeneous phantom. A similar 
approach was used in a study by Nam et al.  [156], where attenuation data induced by 
glass bead scatterers of similar size (10-100 μm) in tissue mimicking phantoms fitted 
almost linearly in the frequency range between 2.5-10 MHz. Figure 3.4 demonstrates the 
experimental setup used for the transmission through attenuation measurements.  
 
Figure 3.4: Experimental setup for the transmission through measurements of a specimen 
of thickness (d) in between the transmitter (T) and receiver (R) all immersed in a tank 
filled with degassed water. 
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Results 
Voltages induced by acoustic waves transmitting through the specimens and reaching the 
receiver were monitored for each sample’s thickness (16 mm and 26 mm). The 
measurements were repeated for each silica concentration (0 %, 1 %, 2 % and 3 %).The 
results are summarized in Figure 3.5 as a plot of attenuation coefficient in units of dB/cm-
MHz as a function of silica concentration demonstrating a linear dependence. 
 
Figure 3.5: Agar-silica gel attenuation coefficient variation for different concentrations 
of silica dioxide.  
3.6.3 Estimation of attenuation coefficient variation for agar gels doped with 
different concentrations of evaporated milk using transmission 
through technique.  
Materials and Methods  
A recipe described by Madsen et al. was used [132], where evaporated milk was added to 
agar gels to produce a solid gel of very low scatter tissue mimicking material. Evaporated 
milk is a dehydrated version of fresh milk, where approximately 50 % of water is 
removed. In the absence of silica dioxide from the gel any drop in the intensity of the 
acoustic field could be attributed primarily to acoustic absorption by the evaporated milk. 
Four sets of agar-milk gel samples of different milk concentrations (10%, 20 %, 40 % and 
50 % v/v) in a 2 % w/v agar based gel were prepared. The evaporated milk used was a 
product by Friesland Campina, Marousi, Greece (NOUNOU condensed milk). According 
to the manufacturer’s nutritional datasheet, 100 ml of milk included 4.2 g of fats and 3.5 
g of proteins. 
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 For each sample, agar powder was mixed with the appropriate volume of distilled 
and degassed water. Similarly like in silica experiments, agar–water mixture was boiled 
with a heater until agar melted. For each concentration sample, the correct volume of 
evaporated milk was boiled up to 55 °C in a separate container. Temperature was 
monitored in both containers using an electronic thermometer (Electrotherm Model TH-
99A, Cooper Instrument Corp., Middlefield, Connecticut, USA). When the temperature 
of the agar-water mixture reached 55 °C, the warm evaporated milk was added and was 
well mixed using a magnetic stir bar. We avoided to add milk while the agar-water 
mixture was hot since proteins denature irreversibly above 55 °C. The agar-milk gel was 
poured and left to solidify overnight in the custom made plastic sample containers (16 
mm and 26 mm). The sample containers were used to determine the attenuation 
coefficient from each agar-milk concentration sample. Once again we used the varying 
thickness technique and monitored the voltage drop in the signal of a 3.5 MHz ultrasound 
transducer- receiver while using the transmission through method. 
Results 
The results for each agar-evaporated milk sample concentration are summarized in Figure 
3.6. A linear correlation of milk concentration to attenuation coefficient was observed, 
which was evident of acoustic absorption mechanism enhancement. The attenuation 
induced by acoustic absorption of different concentrations of evaporated milk embedded 
in a 2 % w/v agar gel was assessed.  Attenuation increased linearly with the concentration 
of milk in the gel primarily due to absorption mechanism.  
 
Figure 3.6: Agar-evaporated milk gel attenuation coefficient variation for different 
concentrations of evaporated milk. 
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The results are in agreement with the results presented by Madsen et al. [132], which 
demonstrated a broadband attenuation coefficient of 0.5 dB/cm-MHz for agar gels doped 
with a 50 % v/v  concentration of evaporated milk for frequencies up to 8 MHz.  
3.6.4 Estimation of attenuation coefficient of ABS samples using 
transmission through technique. 
Materials and Methods 
ABS was tested as the candidate material for replicating bone tissue. Two square plates 
of ABS specimens of different thicknesses, 2.5 mm and 5 mm respectively, were 
produced (4×4 cm) using a rapid prototyping machine (Stratasys, Fortus FDM 400mc, 
Eden Prairie, Minnesota, USA). The produced specimens are shown in Figure 3.7. A solid 
interior printing style was used to fill up the model completely with raw material without 
any air gaps. Details of the printing process will be described in the following chapters. 
 
Figure 3.7:  ABS specimens of 2.5 and 5 mm thickness. 
 
The printed ABS specimens were significantly thinner compared to the agar gel samples 
tested. Attenuation from the plastic was expected to be large and therefore in order to 
measure adequately a signal, specimens’ thicknesses were kept small. The ABS plates 
were secured tightly in the rails of a custom made holder approximately midway between 
the transmitter and receiver (Figure 3.8). The rails hold the ABS plates in an upright 
position for intersecting the field’s propagation direction at right angles. The setup used 
was identical to the one used while testing the attenuation of agar gels doped with various 
additives. The emitted amplitude and the receiver’s gain were set to maximum to amplify 
the very small acoustic signal transmitted through the plastic samples. 
2.5 mm 
5 mm 
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Figure 3.8: Custom made holder for ABS attenuation measurements. 
 
Results  
The ABS attenuation coefficient was calculated using the expression described by 
Equation 2. A linear dependence of attenuation with frequency was assumed. The 
attenuation coefficient was estimated to be equal to 16.01 ± 6.18 dB/cm-MHz. 
3.6.5 Estimation of acoustic speed using pulse echo technique. 
The pulse-echo immersion technique was used for estimating the acoustic speed in the 
candidate materials. The method involved one transducer (Etalon, ESN-410-SCBI). The 
transducer was operating at a central frequency of 3.5 MHz. Specimens of each recipe 
with a  2.6 cm thickness were prepared and molded in custom made containers as shown 
in Figure 3.3B. A pulser/receiver (Panametrics 500PR, Olympus Corp., Tokyo, Japan) 
supplied the electrical pulses to the transducer while set to the T/R (transmit/receive) 
mode. The specimen was positioned in the far field of the transducer and echo reflections 
from each interface were observed on an oscilloscope (Hameg HM203-7, HAMEG 
Instruments GmbH, Mainhausen, Germany).  The transducer-specimen setup was 
immersed in a tank filled with degassed water as shown in Figure 3.9. 
 Acoustic speed in the specimen was estimated by determining the time difference 
Δt between the echoes returning from the interfaces of the specimen. An echo E1 which 
corresponded to the reflection from the first interface (water/specimen) and an echo E2  
from the second specimen/water interface were observed (Figure 3.9). 
Transmitter 
position 
Transmitter holder 
Receiver holder 
2.5 mm rail 
5 mm rail 
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Figure 3.9:  Experimental setup of pulse echo immersion technique for measuring the 
acoustic speed in the tested specimens. 
 
A typical signal with the characteristic echo peaks was displayed on the oscilloscope as 
shown in Figure 3.10, where the 2nd and 3rd peak correspond to E1 and E2 respectively.  
The time required (t1) for E1 to bounce on the first interface while travelling for a distance 
equal to 2d1 in water is given by Equation 5, where vwater represents the propagation speed 
of sound in water.  
 
Figure 3.10: Typical signal produced by reflections at specimen’s interfaces during pulse 
echo immersion technique for estimating acoustic speed. 
Ε1 Ε2 
Δt 
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Following the path of E2 an expression that describes the time t2 required for the echo to 
propagate through a distance of 2d1 in water and 2d2 in the specimen and return back to 
the transducer (Equation 3.5). The expression takes in to consideration that vwater and 
vspecimen are different.  
 
𝑡2 =
2𝑑1
𝑣𝑤𝑎𝑡𝑒𝑟
 +  
2𝑑2
𝑣𝑠𝑝𝑒𝑐𝑖𝑚𝑒𝑛
 (3.5) 
 
The time difference ∆t between the two echoes can be found by deducting t1 from t2 and 
end up with an expression which depends only on d2 and vspecimen (Equation 3.6). 
Solving for vspecimen we end up with an expression that only Δt needs to be measured (d2 
is assumed to be known). 
 𝑣𝑠𝑝𝑒𝑐𝑖𝑚𝑒𝑛 =
2𝑑2
∆𝑡
 (3.7) 
 
 Acoustic speed was calculated using the aforementioned pulse echo method for 
two agar gel recipes that combined both silica dioxide and evaporated milk. The two 
recipes included different concentration of additives and they were selected based on the 
attenuation characteristics of the soft tissues replicated. The brain phantom recipe was 
made out of 2 % w/w agar, 1.2 % w/w SiO2, 25 % v/v evaporated milk whereas the second 
recipe mimicking muscle tissue consisted out of 2 % w/w agar, 2 % w/w SiO2, 40 % v/v 
evaporated milk. Details about the selection of the exact concentrations will be given in 
the following chapters where fabrication of phantoms will be fully described. Specimens 
of both gel recipes were prepared and molded inside the 2.6 cm containers used for the 
attenuation measurements. A thicker sample was selected to increase the time difference 
between E1 and E2 to improve the accuracy in the acoustic speed’s estimation. 
 Initially an attempt to estimate the acoustic speed in ABS specimens was made 
using the pulse echo technique but soon realized that it was not possible. The main 
problem with ABS was that only echoes from the front wall of the specimen were detected 
(E1) by the transceiver and none from the back wall (E2). The main reason for not 
 𝑡1 =
2𝑑1
𝑣𝑤𝑎𝑡𝑒𝑟
 (3.4) 
 
 
∆𝑡 = 𝑡2 − 𝑡1  =
2𝑑2
𝑣𝑠𝑝𝑒𝑐𝑖𝑚𝑒𝑛
 (3.6) 
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detecting the reflection echo was due to disturbance of the propagating wave from the 
inner layers of the specimen. During fused deposition modelling, ABS is deposited in a 
raster pattern and consecutive raster layers are oriented at 45º to each other to minimize 
void space.  Transmission through method was used to determine ABS acoustic velocity 
by observing the change in the time of flight of the transmission signal (S) detected by 
the receiver (Figure 3.11). 
 In the absence of a specimen the time required (t1) for the sound wave (S) 
travelling from the transmitter (T) to the receiver (R) positioned at distance (d1) is given 
by equation 3.8, where vwater corresponds to ultrasound speed in water. 
 
If a specimen of ABS of thickness d2 is immersed in between the two transducers, the 
time of flight of the transmission signal (t2) is described by equation 3.9, where vspecimen 
corresponds to ultrasound speed in the specimen. 
 
 
 
Figure 3.11: Experimental setup of transmission through immersion technique for 
measuring the acoustic speed in ABS specimens. 
 
 
 
𝑡1  =
𝑑1
𝑣𝑤𝑎𝑡𝑒𝑟
  (3.8) 
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By substituting equation 3.8 to equation 3.9 a simple expression for calculating vspecimen, 
is derived. 
  
 A specimen of intermediate thickness (d2 = 1 cm) was used to balance between 
heavy attenuation of the transmitted signal by ABS ( -56dB at 3.5 MHz) and adequate 
change in the time of flight. The acoustic speed in water was taken as 1480 m/s, whereas 
Δt was found by measuring the relative change in the time of flight of transmission signal 
with (t2) and without the specimen in place (t1). 
Results 
For the brain mimicking gel recipe (2 % w/w agar, 1.2 % w/w SiO2, 25 % v/v evaporated 
milk ), acoustic speed was estimated at 1485 ± 12 m/s. For the muscle mimicking gel 
(2 % w/w agar, 2 % w/w SiO2, 4 0% v/v evaporated milk) acoustic speed increased to 
1529 ± 13 m/s. Acoustic speed in an ABS sample was calculated at 2048 ± 79 m/s. 
 
3.7 Mass density measurements using the water volume displacement 
method. 
 The aforementioned soft tissue phantom recipes were tested to quantify their mass 
density. Samples of 100 ml volume for each gel recipe were prepared. The gels were 
sliced in approximately equal volumes, with dimensions small enough to fit inside a 
volumetric tube. Each piece was first weighed with a high precision (±0.01 g) electronic 
scale (Tanita 1479V digital mini scale, Preston, Washington, USA) and then its volume 
was deduced by measuring water displacement in a volumetric tube (±1 ml). The greatest 
source of error in these measurements was the precision of the volumetric tube, therefore 
the specimens used were as large as possible to minimize the fractional error in volume 
measurements. Six specimens were taken from the same batch and the average mass 
density in g/cm3 was calculated. 
 𝑡2  =
𝑑1−𝑑2
𝑣𝑤𝑎𝑡𝑒𝑟
 +  
𝑑2
𝑣𝑠𝑝𝑒𝑐𝑖𝑚𝑒𝑛
 = 
𝑑1
𝑣𝑤𝑎𝑡𝑒𝑟
 −  
𝑑2
𝑣𝑤𝑎𝑡𝑒𝑟
 +  
𝑑2
𝑣𝑠𝑝𝑒𝑐𝑖𝑚𝑒𝑛
 (3.9) 
 𝑣𝑠𝑝𝑒𝑐𝑖𝑚𝑒𝑛  =  
𝑑2
(𝑡2 − 𝑡1) + 
𝑑2
𝑣𝑤𝑎𝑡𝑒𝑟
 
 =  
𝑑2
𝛥𝑡 + 
𝑑2
𝑣𝑤𝑎𝑡𝑒𝑟
 
   (3.10) 
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 The density of the brain mimicking phantom recipe (2 % w/w agar, 1.2 % w/w 
SiO2, 25 % v/v evaporated milk) was found to be 1.05±0.01 g/cm3 and similarly for the 
muscle recipe (2 % w/w agar, 2 % w/w SiO2, 40 % v/v evaporated milk), mass density 
was estimated to be  1.07±0.01 g/cm3. ABS density was taken from the manufacturer’s 
datasheet [157] which was reported at 1.04 g/cm3. 
3.8 Estimation of soft tissue phantoms thermal properties 
 The goal of this study was to develop tissue mimicking phantoms destined for 
testing thermal protocols under HIFU. Therefore in order to make comparisons and 
extract conclusions that are either directly or indirectly transferrable to in vitro, in vivo or 
numerical simulation studies, the thermal properties of the candidate materials must be 
characterized. 
3.8.1 Estimation of soft tissue phantoms thermal properties using a 
noninvasive MR thermometry technique. 
Materials and Methods 
Thermal conductivity is an intrinsic thermal property of materials that describes the 
ability of the material to conduct heat away from hotter to colder areas until thermal 
equilibrium is established. Numerically it is expressed as the rate of transferred heat 
between two conducting surfaces of the material per unit surface area (W/m2) divided by 
their temperature gradient (K/m1 or ºC/m). The units of thermal conductivity are W/m-K 
or W/m-ºC. 
 The traditional methods for measuring thermal conductivity of a material can be 
categorized in steady state and transient methods. In steady state methods measurements 
are performed while the temperature of the material under examination does not change 
over time, whereas in transient techniques measurements are done while heating the 
material. Both methods require specialized equipment like heat sources and sensors of 
various geometries. The aforementioned methods are partially invasive since they require 
embedding temperature sensors inside the material under examination, thus affecting its 
structural integrity. Instead a completely noninvasive approach first presented by Cheng 
et al. [158] was used, where thermal conductivity estimation is possible by combining  
magnetic resonance temperature imaging (MRTI) and HIFU. 
 The method uses HIFU to induce moderate heating to tissue whilst monitoring 
temperature with MRTI. Following the end of sonication, thermal clearance can be 
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characterized by a 2D space and time analysis of the Bioheat Equation (BHT) described 
by Pennes et al. [159]: 
 
 
, where T is the tissue’s temperature, kt is the thermal conductivity of tissue, t is time, ρt 
corresponds to tissue density, ct and cb are the specific heats of tissue and blood (water 
equivalent), wb is the blood perfusion rate, Ta is the arterial blood temperature and Q is 
the total power deposition. The BHT equation assumes that thermal clearance in tissues 
is governed by two mechanisms: conduction and perfusion. The non-directional term of 
perfusion represents the cumulative effect of a dense capillary network which in the 
absence of a large vessel acts as spatially uniform heat sink. 
 Cline et al. [160] showed that the focusing patterns from a spherically focused 
transducer can be approximated with elliptical Gaussian functions with radial (ro) and 
axial (zo) radii and provide an exact analytic solution of  the BHT equation. For a time 
impulse source of heat provided by focused ultrasound, the exact solution of BHT at focus 
(z=0)  and in a plane perpendicular to sound propagation simplifies to the following 2D 
Gaussian function for T(r,t) along the focal plane: 
, where D corresponds to the diffusivity and τR to the heat diffusion time constant along 
the radial direction. In heat transfer analysis the diffusivity coefficient (D) is the ratio of 
thermal conductivity (kt) divided by the tissue’s density (ρt) multiplied by its specific 
heat capacity (ct) at constant pressure (equation 3.13). 
 𝐷 =
𝑘𝑡
𝜌𝑡𝑐𝑡
 
(3.13) 
 
The final form of Equation 12 represents a Gaussian shaped temperature profile with a 
time dependent radius R(t) which expands with time. The expansion rate of R2(t) can 
calculated by differentiation in Equation 3.14. 
 
Using the final form of equation 3.14 the unknown tissue conductivity coefficient kt can 
be derived by monitoring the expansion of squared radius R2(t) of the Gaussian 
temperature profiles over time during cooling period as demonstrated in  Figure 3.12A. 
 
𝜌𝑡𝑐𝑡
𝜕𝑇
𝜕𝑡
 =  𝑘𝑡∇
2𝑇 − 𝑤𝑏𝑐𝑏(𝑇 − 𝑇𝑎)  +  𝑄 (3.11) 
𝑇(𝑟, 𝑡) = 𝐴(𝑡) 𝑒
(−
𝑟2
4𝐷(𝑡+𝜏𝑅)
)
 =  𝐴(𝑡) 𝑒
(−
𝑟2
𝑅2(𝑡)
)
 
 
(3.12) 
 𝜕𝑅2(𝑡)
𝜕𝑡
 =  
𝜕
𝜕𝑡
(4𝐷(𝑡 + 𝜏𝑅))  =  4𝐷 =  
4𝑘𝑡
𝜌𝑡𝑐𝑡
 (3.14) 
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As expected from equation 3.14 a plot of R2(t) against time (t) would yield a straight line 
with a gradient proportional to the conductivity coefficient kt  as showed in Figure 3.12B. 
 The method described above was used to quantify the thermal properties of the 
two soft tissue phantom recipes (brain and muscle). A spherically focused ultrasound 
transducer (Sonic Concepts, Inc., Bothell, Washington, USA) driven by a 750 W 
amplifier (JJ&A Instruments, Duvall, WA, USA) was used to sonicate the gel phantoms 
and raise the temperature at the focus. The transducer consisted of a single element 
piezoelectric crystal of 4 cm diameter and with a focal length of 95 mm.  
 
 
Figure 3.12: A) Temperature measured at a focal plane for different times (t) post 
sonication across the focus. The distribution of temperature across the focus was fitted to 
a Gaussian profile centred at maximum temperature for each point in time. R(t) 
represents the Gaussian radius which is equal to half width at half maximum of the 
Gaussian profile. B) Linear dependence of squared Gaussian radius R2(t) at different post 
sonication times (t). The gradient of the linear fit is proportional to the tissue specific 
thermal conductivity (kt) [158]. 
 
Each of the phantom gels was molded inside a rectangular container with an open top to 
allow propagation of ultrasound. The transducer and gels were positioned inside a plastic 
tank filled with degassed water.  The transducer was fixed using a holder on top of the 
gel phantom. The distance between the transducer and the gel’s top surface was shorter 
than the focal length (< 95 mm) so that the focus is created in the center of the phantom. 
The experimental setup prior to moving inside the MRI bore’s isocentre is demonstrated 
in Figure 3.13. MR temperature imaging was used to monitor temperature elevation and 
drop during the exposure. A flexible surface imaging coil (GPFLEX coil by General 
Electric, Milwaukee, USA) was positioned under the water tank. Since the surface coil 
had a limited sensitivity range (approximately 20 cm) by using this configuration the 
region of interest inside the gel phantom was brought as close as possible. 
B A 
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 The setup was positioned at the isocentre of a 1.5 Tesla MRI scanner (General 
Electric Signa Excite, Milwaukee, USA). Temperature changes were calculated using the 
proton resonance frequency shift method.  The acquisition protocol used for thermometry 
is presented in 2D SPGR sequence (repetition time (TR): 38.5ms, echo time (TE): 20 ms, 
receiver bandwidth (rBW): 15 kHz, matrix: 128 x 128 pixels, slice thickness: 5 mm, 
number of excitations (NEX): 1, displayed field of view (DFOV): 25 x 25 cm2). The 
thermometry slice was prescribed in a plane perpendicular to sound propagation and at 
the level of the focus. Following analysis a single thermal map was produced every 12 s. 
Details about magnetic resonance thermometry will be given in later chapters. Typical 
thermal maps in 2D and 3D are demonstrated in Figure 3.14. 
 
Figure 3.14:  A) Representation of thermal map of the soft tissue mimicking gel in 2D, 
B) The thermal map is illustrated in 3D with temperature being the third dimension. 
Tank with 
degassed water 
Soft tissue phantom 
Transducer 
Figure 3.13: Setup for conducting measurements of soft tissue mimicking phantoms 
thermal properties using MR thermometry techniques. 
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 The two phantoms were heated using the same sonication protocol (Acoustic 
Power: 25 W, 60 s of sonication duration). Acoustic power conversion efficiency was 
calculated using previously acquired radiation force calibration data for this particular 
transducer. The efficiency was calculated approximately at 50 % conversion of electric 
to acoustic power. The phantoms were targeted in their center in order to maintain 
uniform temperature gradients in all directions. The targeted depth was not exactly the 
same but this was not important since according to Cheng et al. [158],  conductivity only 
affected the rate of the radial expansion and not the amplitude of the Gaussian profile. 
Five temperature profiles post sonication (12, 24, 36, 48 and 60 s) were collected since 
late Gaussian peaks were masked by noise. For each profile the coefficients of the best 
fitted Gaussian function were found by using the least squares regression criterion 
between raw and modelled data. The standard deviation or sigma (σ) of each fitted 
Gaussian was used to calculate the full width at half maximum (FWHM) of the Gaussian 
temperature profile. The FWHM of a Gaussian function and the associated Gaussian 
radius R can be calculated by: 
 
The mean Gaussian radius for each point in time was calculated by averaging the radii of 
two orthogonal temperature profiles which were 15 pixels long (approximately 15 mm) 
and centered over the maximum temperature pixel as shown in (Figure 3.15). 
 
 
Figure 3.15: The two orthogonal 15 pixel long profiles (black lines) centred over the 
maximum temperature pixel used to calculate the average Gaussian radius. 
 𝑭𝑾𝑯𝑴 ≈ 𝟐. 𝟑𝟓𝟒𝟖 𝝈 ≈  𝟐𝑹 (3.15) 
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Results 
The average squared Gaussian radius of the temperature profile for the brain and muscle 
tissue mimicking phantom recipes versus the time post sonication are illustrated in Figure 
3.16. The linear dependence for both sets of data between R2(t) and time demonstrated 
that the radial expansion of the temperature profile “decelerates” with time. The two 
tested recipes resulted in slightly different slopes as a result of their difference in thermal 
conductivity. Thermal conductivity was estimated by equating the slopes of the fitted data 
with the right hand side of equation 3.14. Mass density (ρt) for each recipe was calculated 
in section 3.7 using the water displacement technique. The heat capacity of each phantom 
was estimated by using a weighted sum of the heat capacity of the two main ingredients, 
which were water and evaporated milk. This was a reasonable assumption since both 
together consisted for more than 95 % of the gel’s mass. 
 
Figure 3.16: Plot of the temperature profile’s squared Gaussian radius R2(t) versus post 
sonication time (t) for the brain and muscle agar gel phantom. 
 
From literature it was found that the nominal heat capacities for water is 4.19 J/g-ºC and 
for evaporated milk 3.94 J/g-ºC [161]. The weighted heat capacity for the brain phantom 
(75 % v/v water, 25 % v/v evaporated milk) was calculated at 4.13 J/g-ºC and for the 
muscle phantom (60% v/v water, 40% v/v evaporated milk) 4.09 J/g-ºC. 
 By substituting the above in equation 3.13, the thermal conductivities of the brain 
and muscle phantom were estimated at 0.52±0.06 W/m-ºC and 0.57±0.10 W/m-ºC 
respectively. Thermal diffusivity (D) which is a thermal property derived by dividing 
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conductivity with density and specific heat capacity, describes how quickly a material 
reacts to a change in temperature. The calculated diffusivity (D) for the brain phantom 
was 0.0012±0.0001 cm2/s and for the muscle phantom 0.0013±0.0001 cm2/s. Errors in 
conductivity and diffusivity coefficients were estimated by considering the error in slope 
of the fitted data. 
 
3.9 Conclusions 
Two calibration curves were calculated by fitting a linear model that characterized 
attenuation variation with the concentration of either silica dioxide or evaporated milk 
embedded in agar gels of 2 % weight to volume concentration. It was assumed that silica 
dioxide primarily induced only Rayleigh scattering due to the small size of particles 
compared to ultrasound’s wavelength. Evaporated milk which was introduced as a very 
low scattering material, was the primary source of acoustic absorption. For the range of 
the concentrations tested, the agar-silica dioxide gels demonstrated a linear scattering 
induced attenuation coefficients of up to 0.85 dB/cm-MHz. Compared with the study of 
Partanen et al. [4], silica produced a higher degree of attenuation for the same 
concentration. Similarly agar-evaporated milk gels transmission through assessment 
resulted in absorption induced attenuation coefficients of up to 0.38 dB/cm-MHz. The 
slopes of the two calibration curves were used to interpolate and calculate the required 
concentration for each of the two additive materials to deliver a prescribed total 
attenuation coefficient while independently controlling the contributions of scattering and 
absorption (Table 3-1).  
 
 
Table 3-1: Attenuation coefficient variation with concentration of scattering and 
absorption enhancing additives to agar gels. 
 
 Based on these calibration curves two soft tissue recipes were prepared. The brain 
recipe (2 % w/w agar, 1.2 % w/w SiO2, 25 % v/v evaporated milk) combined the two 
 Agar 2 %  (w/v)  
+ Silica Dioxide  
0 % - 3 % (w/v) 
Agar 2 %  (w/v)  
+ Evaporated Milk  
10 %-40 % (v/v) 
Attenuation Coefficient 
Primary Scattering 
(dB/cm-MHz) 
(0.28± 0.03) × % M Silica Dioxide - 
Attenuation Coefficient 
Primary Absorption 
(dB/cm-MHz) 
- (0.01±0.00) × % V Evaporated Milk 
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additives previously tested to produce a final product with a total attenuation coefficient 
(0.59 dB/cm-MHz) within the range of bibliographic data [17], [20], [162]. The relative 
contributions of scattering and absorption of 0.34 dB/cm-MHz and 0.25 dB/cm-MHz 
respectively were achieved according to attenuation and absorption measurements in 
mammalian tissues presented by Goss et al. [20] and Sehgal et al. [163]. The muscle 
phantom recipe (2 % w/w agar, 2 % w/w SiO2, 40 % v/v evaporated milk) was designed 
with an attenuation coefficient equal to 0.99 dB/cm-MHz which agreed with values (0.5–
4.1 dB/cm-MHz) found from bibliography [164], [165]. The relatively wide range of 
attenuation coefficients is due to the fact that muscles are highly anisotropic tissues since 
they have a strong directional distribution of fibers.  Experiments exploring the anisotropy 
in acoustic speed, attenuation and backscattering in rodents skeletal muscles with fibers 
orientated at  90º and 45º relative to the incident beam were conclusive [166]. It was 
suggested that the mechanisms which are responsible for anisotropy in these parameters 
were related to orientation of the elastic tissue structure and to muscle fibers acting as 
scatterers. It was assumed that there was no directional dependence of attenuation in the 
muscle phantom recipe since silica particles were orientated randomly inside the gel 
without any directional prevalence.  
 ABS was tested as a bone mimicking candidate material and its attenuation 
coefficient was assessed using the transmission through technique. It was found that ABS 
was very efficient in attenuating acoustic waves (16 dB/cm-MHz). The measured 
attenuation coefficient was within the range of values found in literature. Human bone 
attenuation data reported in bibliography are very broad as a result of the wide range of 
porosity, mineralization, bone architecture, choice of anatomical structure and the 
experimental method followed. The broadband ultrasound attenuation (BUA) coefficient 
of cortical bone, which forms the compact outer shell surrounding cancellous bone, was 
measured at different frequencies and ranged between 3.5-8.5 dB/cm-MHz [167]–[172]. 
In a comprehensive report by Duck et al. [17] skull bone attenuation (all layers) was 
measured at 22 dB/cm at 1 MHz.  Aubry et al. [173] presented a numerical model that 
correlated skull diploe layer porosity with absorption coefficient which ranged from 2-80 
dB/cm at 1.5 MHz for the same skull sample.  
 Measurements of the longitudinal acoustic speed of the two soft tissue recipes 
were also within the range of biological soft tissues (1478 m/s - 1595 m/s) [162]. The 
speed inside the muscle phantom (1529±13 m/s) was significantly higher from the brain’s 
(1485±12 m/s) because of its higher evaporated milk content. These observations agreed 
with a recent study by Farrer et al. [149] where acoustic speed in gelatin gels increased 
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with the concentration of evaporated milk concentration. Acoustic speed inside ABS 
(2048±79 m/s) was in the lower end of a typical range of values found in literature. Culjat 
et al. [162] reported a speed of 1886 m/s in trabecular bone  and of 3476 m/s in cortical 
bone.  
 The measured mass density of the muscle phantom (1.07±0.01 g/cm3) was found 
higher from brain (1.05±0.01 g/cm3). The densities of both soft tissue recipes were in 
good agreement of the values reported individually for brain (1.04 g/cm3) and muscle 
(1.09 g/cm3) tissue [162]. Density of ABS (1.04 g/cm3) was obtained by the 
manufacturer’s datasheet and was considerably lower from typical cortical bone density 
(1.97 g/cm3). Acoustic impedance was calculated by multiplying mass density with 
acoustic speed for each soft tissue recipe and the ABS bone replica. The acoustic 
impedance of ABS (2.13± 0.08 MRayl) was significantly lower from typical cortical bone 
(7.38 MRayl) [162]. This difference should be taken in to account when using the 
proposed phantoms for validating numerical models since the degree of reflected energy 
at the interface will be significantly lower compared to bone. The assessment results for 
the candidate materials acoustic properties are summarized in Table 3-2 and Table 3-3. 
 The thermal properties of the brain and muscle recipes were assessed by 
correlating the change of the temperature profile’s Gaussian radius over time at a plane 
perpendicular to the thermal focus formed by a HIFU impulse sonication. The method 
was described in a publication by Cheng et al. [158].  Thermal conductivity (0.52±0.06 
W/m-ºC for brain and 0.57±0.10 W/m-ºC for muscle) and diffusivity (0.0012±0.0001 
cm2/s for brain and 0.0013±0.0001 cm2/s for muscle) for both phantom recipes were 
found to mimic published values for non-perfused soft tissues. Creeze et al. [174] reported 
a thermal conductivity range of 0.5-0.6 W/m-ºC for non-perfused muscle while in another 
study by Diederich et al.[175], a range of 0.3-0.7 W/m-ºC for unspecified tissue samples 
was given. Thermal of properties of ABS, which was tested as a bone candidate material, 
were not assessed since in the majority of focused ultrasound applications energy is 
delivered to soft tissue. For bone applications apparent temperature is monitored in nearby 
adjacent soft tissue since bone possesses a very short T2 relaxation time and consequently 
the MR signal produced is short lived.  The specific heat of each recipe was calculated 
using a weighted linear combination of the water and milk specific heat.  The estimated 
thermal properties for the two recipes from mimicking brain and muscle tissue are 
summarized in Table 3-4. 
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Table 3-2: Acoustic properties of soft tissue mimicking materials. 
 
 
Table 3-3: Acoustic properties of bone tissue mimicking material. 
 Bone phantom 
ABS-M30 (Stratasys Ltd) 
Bone tissues of interest [162] 
Attenuation Coefficient Total 
(dB/cm-MHz) 
 
16.01 ± 6.18 22 (skull) 
12.5 (long bones) 
Acoustic speed 
 (m/s) 
2048 ± 79 2590 - 2960 (skull) 
3190 – 3406 (long bones) 
 
Mass Density 
 (g/cm3) 
1.04 [157] 1.61 (skull) 
1.42 (femur bone) 
1.41 – 1.52 (rib) 
 
Acoustic Impedance 
(MRayl) 
2.13 ± 0.08 4.17 (skull) 
4.53 – 4.84 (femur bone) 
 
 
 
Brain 
phantom 
 
Brain tissue 
[17], [20], [162], 
[163] 
Muscle 
phantom 
Muscle 
tissue 
[164], [165] 
Attenuation Coefficient 
Primary Scattering 
(dB/cm-MHz) 
 
0.34 ± 0.04 0.34 0.59 ±0.07 - 
Attenuation Coefficient 
Primary Absorption 
(dB/cm-MHz) 
 
0.25 ± 0.03 0.26  0.40 ±0.04 - 
Attenuation Coefficient 
Total 
(dB/cm-MHz) 
0.59 ± 0.05 0.6 0.99 ±0.08 0.5 - 4.1 
Acoustic speed (m/s) 1485 ± 12 1460 - 1580 1529 ± 13 1550 - 1630 
Mass Density (g/cm3) 1.05 ± 0.01 1.03 - 1.04 1.07 ± 0.01 1.04 - 1.06 
Acoustic Impedance 
(MRayl) 
1.56 ± 0.02 1.50 - 1.64 1.64 ± 0.02 1.65 - 1.74 
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Table 3-4: Thermal properties of soft tissue mimicking gel recipes. 
 
3.10  Summary 
 This chapter described the work done for characterizing important acoustic and 
thermal properties of materials destined to be used for constructing tissue mimicking 
phantoms, suitable for testing focused ultrasound thermal protocols. The acoustic 
attenuation coefficient and speed of sound of candidate materials for replicating bone 
(ABS) and soft tissue (agar-based gels) were investigated using pulse immersion 
techniques.  The agar-based gels were doped with additives to control independently from 
each other, the two main acoustic energy loss mechanisms (scattering and absorption) of 
sound energy propagating through biological tissue. Agar gels were convenient to work 
with since they possess a high melting temperature, non-toxic, easy to prepare and can be 
produced with relatively low cost. ABS is a thermoplastic material used in fused 
deposition modelling for creating geometrically accurate models. Additionally the 
thermal conductivity of the finalized agar-based gel recipes was estimated since it governs 
the rate of heat transfer from the thermal focus to the surroundings. 
 The results of this study demonstrated that the selected materials can be used to 
approximate relevant physical properties of the replicated tissues that control the 
interaction of focused ultrasound. Composite phantoms that include both bony and soft 
tissue mimicking parts of the replicated anatomy are important for testing whether the 
therapeutic goal of a focused ultrasound thermal protocol has be reached, to observe the 
temperature spatial distribution and to investigate safety issues raised by the interaction 
of ultrasound with obstructions like bone. Innovations or improvements in current 
hardware and software need to be tested prior to clinical use and therefore a tissue 
 
Brain phantom 
 
Brain tissue [17] Muscle Phantom 
 
Muscle tissue [17] 
Thermal Conductivity 
(W/mº-C) 
 
0.52±0.06  0.50 - 0.57 
(* in vitro) 
0.57±0.10 0.5 - 0.6 [174] 
(* in vitro) 
Thermal Diffusivity 
(cm2/s) 
 
0.0012±0.0001 0.0014 ± 0.0001 
(* in vitro) 
0.0013±0.0001 0.0015 ± 0.0001 
(* in vitro) 
Specific Heat (J/g-ºC) 4.13 3.6 
(* in vitro) 
4.09 3.43 
(* in vitro) 
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mimicking phantom is a very convenient tool for doing so. Close matching between 
relevant acoustic and thermal properties of the phantoms with the equivalent ones of the 
replicated biological tissue govern the validity of results produced by phantom studies.  
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4 Design and preparation of composite phantoms 
 This chapter describes the design and preparation of composite phantoms made 
out of suitable materials tested in a previous chapter. The phantoms are composed of soft 
and bone tissue mimicking materials. Three phantoms were developed and they were 
chosen to cover a wide range of HIFU hyperthermia and ablation applications guided by 
MRI that are currently approved as either a treatment option or are still under preclinical 
investigation. All three phantoms had customized attenuation properties according to the 
mimicked soft tissue. The bone components of each phantom affected the incident beam 
in a different way depending on the application. Skull bone in transcranial applications 
acts as an obstructing transmission medium in the near field whereas in bone applications 
focus is targeted on the bone directly to use constructively its high absorption coefficient 
and elevate the temperature locally to the diseased bone tissue. In rib-breast applications 
safety issues are raised from increased acoustic absorption and reflection from bone 
surface when it is situated in the far field.  
4.1 Design and fabrication of a composite head phantom for testing 
transcranial MRgFUS thermal protocols 
4.1.1 Human skull anatomy 
 The human skull consists of 28 bones that can be categorized in to two groups, 
the cranial and the facial bones. The cranial bones serve to protect and support the brain 
and the related neurovascular structures whilst facial bones hold the oral and nasal 
cavities, the sinuses and orbits.  The largest cranial bones that surround the brain consist 
of the frontal bone, the left and right parietal bone, the occipital bone and the left and 
right temporal bones. In transcranial HIFU applications, the acoustic beam is transmitted 
through the cranial bones because they usually lack any obstructing bone-air cavities and 
coupling is easier due to the smooth geometry. 
 A typical cross section of a dry frontal cranial bone is shown in Figure 4.1. Inner 
and outer tables of cortical bone enclose a layer of trabecular bone also known as diploë. 
Cortical bone is dense and tough and serves to support whole body structure and protect 
trabecular bone. Trabecular bone which has a very porous structure, is made out by a 
complex network of trabeculae. Trabeculae are thin rod and plate like shaped network of 
bone tissue. Empty space between trabeculae is filled with red bone marrow which is 
responsible for producing blood cell constituents (red and white blood cells, platelets).  
  
 71 
 
Figure 4.1: Dried human skull bone cross section [176]. Typical adult human skull 
thickness varies approximately between 5-10 mm depending on age, gender, race and 
anatomical location. 
 
Some sections of red bone marrow are vascularized to supply bone with nutrients, 
transport blood stem cells and remove mature blood cells away from the bone and into 
circulation. Air cavities better known as sinuses are voids found in the forehead and in 
face. Nasal sinuses are known to secrete mucus that moisten air flow whilst others in the 
absence of bone decrease the overall weight of the skull. Frequently at the dome of a 
human skull the two cortical tables can fuse together in the absence of a trabecular bone 
layer. 
 
4.1.2 Computed tomography (CT) of a human skull 
 High resolution CT head scan images of an anonymized adult male patient were 
randomly chosen from a public hospital’s database (Limassol General Hospital, Cyprus). 
The selected set consisted of 219 slices acquired with a CT scanner (Toshiba Aquilion 
16, Toshiba Europe GmbH) in helical mode with the following scanning parameters: 
120 kV, 322 mAs, 24 cm FOV, 16 × 0.5 mm collimation, 0.73 mm effective slice 
thickness and a 512 × 512 matrix. Using slice thinner than 1 mm was essential in order to 
minimize helical artefacts on the final 3D model of the segmented skull bone. The images 
produced by the CT scanner were DICOM (Digital Imaging and Communications in 
Medicine) formatted. DICOM images do not contain only voxel data information, but 
come with an embedded header that contains tags with information related to the patient, 
the examination and study identifiers. CT images represent a map of volume elements 
Inner table (cortical bone) 
Outer table (cortical bone) 
Trabecular bone 
Bone-air cavity 
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(voxels), where each voxel is assigned a value based on the Hounsfield scale. Hounsfield 
units (HU) of each voxel are obtained from a linear transformation of the measured linear 
attenuation coefficients. The linear attenuation coefficient describes the rate of energy 
loss by a photon beam per centimetre within a medium and depends on the medium’s 
density and of course the beam’s energy. This transformation is based on arbitrary 
definitions of the radiodensity of distilled water and air at standard temperature and 
pressure to 0 HU and -1000 HU respectively.   
4.1.3 Skull bone segmentation  
 The produced CT head scan images were imported in DICOM format into an 
interactive segmentation software (Materialise Mimics 10.0, Leuven, Belgium). This 
software can be used for segmenting images produced by 3D medical modalities like CT 
or MRI. Segmentation refers to a process that divides an image or a set of images into 
regions of similar gray level (radiodensity), color, texture, brightness, and contrast [177]. 
Following the import of CT images, the software displayed the raw axial images and the 
associated multiplanar reconstructions in the coronal and sagittal planes. 
 Skull bone is made out of layers of cortical and cancellous bone which are dense 
tissues and therefore appear on CT images as pixels with high HU (Cortical bone > 1200 
HU, Cancellous bone 300-1200 HU) [178].   A mask was created manually by setting the 
minimum and maximum threshold of radiodensities in HU to be included. Automatic 
selection was also available based on predefined HU ranges for specific anatomies. For 
this individual patient, the selected range was approximately from 360-1800 HU and 
included both cortical and cancellous bone of the skull. The selected mask displayed in 
green color is shown in Figure 4.2. 
 
Figure 4.2: Interactive segmentation of skull while discarding surrounding soft tissue. 
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 Once the mask was selected, a cropping tool was used to decrease the anatomical 
coverage in the head-feet direction. The mask was reduced to the supraorbital region since 
this was the region free of air cavities that can severely obstruct the acoustic beam. It was 
decided to create a craniotomy section on the right side of the skull’s model in order to 
provide an easy way of performing in the future sonications with and without intervening 
plastic skull. The craniotomy section was created by editing the mask in 3D mode and 
applying a circular separation filter with a diameter of 60 mm. This diameter was made 
sufficiently larger from all of the transducers to ensure that the focused field propagated 
through the craniotomy section without any interruption. The craniotomy section was 
saved as a separate mask. The next step was to calculate 3D geometries through surface 
rendering of both masks, using optimal reconstruction settings. These 3D models were 
finalized by exporting them in STL format. The acronym STL stands for Standard 
Tessellation Language format which is a file type widely used by rapid prototyping 
machines. This file type approximates geometries of closed surfaces and solid entities 
through a triangular facet-based representation. Each facet is characterized by the x, y and 
z coordinates for each of its vertices and a unit normal that defines the facet’s pointing 
out direction.  A magnified wireframe view of the skull’s STL is demonstrated in Figure 
4.3, whereas solid views of both 3D reconstructed geometries (skull and craniotomy 
section) are displayed in Figure 4.4A and Figure 4.4B respectively. 
 
 
Figure 4.3: Magnified wireframe view of the skull’s STL. 
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Figure 4.4:  A) Solid view of the skull’s STL with craniotomy, B) Magnified solid view of 
the skull’s craniotomy section. 
 The STL files were fine corrected using a diameter filter of the open source 
MeshLab software (Istituto di Scienza e Tecnologie dell'Informazione, Consiglio 
Nazionale delle Ricerche (CNR), Italy).  This was necessary to remove fragments of 
calcified vessels that were included in the radiodensity threshold range during 
segmentation. MeshLab’s automatic filters for closing open holes in the surface were also 
employed in order to produce a watertight model. The dimensions of the final skull model 
were 142 × 187 × 105 mm. 
4.1.4 Plastic skull prototyping 
 A rapid prototyping machine (Stratasys, Fortus FDM 400mc) that employs 
additive manufacturing technology was used to build a plastic replica of the segmented 
3D skull model. The building envelope of this 3D printer was 355 × 254 × 254 mm and 
it can be upgraded to 406 × 355 × 406 mm. New layers in the bottom to top direction 
were added by moving the platform in the downward direction. The printer builds the 
parts layer by layer from the bottom up direction by moving the platform in the downward 
direction. The platform’s displacement defines the layer thickness and consequently the 
replication’s though plane resolution. All models of this study were printed using the 
minimum allowable layer thickness for optimum results which was 254 μm. During 
production solid thermoplastic filament was fed from a canister at the base of the printer 
to the extrusion head. The extrusion head which hanged from the top of the printer’s oven 
was driven by computer controlled motors set to follow precisely the extrusion pathway 
in every layer. The thermoplastic material was heated until liquefied and extruded through 
the tip of a nozzle in ultra-fine beads along the extrusion path. The tip type used was 
A B 
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recommended by Stratasys as the optimal size for compromising between building time 
and through plane resolution for the particular part’s size. The 3D printer’s main parts are 
shown in Figure 4.5A-C. 
 
 
 
 For the fabrication of the skull phantom, ivory thermoplastic ABS-M30 was 
selected as the building material since its acoustic properties have been characterized in 
a previous chapter. ABS-M30 is up to 25-70 % stronger than standard ABS and is an ideal 
material for conceptual modelling, functional prototyping, manufacturing tools and end-
use-parts. According to the manufacturer’s datasheet, ABS-M30 has greater tensile, 
impact and flexural strength than standard ABS. Layer bonding is significantly stronger 
than that of standard ABS, for more durable parts. The finalized STL files were loaded in 
the Insight Stratasys software (Stratasys, Version 6.4.1, Version 3927), which was used 
to process STL models into CMB (printer’s native format) files. The CMB extension files 
are the files types used by the Stratasys printers that include all the necessary information 
to build the 3D object. During this procedure the following parameters were set by the 
user: 
1) Modeler configuration - The type of 3D printer, the type of model and support 
materials, the size of the model and support extrusion tips and finally the desired layer 
A 
B 
C 
Printing platform 
Extrusion Head 
Extrusion Tip 
Figure 4.5: A) Stratasys Fortus FDM 400mc, B) 3D Printer’s oven with platform, C) 
Extrusion head. 
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thickness were selected. The support material was a secondary material used in additive 
manufacturing technology and its purpose was to support the overhanging area of the 
object from base to top. The support style was set to sparse to save material by leaving 
air gaps. 
2) STL model orientation - The STL model can be orientated manually in any possible 
direction. Instead an automatically optimized orientation was chosen that satisfied the 
least amount of support material criterion. 
3) STL model slicing - The software calculated the slices of the orientated STL model in 
the horizontal plane based on the layer thickness set by the user in the modeler’s 
configuration section. 
4) Creating toolpath fill for model and support curves - The software calculated the 
pathway of the extrusion tip for each of the model and support material. This operation 
created the toolpaths for each layer by dividing it into regions. Each region was filled 
with toolpaths from the perimeter inwards. The first toolpath traced the perimeter of the 
region. Subsequent toolpaths followed the contour of the perimeter, until the distance 
from the perimeter was greater than or equal to the contour depth. The rest of the region 
was filled with rasters. Raster lines were 90º off between successive layers (-45º to +45º) 
in order to reduce gaps and produce a solid object. The whole processing ran 
automatically and it was completed approximately within 4 minutes on a computer 
equipped with an Intel Core i7 processor and 4 GB DDR3 RAM. Following the 
processing, the building job was manually reviewed for every slice. The processed job 
displayed the contour of the building material, the toolpath rasters and the support 
material. A snapshot of the finalized processed job is shown in Figure 4.6.   
 
Figure 4.6: Processed and ready for prototyping skull STL file. 
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5) Creating a toolpath file (CMB) - The calculated toolpaths and settings for each 
material (model and support) were written in machine specific language files.  
6) Downloading toolpath files to modeler for part building - The CMB job file was 
finally loaded in the FDM 400mc control center to set the position of the designed object 
over the available building envelope area as shown in Figure 4.7. 
 
Figure 4.7: FDM 400mc control centre after loading the model’s CMB file. 
 
 A thin plastic film was placed on the printer’s platform that prevented the hot 
materials from sticking on it and secured the oven’s door. The printing was initialized 
after the printer ran calibrations for the tips positioning system. The building time lasted 
about 24 hours. Once the printing job was finished, the larger parts of support material 
were removed manually from the printed plastic skull. The remaining parts were removed 
by immersing the model in a bath of warm water (70 ºC) that contained an acidic powder 
supplied by Stratasys (Waterworks). The ratio of water needed was 42 L of water per one 
bottle (950 g) of the soluble concentrate. The models were left to soak in the water bath 
for about 8 hours after which were removed and rinsed with clean tap water. 
 The craniotomy section was retrofitted with bronze pins to allow easy attachment 
to the plastic skull model. The pins were not expected to introduce severe MR artifacts 
while scanning the skull model, since bronze was not a ferromagnetic material. Stepping 
artifacts produced by helical CT scanning were observed on the plastic model. The 
artifacts were smoothed out by gently rubbing the plastic model with a cloth soaked with 
liquid acetone which temporarily softened ABS. A hole was drilled on the skull’s top to 
screw the skull against a platform to prevent it from moving around during experiments. 
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The final ABS skull model with the associated craniotomy section are shown in Figure 
4.8. 
 
Figure 4.8: Finalised plastic skull model produced with FDM technology. 
 
4.1.5 Composite Head Phantom 
 A composite head phantom was fabricated by molding agar gel inside the 3D 
printed plastic skull. The acoustic and thermal properties of the brain mimicking agar-
based gel recipe (2 % w/w agar, 1.2 % w/w SiO2, 25 % v/v evaporated milk) have been 
characterized in previous chapters.  The desired total gel volume was estimated at 800 
ml. The gel was prepared by dissolving 16 g of granulated agar in 660 ml of degassed and 
distilled water and was boiled to above 85 ºC. Throughout the whole process the mixture 
was continuously stirred using a magnetic Teflon stirrer. Extra 10% of water volume (60 
ml) was added to mixture to compensate for evaporation during boiling. Once agar was 
dissolved 9.6 g of silica dioxide was added to enhance attenuation through scattering. The 
mixture was left to cool down to approximately 55 ºC before adding 200 ml of degassed 
evaporated milk mildly warmed to the same temperature. Evaporated milk is a low scatter 
material that enhanced attenuation through acoustic absorption. Stirring was kept for 1-2 
min after adding milk up until the mixture homogenized. The inner surface of the plastic 
skull was covered with a Mylar film before pouring the liquid agar-silica-evaporated milk 
mixture.  This was done to prevent the gel for sticking to the walls of the plastic skull and 
trapping air. The gel was poured to fill the skull phantom and was stored overnight in a 
refrigerator to solidify. The final composite head phantom is shown in Figure 4.9 
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Figure 4.9:  Finalised composite head phantom. 
 
4.2 Design and fabrication of a composite femur bone - muscle 
phantom for testing MRgFUS thermal protocols. 
4.2.1 Femur Bone anatomy 
 The femur is the longest and strongest bone of the human skeleton and it is located 
in the thigh. The femur extends from a spherical process known as the head of femur in 
the proximal epiphysis and extends to the knee joint with the tibia of the lower leg in the 
distal epiphysis. The femur is considered as a weight bearing bone since its main function 
is to support the body’s whole weight during everyday activities. The epiphysis of femur 
bone is made out of cortical and trabecular bone. The trabecular bone in the epiphysis is 
filled with red bone marrow which is responsible of producing blood components though 
a process known as hematopoiesis. At the diaphysis level cortical bone surrounds the 
medullar cavity where yellow marrow (fat) is stored. The bone at its proximal and distal 
edges is covered with articular cartilage which is a connective tissue that provides a 
smooth, lubricated surface for articulation and to facilitate the transmission of loads with 
a low frictional coefficient. Periosteum and endosteum are membranes of connective 
tissue that exist in the exterior and interior surface of the bone. Their main function is to 
accommodate the bone stem cells, the ones that are going to further develop into 
osteoblasts and osteoclasts, which play a very important role during regeneration or 
resorption of bone tissue. The main anatomical features of a human femur bone are 
demonstrated in Figure 4.10. 
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Figure 4.10:  Anatomical features of a human femur bone [179]. 
4.2.2 CT of a human femur bone 
 High resolution images from a CT lower limbs scan of an anonymized adult 
patient were randomly chosen from a hospital’s database. The selected set consisted of 
1120 slices was acquired with a CT scanner (Toshiba Aquilion 16, Toshiba Europe 
GmbH) in helical mode with the following scanning parameters: 120 kV, automatic mA 
modulation (minimum 100 mA- maximum 450 mA) for a 12.50 standard deviation image 
quality setting, 0.5 seconds of rotation time, 38 cm of DFOV and 16×1 mm collimation. 
The reconstructed slice thickness was 1 mm with a 0.8 mm of inter-slice spacing. Back 
projected CT data were mapped in a 512 × 512 pixel matrix and with a bone reconstruction 
kernel for improved visualization. 
4.2.3  Femur bone segmentation 
 The methodology and tools used for segmenting the femur bone were exactly the 
same as the one used for the skull bone.  A mask of bone tissue was interactively created 
by manually selecting an appropriate density range (370-3070 Hounsfield units). The 
mask was cropped to include only the femur bone. Using a dynamic growth region 
segmentation tool, a second mask encapsulating the red bone marrow was first created 
and then subtracted from the initial femur bone mask. The reason of doing so was to create 
a void to be filled with Tissue Mimicking Material (TMM) in order to observe any 
temperature elevations in the medullary cavity under MR thermometry. The resulting 
model consisted of a hollow bone that included only the surrounding compact bone. The 
head and base of the femur bone were also cropped electronically to allow pouring the 
  
 81 
tissue mimicking gel inside the bone model. Views of the original STL femur bone model 
and of the finalized cropped masks are shown in Figure 4.11. 
 
 
Figure 4.11: A) View of the original femur bone STL model, B) Superior to inferior view 
of the finalised cropped femur bone STL model, and C) Inferior to superior view of the 
finalised cropped femur bone STL model. 
4.2.4 Plastic femur bone prototyping 
 The finalised STL model was printed using the Stratasys Fortus FDM 400mc. 
ABS-M30 was used as the build material. The prototyping settings were identical to the 
ones used for the plastic skull production. The maximum dimensions of the produced 
plastic bone model were 42 × 38 × 192 mm.  
4.2.5 Composite Femur-Muscle Phantom 
 The printed ABS femur bone model was embedded in an agar based gel used to 
mimic the attenuation of the surrounding skeletal muscles and provide an adequate 
acoustic window from the focused ultrasound transducer to the model of bone/muscle 
tissue interface. The fabricated muscle mimicking agar gel (2 % w/v agar, 2 % w/v silica 
dioxide, 40 % v/v evaporated milk) approximately matched an attenuation coefficient of 
1 dB/cm-MHz, which was typical for propagation normal to skeletal muscle fibers [164]. 
The muscle replica was of cylindrical shape with 15 cm diameter. The medullar cavity of 
the bone phantom was also filled with gel of the same recipe. Although bone marrow has 
a high concentration of fats and different acoustic properties from muscle tissue this was 
not taken into account since the main purpose was to observe qualitatively heat diffusion 
in the region.  Figure 4.12 shows the final form of the composite femur-muscle phantom. 
A 
B C 
38 mm 
192 mm 192 mm 
42 mm 
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Figure 4.12: ABS femur bone embedded inside a cylindrical skeletal muscle mimicking 
agar gel. 
 
4.3 Design and fabrication of a composite rib - breast phantom for 
testing MRgFUS thermal protocols. 
4.3.1 Breast anatomy 
 Breast is considered as an organ of the female reproductive system since it 
includes a milk producing gland. The gland is made out of 15-20 lobes which are 
comparted between them by adipose tissue (fat). Each lobe is divided in smaller 
compartments known as lobules each consisting of grape like alveoli which are 
responsible for secreting milk. Lobules are interconnected by tiny ducts which 
progressively increase in size to larger ducts to propel milk to the nipple. The gland is 
surrounded in its majority by adipose tissue which is usually the governing tissue that 
controls the breast’s size. Connective tissue and ligaments also exist around the mammary 
gland and their function is to support the breast and maintain its shape. 
 The breast sits over the pectoral muscles which are found posteriorly to the breast 
tissue. The main function of the pectoralis group of muscles is to control the movement 
of the arm and additionally by contracting to create void space for the ribcage to expand 
during deep inhalation. The ribcage is adjacent posteriorly to the pectoralis muscles and 
serves as a protective cage of internal thoracic organs. It consists of two bilateral sets of 
twelve bones (ribs) which articulate from the vertebral column and terminate anteriorly 
as cartilage. The cartilage endings known as costal cartilage of the first seven connect 
with the sternum directly, the next three with the lower border of the seventh rib costal 
cartilage and the remaining two are floating. The cross section of human rib is similar to 
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the femur bone with concentric layers of red bone marrow, trabecular and cortical bone. 
Typical coronal and lateral cross sections of the breast-ribcage anatomical features are 
shown in Figure 4.13.  
 
4.3.2 CT of a human rib cage 
 The rib cage model was reconstructed using a set of high resolution CT chest 
images of an anonymized female patient of medium frame size. The images set was 
acquired with a Toshiba 16-slice CT scanner (Toshiba Aquilion 16, Toshiba Europe 
GmbH) in helical mode with the following scanning parameters: 120 kV anode voltage, 
300 mA tube current, 0.9375 pitch, 0.5 s of rotation time, 15 mm table feed per rotation, 
400 mm of DFOV, 16×1 mm collimation with 1mm/1mm reconstructed slice thickness 
and inter-slice interval. Filtered backprojected CT data were mapped in a 512 × 512 pixel 
matrix and a reconstruction kernel for optimum bone visualization was used.  
4.3.3 Rib cage segmentation 
 Rib cage segmentation was completed by repeating the procedure followed for 
the skull and femur bone phantom. The mask was cropped to include the right anterior 
first rib down to the sixth. These were the ribs found behind the breast and the pectoralis 
muscle of the observed patient. The model was edited in an open source 3D mesh 
processing software (MeshLab, ISTI - CNR research center, University of Pisa , 2005). 
Using MeshLab all unnecessary fragments were removed using a minimum diameter 
Figure 4.13: Anatomical features of breast tissue. 
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filter. Craters and spikes were also removed using a smoothing filter. The maximum 
dimensions of the segmented rib cage model were 145×117×199 mm. The cropped final 
STL rib cage model is showed in Figure 4.14. 
 
 
Figure 4.14: STL partial model of the right anterior rib cage produced by segmentation 
of patient’s CT images. 
 
4.3.4 Plastic rib cage prototyping  
 The STL model was 3D printed in grey ABS-M30 using the FDM-400mc 
(Stratasys) prototyping machine. Grey ABS-M30 had identical acoustic and thermal 
properties with ivory ABS-M30 used previously.  
4.3.5 Composite breast-rib phantom 
 Breast consists mainly of adipose, glandular (lobules), connective and muscle 
tissue. The majority of breast cancer tumors are carcinomas, a type of cancer that starts 
in the cells (epithelial cells) that line organs and tissues like the breast. In fact, breast 
cancer is often a type of carcinoma called adenocarcinoma, which is carcinoma that starts 
in glandular tissue. Other types of cancers can occur in the breast, too, such as sarcomas, 
which start in the cells of muscle, fat, or connective tissue. Studies suggest that the mean 
ultrasonic speed of sound and attenuation coefficient in breasts are age related [180]. This 
fact is attributed to anatomic and physiologic changes associated with reproductivity and 
menopause. Katz-Hanani et al. [180] reported that the mean speed of sound decreases 
from 1504 ± 35 m/s at <30 y to 1452 ± 9 m/s at >60 y (p < 0.01), and the attenuation 
1st anterior right rib 
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coefficient decreases from 1.27 ± 0.32 to 0.96 ± 0.13 dB/cm-MHz (p < 0.03), 
respectively.  
 Breast tissue was mimicked with a simplistic approach. A homogeneous breast 
phantom was designed with an attenuation coefficient close to 1 dB/cm-MHz. The final 
gel product consisted of 2 % w/v agar, 2 % w/v silica dioxide and 40 % v/v evaporated 
milk. Evaporated milk contained about 7.5 % milk fat therefore the overall fat content to 
the whole volume of the breast mimicking phantom was about 3 %. This fat content was 
relatively low compared to a typical breast with a 50 % adipose (fat) tissue. A low fat 
concentration was preferred in MR thermometry studies since fat is not sensitive to proton 
resonance frequency (PRF) changes during heating. The gel was prepared and was left to 
settle inside a breast-like mold. The rib cage was sank inside the gel during molding to 
establish an acoustic window that will allow us to test the effect of bone’s interaction with 
ultrasound during exposures. The finalized composite rib-breast phantom is shown in 
Figure 4.15. 
 
Figure 4.15: Composite breast-rib phantom. 
 
4.4 Summary 
 This chapter described the design and fabrication of three composite phantoms 
(head, femur/muscle and rib/breast), each composed of a bone and a soft tissue bone part. 
The particular phantoms represented anatomies, where the application of focused 
ultrasound thermal therapy gathers great research interest. Bone replicas for each 
phantom (skull, femur and rib) were produced by 3D printing in thermoplastic ABS 
models of the segmented bony tissue from patients CT images. Soft tissue parts (brain, 
muscle and breast) were made out of agar-based gels doped with attenuation enhancing 
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agents. The gels were molded either inside or around the bone parts depending on the 
represented anatomy, to establish adequate acoustic coupling before testing their 
functionality with focused ultrasound under MRI guidance. 
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5 MR Thermometry for monitoring FUS applications 
5.1 Introduction 
  Thermal therapy options that can be used for the treatment of malignant and 
benign focal diseases are gaining popularity amongst the medical community. The 
therapeutic goal in malignant and benign tumour ablative thermal therapies is to deliver 
an adequate amount of heat to induce cellular necrosis in the delineated target which 
usually includes a margin of 0.5-1 cm of the surrounding healthy tissue. In order to 
establish efficacy of the treatment and safety for the patient throughout the whole 
procedure, these thermal therapies are guided by imaging modalities. US and MRI are the 
main modalities employed to guide HIFU nowadays. MRI guided HIFU is preferred in 
the USA and Europe for guiding prostate and uterine fibroid procedures whereas in China 
ultrasound guided systems are used for treating liver carcinomas and other solid tumours 
[181]. None of them is perfect by itself and both demonstrate advantages and 
disadvantages.  
5.2 MR vs US guided FUS 
 The success of procedural guidance during HIFU treatments depends on the 
ability of the imaging system in accurately targeting and positioning the focus and 
correlating tissue damage threshold with a measurable physical quantity or direct 
observation (e.g. temperature, bubble activity, tissue changes in their stiffness and 
attenuation). Another important aspect of an optimized HIFU guiding modality is the 
ability to simultaneously monitor the targeted volume with its boundaries and critical 
structures that sit in either pre-focal or post-focal regions in order to avoid any treatment 
related adverse events. 
 In order to fulfil the prerequisites described above, a HIFU guiding system must 
be capable of producing images of adequate spatial and temporal resolution.  Spatial 
resolution controls targeting accuracy and the sensitivity of monitoring in tissue changes 
throughout the treatment, whereas temporal resolution controls how frequently tissue 
damage is assessed. Additionally in HIFU applications where the targeted or intervening 
tissue moves, guiding systems of high temporal resolution are needed to provide feedback 
to the treatment system which can use the incoming information to apply real time 
corrections. 
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 Current state-of-the art US and MRI systems have comparable spatial and 
temporal resolution capabilities. Spatial resolution in US systems depends on the 
transducer’s operating frequency (Axial: 0.5-3 mm, Lateral: 1-3 mm) while its temporal 
resolution is correlated with the frame rate (25 ms -100 ms). In MRI the size of acquisition 
matrix and therefore the degree of spatial resolution depends on acquisition time with the 
in plane resolution typically ranging from 0.5 to 4 mm. Images of high spatial resolution 
come at cost of decreased temporal resolution ranging between 30-120 ms. A finer matrix 
requires a larger number of phase encoding steps which increases acquisition time. 
Accelerated MR techniques that use gradient echo planar imaging (GRE-EPI) or 
segmented-EPI sequences can produce temperature maps fast enough to control treatment 
outcome by filling the whole or part of k-space in one TR duration [182], [183]. Partially 
parallel imaging techniques have been successfully used in phantom studies to improve 
the temporal resolution required for temperature imaging in HIFU without compromising 
spatial resolution, slice coverage or phase sensitivity [184]. 
 Amongst the disadvantages of ultrasound guidance is its inability to penetrate 
bone and gas that raises important safety issues when critical tissue structures under 
monitoring reside in an acoustic shadow area. On the other hand in US guided systems 
the diagnostic ultrasound transducer is usually positioned concentrically relatively to the 
spherical transducer and produces a beam’s eye view. This enables the user to recognise 
acoustic shadowing along the pathway of the therapeutic beam which could potentially 
induce unwanted hot spots during HIFU sonication unless corrected. MRI is immune to 
bone and gas and can provide high quality images in adjacent areas. The FOV used in 
MRI are large which is desirable while monitoring pre-focal and post focal areas whereas 
in ultrasound the FOV is limited by operating frequency, penetration, power and 
transducer geometry. Ultrasound guided systems are compact, affordable and they do not 
raise image quality and safety concerns in the vicinity of metallic implants or objects 
compared to MR guided systems. Conventional scanning used in MRI for pre procedural 
treatment planning can be time consuming while relatively ultrasound imaging is fast. 
 The biggest difference between these two types of guidance systems that makes 
MR guided systems the primary choice when budgeting is not an issue, is its ability to 
monitor quantitatively the degree of tissue damage. MR thermometry techniques 
correlates pixel values of image produced by special sequences in quasi-real time with 
local temperature with adequate accuracy and sensitivity. By observing the produced 
thermal maps, the operator monitors the distribution of thermal dose delivered [185]. The 
threshold of cellular necrosis is tissue specific and by estimating the thermal dose 
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delivered, the efficacy of the treatment at the targeted volume can be assessed. 
Additionally temperature raise in critical structures is also continuously monitored and 
irreversible adverse effects from exceeding the threshold of thermal dose can be avoided. 
US thermometry is not yet available in clinical systems, but efforts have been made to 
develop thermal strain imaging which is a technique that correlates changes in the speed 
of sound and tissue thermal expansion with temperature [186], [187]. Currently 
monitoring of real time HIFU thermal ablation in clinical systems using ultrasound relies 
on observing hyper-echoes produced by boiling in the treated tissue which is subjective 
and can potentially lead to overtreating the area. 
5.3 MR guidance for monitoring designed tissue mimicking phantoms 
HIFU thermal protocols 
 The acoustically tissue mimicking phantoms described in previous chapters were 
designed to serve as useful tools in testing thermal HIFU protocols. As mentioned in the 
previous section, MRI is currently the only modality used in clinical systems that provides 
quantitative methods for monitoring in near real time the raise of temperature during 
treatment. Therefore for the remainder of this project the evaluation of the phantoms 
during HIFU sonications was conducted using an MRI scanner. Description of MRI 
Scanner used for guiding focused ultrasound thermal protocols in phantoms 
 For the purposes of this project a 1.5 Tesla (T) actively shielded superconducting 
magnetic resonance imaging system (General Electric Signa Excite HD, Milwaukee, 
Wisconsin, USA) installed at a private hospital (Ygia Polyclinic, Limassol, Cyprus) was 
used. The superconducting coils of the magnet were cooled with liquid helium cryogen. 
The system was equipped with a 60 cm bore and with an Echo Speed Plus set of gradients. 
The maximum amplitude of the gradients was 33 mT.m-1 with a slew rate of 120 mT.m-
1.ms-1. The data pipeline of the system uses 8 independent channels with 16 quadrature 
inputs. The receiver of each channel samples the MR signal at a high bandwidth with 
maximum frequency of 1 MHz, enabling acquisition of images with high fidelity at high 
productivity. The MRI system is illustrated in Figure 5.1. 
 Parallel imaging was also available for some multi-element coils using the GE’s 
encoding Technique named ASSET (Array Spatial Sensitivity Encoding Technique). This 
technique uses the sensitivity profile of each enabled element produced in a calibration 
scan to unwrap aliased images and restore missing k-space lines. ASSET technique 
accelerates the acquisition of compatible sequences with ASSET compatible coils, which 
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allows the user to balance appropriately between image quality and time management 
depending on the application. 
 
Figure 5.1:  Photograph of the 1.5 T GE Signa Excite HD MRI system used for guiding 
HIFU thermal exposures of the designed tissue mimicking phantoms. 
 
 The General Purpose Flexible coil (GPFLEX), which is a single channel-single 
element receive only surface coil that wraps around the anatomy of interest, was mainly 
used for imaging and conducting MR thermometry of the phantoms. It is usually used in 
clinical applications for imaging irregular-shaped regions like the hip, shoulder, brachial 
plexus, large knees that cannot fit inside the dedicated knee coil, ankle, thigh, elbow, etc.  
 HIFU transducers used for sonicating the developed phantoms were moved inside 
the bore of the magnet using an MR compatible robot, which occupied most of the 
available free space.  The GPFLEX coil seemed ideal for imaging in confined space and 
without orientation limitations. Additionally being a single element coil made it easier to 
reconstruct phase sensitive images used for MR thermometry compared to multi-elements 
coils that require tedious reconstruction of the raw data. 
5.3.1 Soft Tissue Phantoms relaxometry 
 MRI offers excellent soft tissue contrast which is ideal for monitoring accurately 
lesion formation and tissue morphological changes under HIFU hyperthermia. Tissue 
contrasts in MRI depend simultaneously on intrinsic properties of tissue like T1 and T2 
relaxation times and proton density (PD). By varying specific acquisition parameters the 
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contrast weighting of PD, T1, and T2 can be exaggerated or suppressed to enhance tissue 
differentiation and pathological changes in the image. 
 It is common practice in MR guided HIFU procedures to acquire T2-weighted 
images prior to therapy and use them for treatment planning. T1-weighted gadolinium 
enhanced images are also acquired at the end of the treatment to assess tissue necrosis 
and check the coincidence of the non-perfused volume (NPV) with the thermal map.  
Despite the fact that the designed soft tissue phantoms were homogeneous and were not 
expected to present any MR signal heterogeneity, their T1 and T2 relaxation times were 
characterized and compared with the replicated tissues for reference purposes. 
 
5.3.1.1 T1 relaxometry   
Materials and Methods 
For measuring the T1 spin-lattice relaxation time, a conventional spin echo Inversion 
Recovery (IR) sequences was used [188]. An IR sequence starts at a time t=0 with the 
application of a 180° radiofrequency (RF) slice selective pulse. This excitation forces the 
fully relaxed longitudinal magnetization vector Mz (t), where Mz (0) equals the net 
magnetization Mo, to invert towards the opposite direction. Immediately after the 
application of the inverting pulse, the longitudinal magnetization vector points in the 
opposite direction (Mz (0
+) = -Mo). Once the RF pulse is switched off the longitudinal 
magnetization relaxes back to establish thermal equilibrium at a rate R1 = 1/T1.  At a time 
t = TI, where TI represents the inversion time, a second 90° excitation RF pulse is applied 
and flips any net longitudinal magnetization that managed to relax in the meantime to the 
transverse plane. The signal is rephased by a second 180° pulse and sampled after some 
time TE in order to form the MRI images. The sequence is repeated at time TR after the 
initial 180° until all phase encoding steps are completed. For a conventional IR sequence 
the longitudinal magnetization Mz can be expressed as a function of inversion time TI 
with the following equation: 
 
𝑴𝒛(𝑻𝑰) = 𝑴𝒐(𝟏 − 𝟐𝒆
−
𝑻𝑰
𝑻𝟏  ) (5.1) 
   
In order to detect a signal in MRI, the longitudinal magnetization must be flipped in the 
transverse xy-plane. Therefore the magnitude of the longitudinal magnetization controls 
the magnitude of the detected signal. By solving the equation above we can see that Mz 
(TI) becomes zero when TI = Τ1/ln2 and therefore no magnetization is flipped with the 
90° pulse to the transverse plane. This prediction was used to estimate the T1 time of the 
soft tissue phantoms developed in previous chapters. 
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 In order to quantify the associated T1 relaxation time of the brain mimicking 
phantom, the gel was first immersed in a water tank to increase the coil’s loading and 
acquire images with acceptable signal to noise ratio. For measuring the spin–lattice 
relaxation time (T1) the phantom was imaged using the (cervical-thoracic-lumbar) CTL 
spine coil using an Inversion Recovery Spin Echo (IR-SE) pulse sequence [188] with the 
following acquisition parameters: TR = 5000 ms, TE = 20 ms, slice thickness = 5 mm, 
NEX = 4, matrix = 320 × 160 and a variable TI = 66, 316, 616, 750 ms. The mean pixel 
value of an image slice passing through the mid-section of the brain phantom for each of 
the different inversion times was calculated. The calculation was done by using a region 
of interest statistics tool which was available on the scanner. The mean pixel value is 
directly proportional to the magnetization signal in the transverse plane.  When the 
inversion time reached the limiting value of T1/ln2 as explained before, this signal 
consequently became zero. The spin lattice relaxation time was estimated by applying a 
3rd order polynomial fit to the data and were interpolated to find the nulling inversion 
time. The same methodology was used to estimate T1 for the muscle tissue mimicking 
phantom recipe. 
 
5.3.1.2 T2 relaxometry  
Materials and Methods  
The T2 or spin-spin relaxation time was estimated by taking a series of Fast Spin Echo 
(FSE) T2 weighted sequences for different effective TE: 18, 36, 63, 81 and 99 ms [188].  
In a FSE T2 weighted sequence a 90º RF excitation pulse flips the fully relaxed 
longitudinal magnetization Mz to the transverse plane. The loss of phase coherence of the 
spins results in a gradual decay of the signal in xy plane. By acquiring the decaying signal 
at different echo times TE per TR the rate of spin-spin relaxation can be estimated. In 
order to estimate the brain recipe’s T2, the phantom was scanned using the same setup 
and equipment as in the T1 relaxometry session. The scanning parameters used were: 
TR = 2500 ms, slice thickness = 3 mm, matrix = 256×256, FOV = 16 cm, Number of 
NEX = 1 and Echo Train Length (ETL) = 8. For a sufficiently long TR that allowed a full 
longitudinal magnetization relaxation between successive 90º excitations, the signal of a 
T2 weighted image can be approximated by equation 5.2, where Mxy stands for the 
transverse magnetization signal at a time TE following the excitation. 
 
 
 𝑴𝒙𝒚 (𝑻𝑬) = 𝑴𝒐𝒆
−
𝑻𝑬
𝑻𝟐
 
 (5.2) 
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Mean pixel values from the T2 weighted images of the phantom at the different echo times 
were plotted. T2 relaxation time was deduced by applying an exponential fit to the data. 
The same methodology was used for estimating T2 characteristic time for the muscle and 
breast mimicking phantom recipe. 
5.3.2 Phantom relaxometry results 
 The data acquired for the estimation of T1 relaxation time of the brain, muscle and 
breast recipe are shown in Figure 5.2 and Figure 5.3 respectively. The TI for which the 
mean pixel value became zero was interpolated. This value was substituted in the limiting 
condition where TI is equal to T1/ln2 in equation 5.1 and the associated T1 times for each 
of the two phantom recipes were estimated. The results of the estimated spin lattice 
relaxation times T1 are shown in Table 5-1. 
 
Figure 5.2: Inversion Recovery fitted data for estimating the spin-lattice (T1) relaxation 
time of the brain gel phantom. 
 
Figure 5.3: Inversion Recovery fitted data for estimating the spin-lattice (T1) relaxation 
time of the muscle gel phantom. 
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 The data for estimating the spin-spin (T2) relaxation time of the two phantom 
recipes were plotted in Figure 5.4 and Figure 5.5 respectively. An exponential trend line 
was used to fit the data acquired. An exponential trend line was used to fit the data 
acquired. The measured mean pixel value in a region of interest covering at least 50 % of 
the phantom was recorded for each TE. Since the MR signal was directly proportional to 
the transverse magnetization Mxy, the same can be assumed for the MPV.  According to 
equation 5.2 and T2 was calculated by finding the reciprocal of the fit’s exponent. All 
relaxometry results are summarized in Table 5-1. 
 
Figure 5.4: Fast Spin Echo sequence data fitted for estimating the spin-spin (T2) 
relaxation time of the brain phantom. 
  
Figure 5.5: Fast Spin Echo sequence data fitted for estimating the spin-spin (T2) 
relaxation time of the muscle phantom. 
TE (ms) 
TE (ms) 
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Table 5-1: Summary of T1 and T2 estimations for the proposed soft tissue phantom recipes 
Phantom recipe T1 (ms) T2 (ms) 
Brain phantom 910 97 
Muscle phantom 785 66 
 
Conclusions 
The results agreed with the range of relaxation times  found in white (T1:560-756 ms, 
T2:67-87 ms)  and gray (T1:1105-1200 ms, T2:77-92ms)  matter at 1.5 Tesla relaxometry 
studies [189]–[193].  The estimated T1 was in the mid-range of bibliographic data whereas 
T2 was on the higher end.  In vivo relaxometry studies [194], [195] of skeletal muscle 
demonstrated a significantly higher range  of T1 times (1008 -1180 ms) and slightly lower 
T2 times ranging between 35 and 44 ms. Breast tissue relaxometry results are usually 
reported separately for adipose and glandular tissue due to the large difference in their 
relaxation times. Relevant studies [196], [197] reported a T1 range of 367-423 ms for 
adipose tissue and 1445-1680 ms for glandular tissue. Similarly T2 in breast adipose tissue 
ranged between 53-154 ms and 54-71 ms for glandular tissue. The breast phantom 
developed was homogeneous and both of its characteristic times were found in range of 
the reported values for the main types of tissue present in a breast. The relaxation times 
of the two recipes seemed to be affected by the introduction of different milk 
concentrations that controlled water, fat and protein content per unit volume. The 
differences in T1 and T2 times can be attributed to their dependence in the molecular 
tumbling rate. Fat and protein molecules are larger in size compared to water molecules 
and tumble in a slow rate therefore exhibiting shorter relaxation times. Nevertheless the 
priority of this project was not to match the MR properties of the tissue mimicking 
phantoms and therefore deviations from tissue characteristic relaxation times was not a 
matter of great concern. As part of future work these recipes can be doped with agents 
that control T1 and T2 independently.  
5.4 MR Imaging of Skull-Brain Composite Phantom. 
 The skull-brain composite phantom was chosen to check the appearance of the 
developed phantoms in conventional MRI T1 and T2 weighted images. The phantom was 
immersed inside a water tank and was scanned using the 1.5T GE Signa Excite MRI 
scanner (GE, Milwaukee, USA) with conventional FSE T1 and T2 sequences. The 
acquisition parameters for the FSE T1 sequence were TR: 600 ms, TE: 20 ms, flip 
angle:90º, matrix:256×256, bandwidth:15 kHz, Echo Train Length:4 and for the FSE T2 
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were TR:2400 ms, TE:80 ms, flip angle:90⁰, matrix:256×256, bandwidth:15 kHz, Echo 
Train Length:12. The CTL spine coil (GE, Milwaukee, USA) was used since it produced 
the maximum signal to noise ratio from the rest of the coils. The T1 and T2 weighted of 
the composite skull-brain phantom images are shown in Figure 5.6. 
 These images provided sufficient proof that the phantom contained only MR 
compatible materials. As expected no severe artifacts were induced in the vicinity of the 
phantom. Some susceptibility artefacts were observed on the T1w image near the plastic 
skull/water interface. The plastic skull part appeared dark in both sequences due to the 
absence of water content. In the T1w image there was little contrast between the phantom 
and the surrounding water probably due the selection of a rather short TR compared to 
the phantom’s T1, whereas in the T2w image the contrast increased. Water appeared 
brighter from the brain phantom because of its long T2 relaxation time compared to the 
short T2 of the phantom that resulted in a fast MR signal decay. The contrast of the brain 
phantom with water in the T1w image looked quite similar compared to the contrast of 
the real brain with the cerebrospinal fluid (CSF) gathered in the ventricles. Similarly in 
the T2w image the CSF appeared much brighter compared to the darker brain tissue, as it 
was the case in the phantom image. Of course the composite skull-brain phantom lacked 
morphological structures visible in a real brain image resulting from the range of 
relaxation times apparent due to the coexistence of gray and white matter and other 
structures. Unlike the phantom’s case skull bone produces MR signal with the frontal 
sinuses being void. These cavities were flooded with surrounding water in the case of the 
phantom and followed water’s signal intensity behavior. Last the phantom did not 
replicate skin and muscle tissue surrounding the skull. 
 
Figure 5.6: A) T1 weighted image and B) T2 weighted images of the head phantom 
immersed in a water tank. 
A B 
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For comparison purposes, typical T1 and T2 weighted images of an adult human head are 
shown in Figure 5.7. 
 
Figure 5.7: Typical A) FSE T1 weighted image and B) FSE T2 weighted images of an 
adult’s head in a 1.5 T MRI scanner [198]. 
5.5 Proton Resonance Frequency shift (PRFS) MR Thermometry. 
 This technique is characterized by an excellent linearity for a wide range of 
temperatures (-15 ⁰C to 100 ⁰C) [199] and a near independence with tissue type and its 
thermal history [200]. PRFS has the best sensitivity response to temperature changes of 
less than 1 ⁰C and using accelerated MRI acquisition techniques it is feasible to achieve 
a temporal resolution below 1 second combined with a spatial resolution of about 2 mm 
[201].  
 PRFS thermometry can be applied through spectroscopic or phase imaging. The 
first involves the acquisition of a considerably large voxel and calculating the water 
resonance peak shift with a change in temperature from an internal reference. The internal 
reference of the acquired frequency spectrum is provided by the lipids resonance peak 
(fat) which is known of being insensitive to temperature [202]. Unfortunately 
spectroscopy sequences are slow and lack spatial resolution making them unsuitable for 
a real time accurate thermometry tool in MRI [185]. 
 On the other hand phase imaging calculates the phase change of the MR signal 
which is related to the temperature dependent PRFS. The phase imaging method can 
produce superior temporal and spatial thermal maps that satisfy the prerequisite of 
accurate real time temperature monitoring [200]. The biggest disadvantage of this method 
is its vulnerability in motion that can cause pixel misregistration and produce erroneous  
A B 
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temperature results [203]. Like in almost all other MR thermometry methods, 
implementation of fat suppression techniques is required to suppress the temperature 
insensitive MR signal from fat-rich organs.  
 For the purposes of this project PRFS thermometry was chosen to assess the 
application of HIFU thermal protocols in the developed phantoms due to the 
aforementioned advantages over the other techniques. The sensitivity of PRFS to motion 
artifacts was not an issue since the phantoms were immobile and the use of low fat content 
materials minimized the possibility of false thermometry results.  
5.5.1 Theory behind PRFS MR Thermometry. 
 The signal in clinical MRI is originates from resonating hydrogen protons of water 
molecules that constitute over 70 % of a human’s body weight. The hydrogen nucleus of 
a water molecule in free-state is shielded by the molecule’s mobile electrons. The degree 
of electronic screening around the hydrogen nucleus (proton), depends on its 
configuration and temperature. In biological tissue, water molecules are hydrogen bonded 
and form a liquid. Hydrogen bonds reduce electronic screening due to electrostatic 
attraction of the electropositive proton to its neighboring water molecule’s 
electronegative oxygen. In the vicinity of an externally applied magnetic field Bo, the 
apparent field experienced by the molecule’s hydrogen nucleus Bo′ is smaller than Bo. 
When temperature increases, water molecules spend less time in a hydrogen bonded state 
since this type of bonds are weak and require small amounts of energy to deflect or even 
break. The induced electronic screening increase and the apparent field’s decrease are 
observed as a temperature dependent decrease of the Larmor precession frequency. 
 The apparent magnetic field (Bo′) felt by these protons is related to the externally 
applied field (Bo) with following expression, where σ(T) refers to the temperature 
dependent electronic screening constant which is measure in ppm (parts per million). 
As a result the shifted proton resonance frequency (fp,T) is a function of temperature (T) 
and it can be calculated by the following Larmor Equation, where γ stands for the shielded 
proton gyromagnetic ratio (42.58 MHz /T or 267.513×106 rad/s-T).  
 
 𝑩𝒐
′ = [𝟏 −  𝝈(𝑻)] × 𝑩𝒐 (5.3) 
   
 𝒇𝒑,𝑻 =  𝜸 × 𝑩𝒐
′ =  𝜸 × [𝟏 − 𝝈(𝑻)] × 𝑩𝒐 (5.4) 
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 From equation 5.4 it can be concluded that an increase of temperature tends to 
decrease the Larmour precession frequency.Temperature change from an initial reference 
temperature level (To) to a new level (T1) can be deduced by calculating the accumulated 
phase difference that results from the change in the precession frequency [204].  The 
change in temperature from baseline (ΔΤTo, T1) is given in  equation 5.5, where ΔfTo,T1 is 
the shift in frequency in Hz and α is the proportionality constant. This constant is tissue 
independent and has been estimated to be  -0.0098±0.0005 ppm/ºC  [205]. 
 
 
∆𝑻𝑻𝒐,𝑻𝟏 =  
∆𝒇𝑻𝒐 ,𝑻𝟏
𝜸 × 𝜶 × 𝑩𝒐
 (5.5) 
   
Using a gradient echo MR sequence, the equivalent phase shift in radians (∆𝛷𝑇𝑜 ,𝑇1) 
accumulated for a time equal to TE can be calculated by modifying equation 5.5 to the 
following expression. 
 
∆𝑻𝑻𝒐,𝑻𝟏 =  
∆𝜱𝑻𝒐 ,𝑻𝟏
𝟐𝝅×𝜸×𝜶×𝑩𝒐 ×𝑻𝑬
  (5.6) 
  
Spin echo MR sequences are not used in phase imaging since the 180º pulse refocuses the 
temperature induced phase. 
 
5.6 Development of an MR Thermometry analysis software based on 
PRFS method. 
5.6.1 Overview of the Temperature Mapping Software. 
 A graphic user interface (GUI) was developed in Matlab R2014A (Mathworks, 
Natick , Massachusetts, USA) for calculating 2-dimensional temperature elevation maps 
direclty from MRI phase images using the PRFS method. Matlab is a popular 
programming language optimized for solving engineering and scientific problems with 
libraries and functions dedicated for image processing and analysis. The TempMap1 GUI 
was designed to subtract a phase image acquired at baseline temperature (Mask Image) 
from a phase image at the same location immediately thoughout the HIFU thermal 
treatment (Ablation Image).  
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5.6.2 Data collection using a phase sensitive imaging coil. 
Images for thermometry analysis were acquired using the GPFLEX coil, which is  a phase 
sensitive coil that supports quadrature detection. In quadrature detection the received 
circularly polarised MR signal is collected by the receivng coil in two orthogonal 
directions. In routine imaging this is done to increase the signal to noise ratio by a factor 
of  √2 since the same signal for each point in k-space is sampled twice. The two 90° phase 
shifted signals can be convieniently assigned to the real and imaginary part of each 
complex data point in k-space which can be manipulated appropriately to recover the 
magnitude and relative phase of the detected MR signal. Signals from real and imaginary 
channels shown in Figure 5.8 are projections of the bulk magnetization’s vector in two 
arbitrary orthogonal axes. 
 
Figure 5.8: Representation of the 90º phase shifted complex data. 
 
The signals from the Real (Re) and Imaginary (Im) channels are mathematically 
correlated with the magnitude (Mag) of the detected signal and its phase angle (Φ) as 
described in the following expressions.  
 
 𝑴𝒂𝒈 =  √𝑹𝒆𝟐 + 𝑰𝒎𝟐 (5.7) 
 
𝛷 =  𝑡𝑎𝑛−1 (
𝐼𝑚
𝑅𝑒
) 
(5.8) 
 
The expressions above were used to construct complex data for the required reference 
and ablation images in order to implement PRFS Thermometry.  
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5.6.3 Complex data reconstruction for PRFS Thermometry. 
 Reconstruction of image type other than magnitude was not available in normal 
operating mode of the GE Signa Excite 1.5 Tesla MRI system. Therefore, before 
acquiring any images the scan was initiated in research mode and reconstruction of 
magnitude, real and imaginary images was enabled by setting appropriately the ‘rhrcctrl’ 
variable. The ‘rhrcctrl’ belongs to a huge list of system specific variables which control 
scanner behaviour and are usually not accessible under normal operating conditions. This 
variable reflects a 4-bit word where the ordering of bits moving from high to low 
correspond to enabling or disabling reconstruction of imaginary, real, phase and 
magnitude images. Depending on which types of reconstructed images the user wishes to 
produce, the ‘rhrcctrl’ variable can take values between 0 and 15. The ‘rhrcctrl’ variable 
was set to 13 which corresponded to reconstructing all types of images except phase. 
Although the system was capable of reconstructing phase images that are necessary for 
PRFS thermometry, individual phase images were calculated from the corresponding real 
and imaginary images using equation 5.8. This was done since the MRI scanner applies 
a correction for gradient non-linearity at the end of every acquisition (‘Gradwarp’ by GE 
Healthcare) that involves multiple interpolations which can set the phase data to deviate 
from their real values. The three data files produced for each instance are exported in a 
unique series folder and are sorted as Magnitude, Real and Imaginary. 
 
5.6.4 Description of the TempMap1 GUI. 
 The interface of the GUI consisted of a set of pushbuttons, each executing some 
sort of function and an images panel for displaying the resulting images. The software 
takes DICOM (Digital Imaging and Communications in Medicine) files as inputs. 
DICOM is a protocol for handling data produced by imaging modalities. A DICOM file 
consists of a header that contains attributes related to patient and the scan including a 
dedicated attribute to pixel data. Unfortunatelly although MATLAB reads the image data 
of DICOM files (dicomread function) and the header’s tags (dicominfo function), it does 
not support a DICOM server functionality. This means that the user cannot import images 
directly from the MRI scanner and an external application is needed to query, retrieve and 
store the DICOM files used by the GUI. The TempMap1 GUI user interface is shown in 
Figure 5.9. 
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Figure 5.9: TempMap1 GUI user interface 
 
5.6.4.1 Single pair analysis 
In single pair analysis mode the user creates the complex data for one pair of reference 
and ablation images. At the end of the sequence a single temperature evolution map is 
produced. Each of pushbuttons MAG1, RE1 and IM1 opens a dialog box where the user 
is asked to browse and import the reconstructed magnitude, real and imaginary images 
produced by the MRI which are necessary for calculating the reference complex image. 
Similarly pushbuttons MAG2, RE2 and IM2 are used to calculate the ablation complex 
image. Importing of the aforementioned data must be done in the order described above 
(left to right in the control panel) otherwise the GUI produces a warning message.  WP1 
and WP2 buttons are used to create a matrix of equal size to the preloaded data, where 
each voxel value is equal to tan-1(IM1/RE1) and tan-1(IM2/RE2).Each voxel value 
represents the phase angle (Φ) of the MR signal and MATLAB calculates it using the 
atan2 function. This function returns phase angles defined in [-π, π] interval and therefore 
any calculated phase angle outside this range is wrapped around. Pushbuttons IC1 and 
IC2 reconstruct the final images of the pair using the complex number polar form for each 
voxel (Z) with coordinates (i, j) as shown in equation 5.9, since it was easier to manipulate 
calculations in the code.  
 𝒁(𝒊, 𝒋)  =  𝑴𝒂𝒈(𝒊, 𝒋) × 𝒆𝒊𝜱(𝒊,𝒋) 
 
(5.9) 
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The next step of the single pair analysis is the calculation of the complex difference phase 
angle matrix ΔΦ (i, j) which is done by pushbutton CD. First the complex difference 
matrix ZCD (i, j) is reconstructed by calculating for every element (i, j) of the matrix the 
product of the complex reference image Zref (i, j) with the complex conjugate of the 
ablation image Zabl (i, j) as shown in the following expressions. 
 
 The complex difference phase angle ΔΦ (i, j) is calculated using MATLAB’s 
angle function which returns the angle in radians of the complex difference matrix ZCD 
(i, j). This angle represents the phase angle difference of the bulk magnetisation vectors 
between the reference and ablation images out of which the Temperature Evolution map 
ΔT (i, j)  is calculated using the PRFS equation 5.5 . The complex difference phase ΔΦ (i, 
j) matrix is then processed by an unwrapping algorithm before pressing the TempMap 
pushbutton which is the last of the sequence. Details for the unwrapping algorithm are 
given in the following sections. 
 TempMap1 produces the final colour coded temperature evolution map using the 
PRFS equation. Calculation requires an input in the editable field where the user defines 
the tissue temperature sensitivity coefficient α in ppm/ºC. The rest of the parameters 
required for PRFS thermometry are automatically extracted from the DICOM header 
using the dicominfo function at the beginning of the sequence. Single pair analysis is 
designed for offline analysis where the input data are exported to the localhost at the end 
of the MRI acquisition. 
 
5.6.4.2 Multiple pair Thermometry analysis  
The Multiple pair analysis mode processes a series of ablation images and can serve as a 
quasi-real time temperature monitoring tool. The first step is exactly the same as in the 
single pair mode where the user must select the three DICOM files (MAG1, RE1 and 
IM1), calculate the wrapped phase matrix (WP1) and complex image (IC1) reference 
image. The series of ablation data are streamed to the GUI by a third party application 
developed in C# by other members of our group because Matlab lacks DICOM server 
functionality. In fact the application saves in a text file defined inside the GUI’s code, the 
localhost or remote host address of the ablation images folder (MAG2, RE2 and IM2). 
 
𝒁𝑪𝑫 (𝒊, 𝒋) =  𝒁𝒓𝒆𝒇(𝒊, 𝒋) ×  𝒄𝒐𝒏𝒋[𝒁𝒂𝒃𝒍(𝒊, 𝒋)] 
 
𝒁𝑪𝑫 (𝒊, 𝒋) =  𝑴𝒂𝒈𝒓𝒆𝒇(𝒊, 𝒋) × 𝑴𝒂𝒈𝒂𝒃𝒍(𝒊, 𝒋) ×  𝒆
𝒊(𝜱𝒓𝒆𝒇(𝒊,𝒋)−𝜱𝒂𝒃𝒍(𝒊,𝒋)) 
(5.10) 
 
(5.11) 
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The GUI automatically browses to the declared address and runs the sequence. The user 
defines prior to initiation of the analysis (Quick TempMap pushbutton) a configurable 
waiting time period in seconds. This is the time that the GUI runs over a loop and checks 
for changes in the ablation images folder address. Every triplet of new images produced 
are saved in a new folder and the GUI detects this by comparing the previous and current 
folder address string. Once a new triplet of images is detected the sequence runs again 
until the waiting time period expires. The output of this mode is a multi-frame colour 
coded figure that contains all the temperature maps produced.  
 
5.6.4.3 Phase Unwrapping algorithm   
 Phase unwrapping is one of the most common and difficult problems to tackle in 
medical and optical imaging. Without correction wrapped phase images appear as 
alternating bright and dark bands. Matlab offers an unwrap function which corrects the 
radian phase angles of a wrapped phase image using a modified two-dimensional version 
of Itoh’s method [206], [207]. It does that by adding multiples of ±2π up until phase 
differences between consecutive voxels of the matrix are greater than or equal to π 
radians.  The sequence is applied for every row of the voxel matrix and then the same 
process is repeated for every column. Unfortunately this method is very sensitive to noise 
present in the image which can be misconceived by the algorithm as wrapped phase 
outside the permissible phase range. Therefore elevated noise levels lead to error 
propagation across rows and columns which are catastrophic for making quantitative 
phase measurements.  
 The TempMap1 GUI uses a robust and computationally efficient unwrapping 
algorithm proposed by Herraez et al [208]. Instead of using a continuous unwrapping path 
like in Itoh’s method, this algorithm uses a quality guided non-continuous unwrapping 
path which is based on the voxels edges reliability. Each pixel is assigned to a reliability 
index (R) which is the reciprocal of the resultant second difference (RSD). The RSD of 
each pixel is a function of the individual second differences across the 4 available 
directions (horizontal, vertical, 1st diagonal, 2nd diagonal). An example of a pixel 
reliability index calculation is demonstrated in Appendix B. The algorithm then calculates 
the edge reliability index all over the pixel matrix. The edge reliability index is equal to 
the sum of the two pixels reliability adjoined at the edge. The algorithm unwraps each 
couple of pixel in a preferential order, starting with maximum edge reliability to 
minimum. Pixel clusters with minimum phase discontinuities (high signal-to-noise ratio 
(SNR)) are unwrapped first and error propagations from random noise are limited.       
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5.6.4.4 Compensation of phase offset artifacts in MR Thermometry. 
 Intermittent artifacts were observed while monitoring with MR Thermometry the 
application of HIFU sonications in the developed composite and soft tissue phantoms. 
More specifically a background phase offset compared to the reference image was 
apparent in some of the ablation images and as a result the quantitative ability of PRFS 
thermometry was obstructed.The phase offset was apparent on some images even in the 
absence of HIFU sonication or the transducer. Therefore it was soon concluded that the 
source of the problem was related to the imaging system and/or timing of the sequence. 
Although it was not investigated thoroughly, there was speculation that the source of the 
aforementioned artifacts emerged from the induction of Eddy currents. Eddy currents 
develop in MRI systems during the application of the pulsed magnetic field gradients 
used from excitation and MR signal spatial encoding. These currents are known of 
resulting in undesired secondary field gradients and magnetic field shifts that distort the 
MR signal [209].  Time dependent homogeneous field shift arising from a spatial offset 
between the gradient isocentre and the centre point of the eddy-current-carrying structures 
and the magnet’s bore tube have been reported [210].  
 In order to overcome this transient problem, a correction was applied for every 
couple of reference and ablation images. Precession frequency shift of hydrogen in lipids 
is not temperature sensitive due to the absence of hydrogen bonds. External references in 
the form of small plastic tubes filled with sunflower oil were wrapped around the 
phantoms and were used to compensate for the spatial and temporal phase shifts. An 
illustration of the oil references used to correct PRFS Thermometry in an agar-based gel 
is shown in Figure 5.10.  
 
Figure 5.10:  Magnitude image of a tissue mimicking agar based gel wrapped around 
with six sunflower oil external references for compensating system induced phase shifts 
during PRFS thermometry. 
Oil references 
External Oil references 
1 cm 
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 The phase shift compensation workflow is embedded inside the TempMap1 GUI 
code. Immediately after the user selects the magnitude reference image (MAG1), the code 
successively creates six (6) Regions of Interest (ROIs). The user drags and drops each of 
the circular ROIs to be contained within each of the available oil references. The GUI 
code records the mean pixel values of each of the user defined ROIs in the final 
unwrapped complex difference phase image. Ideally the complex difference phase should 
be zero everywhere expect the area which has been heated by HIFU.  Phase difference 
measured inside the oil references is immune to temperature fluctuations and is only 
affected by systemic spatial-temporal perturbations of phase. The external oil references 
phase difference values were used to fit with Matlab a linear polynomial surface through 
least squares regression in order to extrapolate the phase shifts developed inside the 
phantom. A linear polynomial fitting was chosen since there were no higher orders of 
phase difference fluctuations observed but rather a phase offset of constant magnitude 
that covered the whole 2D matrix of pixels. The fitted compensation matrix is described 
by the following expression were α0, α1, α2 are the polynomial coefficients and i, j 
correspond to the Cartesian coordinates of the extrapolated pixels. 
 
 
An example of a typical 2D compensation matrix applied is shown in Figure 5.11.  
 
Figure 5.11: Example of a 2D compensation matrix calculated by fitting external oil 
references phase data to a linear polynomial surface using a least absolute residuals 
(LAR) fitting method. 
  
 𝑴(𝒊, 𝒋)  =  𝒂𝟎+𝒂𝟏 ×  𝒊 + 𝒂𝟐 × 𝒋 (5.12) 
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The blue dots in Figure 5.11 represent the mean phase difference measured in each of the 
oil references ROIs. The 2D surface is fitted using equation 5.12 using the least absolutes 
residual criterion (LAR). Once the compensation matrix is calculated, it is then used to 
deduct pixel by pixel the pseudophase offset that potentially masks temperature induced 
phase shifts. When the placement of oil references was not possible a 2D correction 
matrix was created by positioning the ROIs in phantom areas that were as far as possible 
from the heated region and free of any image artefacts. 
 
5.6.5 SPGR Pulse Sequence for MR Thermometry. 
 Temporal resolution of the order of a few seconds is required when monitoring 
HIFU thermal protocols with MR Thermometry. HIFU hyperthermia applications are 
delivered within minutes while ablative HIFU applications involve steep temperature 
gradients delivered within 30-60 seconds sonications with the temperature profile 
constantly changing rapidly across the volume of tissue surrounding the acoustic focus. 
The temporal resolution of any conventional pulse sequence depends on TR, the number 
of encoding steps in phase direction (Np) and NEX. The minimum TR is limited by the 
duration of the RF pulses, the gradient system limitations and TE.  
 An SPGR pulse sequence readily available from the MRI scanner was selected for 
conducting MR Thermometry. It belongs to the GRE family of sequences which are more 
appropriate compared to spin echo when fast imaging is required. SPGR differs from 
conventional gradient echo pulse sequences in the sense that any residual transverse 
magnetization is “spoiled” at the end of every cycle and before the next excitation RF 
pulse. Spoiling is necessary when TR<T2 to disrupt transverse coherences that can affect 
the phase of the transverse magnetization in successive cycles.  
The selection of the acquisition parameters and the reasoning behind it are described 
below: 
 
1) TR: 38.5 ms 
This was the minimum repetition time allowed by the system for the minimum allowable 
matrix size of 128 × 128. In order to fill the whole of k-space for a single image the 
scanner requires 4928 ms (128 × 38.5 ms). A temporal resolution of approximately 5s 
was considered acceptable for monitoring the application of HIFU thermal protocols of 
30-60 seconds duration. 
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2) TE: 20 ms 
This selection was based on a compromise between high signal-to-noise ratio (short 
transverse magnetization decay for phantoms with T2  66ms) and temperature-to-noise 
ratio in temperature maps (larger accumulation of phase for longer TE).  
 
3) Flip angle (α): 30º 
A low flip angle was used in order to allow a significant amount of longitudinal 
magnetization to recover for this short TR. Although the Ernst angle which is the angle 
for maximum longitudinal magnetization for every TR and T1 combination is lower than 
30º, a wider flip angle was used in order to increase the T1 contrast on the magnitude 
images between the hot lesion and the background of the phantom.  
 
4) Matrix Size: 128 × 128  
The smallest possible pixel matrix allowed by the scanner was used to minimize the 
number of phase encoding steps and the overall scan time. On top of the requirement for 
an acceptable temporal resolution, this matrix size corresponded to an in-plane spatial 
resolution that varied between 1.5 – 2.3 mm per pixel for the sizes of FOV used. Such 
spatial resolution was considered adequate for monitoring the acoustic focus produced by 
the HIFU transducer (Sonic Concepts, Inc., Bothell, WA, USA) inside the phantoms 
which according to the manufacturer the -6 dB ellipsoidal iso-pressure contour spans over 
a width of 3.48 mm and 58.25 mm length [211].  
 
5) Slice Thickness: 5 mm 
A 5 mm slice thickness was large enough to contain the short axis of the focus (3.48 mm). 
A thicker slice would increase the signal-to-noise ratio but in expense of partial volume 
effects that would lead to underestimation of temperature shift. A thinner slice would 
decrease the signal-to-noise ratio and require steeper gradient fields. As mentioned 
previously the application of fast switching gradient fields is a potential source of Eddy 
currents. 
 
6) FOV: 20-30 cm 
Depending on the dimension of the phantom imaged and the direction of the acquired 
imaging slice, the FOV varied within the range of 20-30 cm. In some cases the FOV was 
adjusted appropriate to eliminate wrap-around artifacts. Although this phenomenon may 
occur in the frequency-encode direction, it is generally more severe along the phase-
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encode axis. The easiest remedy to overcome this signal misregistration problem is to 
increase the FOV in the appropriate direction to include all the region that produces MR 
signal detectable by the RF imaging coil. 
 
7) NEX: 1 
The minimum number of excitations was used to keep the total scan time to minimum. 
 
8) rBW: 15 kHz 
An intermediated rBW was chosen to balance between signal-to-noise ratio which is 
proportional to reciprocal of the rBW square root and with minimum allowable TE that 
affects the total scan time. 
 
5.6.6 Temperature error estimation in MR thermometry. 
The temperature error (ΔΤ) in each voxel of the thermometry maps is associated with the 
signal-to-noise ratio (SNR) of the magnitude image and can be estimated using the 
following equation [212], [213]. All other variables included in the expression have the 
usual meaning.  
 𝜟𝜯[℃] =
𝟒𝟎𝟎
𝑺𝑵𝑹. 𝑩𝒐[𝑻]. 𝑻𝑬[𝒎𝒔]
 (5.13) 
 
SNR was calculated using the National Electrical Manufacturers Association (NEMA) 
standard [214]. Signal was set to be equal to the mean pixel intensity of the phantom’s 
magnitude image prior to sonication, for a square region of interest containing 100 pixels. 
The standard deviation (σ) of pixel intensities was calculated by taking the mean of zero 
NMR signal region pixel intensities (in air) surrounding the phantom. Noise in MRI 
magnitude images follows a Rician distribution since pixel intensities are assigned to only 
positive values therefore underestimating true noise levels. The NEMA standard 
recommends using the following equation for determining true noise (N). 
 
 𝑵 =  
𝝈
𝟎. 𝟔𝟔
 (5.14) 
 
The Matlab code for TempMap1 GUI is illustrated in Appendix C. 
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5.7 Summary 
 The spin-lattice (T1) and spin-spin (T2) relaxation times of the developed agar-
based gel recipes were characterizing using relaxometry techniques. The estimated 
relaxation times were close to the replicated tissues times and therefore they are expected 
to induce similar temperature induced contrasts in conventional T1 and T2 weighted 
images. The chapter also described the development of a stand-alone TempMap1 GUI 
that calculated thermal maps using the PRFS technique. The TempMap1 GUI was created 
to assess the functionality of the developed composite phantoms using focused ultrasound 
thermal protocols in configurations that simulate clinical applications. 
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6 Functionality tests of the developed composite tissue 
mimicking phantoms using MR guided focused ultrasound. 
 This chapter describes a set of functionality tests ran to test the performance of 
the developed phantoms. These tests involve important quality control metrics of the soft 
tissue mimicking phantoms and assessment of the composite phantoms with setups that 
emulate clinical HIFU applications guided by MRI.  
6.1 MR compatible transducer for HIFU sonications. 
 A single element piezoelectric MR compatible spherically focused ultrasound 
transducer by Sonic Concepts (H-196, Sonic Concepts, Bothell, Washington, USA) 
shown in Figure 6.1, was used to apply high intensity sonications in continuous mode. 
According to the manufacturer’s datasheet [211], the transducer operates at the 
fundamental frequency fo (1.1 MHz) or its 3
rd harmonic 3fo (3.41 MHz). The radius of 
curvature (ROC) of the spherically focused transducer was 100 mm with an active 
element transducer diameter (D) equal to 40 mm. At 1.1 MHz and maximum electric 
power (400 W) the peak pressure at focus in water reaches 8.34 MPa corresponding to a 
spatial peak intensity at focus Isp equal to 2321 W/cm
2. The dimensions of the cigar 
shaped focus defined by the -6dB beam contour (L×W) are 58.25 mm and 3.48 mm 
respectively. 
 
Figure 6.1: Spherically focused MR compatible HIFU transducer 
6.2 Thermal repeatability test. 
Materials and Methods 
The thermal repeatability of the two tissue mimicking phantom recipes (brain and muscle) 
was assessed using PRFS thermometry. The agar based phantoms were molded inside a 
rectangular plastic box.  Each phantom was positioned for a top to bottom sonication 
inside a water tank filled with degassed water. The phantoms were sonicated using the 
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single element MR compatible HIFU transducer operating at 1.1 MHz.  The HIFU 
transducer was driven by the RFG-750 amplifier (JJ&A Instruments). The amplifier and 
transducer were connected via a matching network to minimize the reflected power.  
 This test used five sonications (acoustic power of 25W and duration of 60 s) 
targeting the four corners and the center of the rectangular phantom in order to avoid 
residual heating from neighboring sonications. The transducer was attached on plastic 
rails that allowed manual adjustment of its position in the horizontal plane and its distance 
from the phantom’s top surface. Targeting of focus was approximately 3.8 cm deep for 
the brain phantom and 1.9 cm for the muscle phantom. Temperature assessment was 
conducted using a 2D SPGR pulse sequence (TR: 38.5 ms, TE: 20 ms, rBW: 15 kHz, 
matrix size: 128 × 128, slice thickness: 5 mm, NEX: 1, DFOV: 25 x 25 cm2). MR 
Thermometry was used to record temperature evolution over time in 12 s intervals. 
Although the temporal resolution of the sequence was 5 s, the scanner increased that to 
12 s by introducing a delay between series to adjust transmitter–receiver gain and the 
center frequency of the RF pulse. The average coefficient of variation (CVavg) was 
calculated by averaging the individual coefficients of variation for each point in time for 
all five locations.  Figure 6.2 demonstrates the experimental setup for the brain mimicking 
phantom recipe. 
 
Figure 6.2: Axial magnitude image demonstrating the experimental setup for measuring 
the thermal repeatability of the brain tissue mimicking phantom. 
 
 
 
Transducer 
Agar phantom 
MR Thermometry slice 
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Results  
Plots of the temperature evolution with time in the brain and muscle phantoms are shown 
in Figure 6.3 and Figure 6.4. The average peak temperature rise developed in the muscle 
phantom (67.0 ºC) was significantly higher from the brain phantom since it was 
positioned shallower compared to the brain phantom (32.8 ºC), which introduced lower 
attenuation. Both waveforms demonstrated a rapid drop of temperature after 60 seconds 
when the HIFU beam was disabled. The rate by which temperature initially dropped was 
higher for the muscle phantom since heat transfer to the colder surrounding is faster at 
steeper temperature gradients.  
 
Figure 6.3: Temperature rise over time in brain phantom (3.8 cm deep) for an acoustical 
power of 25 W and 60 s sonication in 5 different locations. 
 
Figure 6.4: Temperature rise over time in muscle phantom (1.9 cm deep) for an acoustical 
power of 25 W and 60 s sonication in 5 different locations. 
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Conclusions  
The thermal repeatability test showed that both phantom recipes performed with similar 
response. The CVavg of temperature measurements in the brain phantom was 2.6 % and 
for 2.7 % for the muscle phantom. This result can be interpreted as a low spatial variability 
of the phantoms acoustic properties, which is an important prerequisite since the 
assessment of FUS thermal protocols depends on observing the distribution of 
temperature across the imaging plane. The CVavg  accumulates the error in temperature 
measurements, which is a function of the image’s SNR and the inherent spatial 
inhomogeneity of the acoustic properties which can be attributed to the nature of the 
fabrication method (inadequate mixing of ingredients, presence of air bubbles, etc). 
6.3 Qualitative evaluation of focused ultrasound induced heating 
dependence using a phantom of variable depth  
Materials and Methods  
A brain mimicking phantom was molded in a step like shape to create three different 
propagation depths (Figure 6.5A and Figure 6.5B).  
 
Figure 6.5:  A) Top view of the depth agar phantom demonstrating the three regions and 
external oil references surrounding the phantom, B) Sagittal T2w FRFSE image (TR: 
2000 ms, TE :61.9 ms, ETL: 16) illustrating a lateral view of the phantom. 
Deep 
Phantom 
Shallow 
Phantom 
  
Medium 
Phantom 
  
External Sunflower Oil References 
A 
B 
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The purpose of this study was to demonstrate qualitatively the correlation of target depth 
inside the phantom (shallow, medium and deep). Small tubes filled with sunflower oil 
were strapped around the phantom as external references to provide phase offset 
correction to the produced temperature maps. The phantom was immersed inside a tank 
filled with degassed water in a top to bottom sonication configuration. The sonication 
protocols used are summarized in Table 6-1. 
 
Table 6-1: Sonication protocols used for evaluating depth phantom 
 
Thermometry was conducted using the following 2D SPGR pulse sequence (TR: 38.5 ms, 
TE: 20 ms, rBW: 15 kHz, Matrix: 128 × 128, slice thickness: 10 mm, NEX: 1, DFOV: 25 
× 25 cm2), with the slices prescribed in the coronal and axial plane. The coronal slices 
were designed to coincide with the expected acoustic focus (96 mm from the transducer’s 
front face) in a plane perpendicular to the propagation direction of the acoustic beam. The 
axial thermometry slices were designed in a parallel plane using the same pulse sequence 
but with a 5 mm slice thickness. This was done to minimize partial volume effects that 
would mask the small dimensions of the focus in that plane. Thermometry images were 
analyzed using the TempMap1 GUI. 
 
Results 
Temperature at focus increased with decreasing phantom depth. Deeper phantoms 
introduced more material along the beam’s pathway and consequently higher degrees of 
attenuation (See Figure 6.6a-e). The maximum temperature rise reached in the deep 
phantom was 11.9 ºC in the coronal plane and 9.1 ºC in the axial plane for the same 
sonication settings (25 W acoustical power-60 s). Temperature rise in the coronal plane 
(20.1 ºC) of the medium phantom was approximately equal to the one measured in the 
axial plane (20.8 ºC) whereas temperatures in the shallow phantom were significantly 
different between the two orientations (37.2 ºC in coronal and 21.9 ºC in axial 
orientations). Coronal thermometry slices (perpendicular to acoustic field) produced more 
Phantom depth (cm) Acoustic Power (W) Duration (s) Orientation 
3.6  25 60 Coronal 
3.6 25 60 Axial 
2.6 25 60 Coronal 
2.6 25 60 Axial 
1.6 25 60 Coronal 
1.6 25 60 Axial 
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reliable temperature measurements from axial slices. Axial slices must be aligned 
perfectly with the central long axis of the beam in order to contain only voxels with 
protons that lie inside the focal region. Considering that the 5 mm slice thickness was 
larger than the -6 dB focal width (3.48 mm), any misalignment underestimates 
temperature measurements as a result of partial volume averaging. Far field heating was 
evident in axial images due to absorption at the bottom of the plastic container that 
conducted heat to adjacent phantom.  
 
Figure 6.6: Coronal and axial thermometry maps at maximum temperature for the (a, b) 
shallow phantom, (c, d) medium phantom and (e, f) deep phantom.  
 
The full time series of thermometry maps for both coronal and axial plane for the three 
different phantom depths is shown in Figures 1-6 in Appendix C. 
 
Conclusions 
The agar phantom attenuated the acoustic beam effectively. The degree of attenuation 
was depth dependent, which is consistent with the exponential decay of acoustic wave 
intensity along the direction of propagation. Far field heating was observed for all depths 
and it was indicative of reflection at the interface. Maximum temperature readings in the 
coronal and axial plane were different due to partial volume averaging. Additionally by 
visually inspecting the thermometry maps, the location of maximum temperature in the 
axial plane was systematically observed at a distance shorter than the focal length. This 
was attributed to nonlinear propagation that induced a shift to the thermal focus.  
6.4 Composite head phantom monitoring during HIFU thermal 
sonications using invasive temperature measurements. 
 
a c e 
b d f 
Thermal focus Thermal focus Thermal focus 
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Materials and Methods  
This experiment was the first conducted amongst others to demonstrate the functionality 
of the developed composite phantoms by exposing them to continuous wave HIFU 
sonications. At the time when the phantom head phantom was developed MR 
Thermometry was not available and therefore temperature measurements were taken 
invasively by embedding a thermocouple wire (Omega Engineering, Inc., Norwalk 
Connecticut, USA) inside the gel phantom. The 3D printed ABS skull was firmly fixed 
on a plastic base. The size of the base was designed to fit firmly inside the water tank. 
The tip of the thermocouple was set in an anterior-posterior axis and perpendicular to the 
acoustic beam’s pathway. The position of the thermocouple wire inside the skull before 
molding the brain mimicking gel is shown in Figure 6.7.  
 
 Figure 6.7: (A) Top view of the 3D-printed skull cavity, (B) Beam’s eye view through the 
60 mm circular craniotomy section showing the tip of the thermocouple wire. 
 
 This orientation was such to allow an easier beam targeting of the thermocouple’s 
tip.  The height of the thermocouple’s position was also adjusted to place its tip in the 
center of the craniotomy. The distance of the thermocouple tip from the plastic skull’s 
craniotomy section was approximately 3.5 cm. The craniotomy section was retrofitted 
with bronze pins to be easily detachable in order to perform sonications with and without 
intervening plastic skull.  The skull was filled with brain mimicking gel according to the 
Anteroposterior Axis 
Acoustic beam’s 
direction 
Plastic 
Skull 
Thermocouple 
60 mm (diameter) 
Thermocouple 
A 
B 
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brain mimicking phantom recipe presented previously (agar 2 % w/v, silica dioxide 1.2 % 
w/v, evaporated milk 25 % v/v). The total volume of the gel (800 ml) was poured inside 
the skull. Care was taken to avoid pouring the gel directly on the thermocouple and 
displacing it. The gel was moulded inside the skull and was left to reach room temperature 
and solidify. The composite head phantom with its base were immersed in a tank filled 
with degassed water. The temperature of the phantom was left to equalize with the 
temperature of the surrounding water (16 ºC). Temperature was monitored for a low 
sonication frequency that is typically used in transcranial HIFU deep brain treatment 
ablations [215]–[217]. A single element spherical transducer of 0.6 MHz central 
frequency (Piezotechnologies, S/N: 602015, diameter (D): 50 mm and focal length (R): 
100 mm) was used. The transducer was attached on a custom made plastic holder that 
allowed manual adjustment of its position in all three orthogonal axes.  The transducer 
front face was placed to point towards the craniotomy’s opening center. The transducer 
was driven by an Agilent 33220A (Keysight Technologies, California, USA) waveform 
generator and the signal was amplified with a Kalmus LA100H 100 W Broadband RF 
power amplifier (Advanced Test Equipment Corp., San Diego, California, USA).  The 
transducer was connected to the amplifier via an impedance matching circuit. The 
matching circuit minimized the reflected power. The setup configuration is shown in 
Figure 6.8. 
 
Figure 6.8: Setup of composite head phantom invasive temperature measurements using 
thermocouple and thermistor thermometers. 
 Prior to the measurement, the transducer’s position was fine adjusted relative to 
the thermocouple by identifying the position of maximum temperature elevated with a 
fast cooling rate, which indicated focal localization. Beam alignment was performed at 
low power to avoid excessive agar heating. Maximum temperature elevation 
Distance 
Thermistor probe with meter 
Immersed Head Phantom  
HIFU transducer with 
positioning holder 
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measurements in three characteristic regions of the acoustic field (near field, focus, far 
field) and on brain surface were recorded for an acoustic power of 30 W. Sonications 
lasted up until temperature readings reached a maximum. Measurements at the focus (3.5 
cm) were repeated for intact skull and in the absence of the craniotomy section.  
Results 
Temperature elevations at different locations across the beam’s propagation axis are 
shown in Table 6-2. 
Table 6-2:  Maximum Temperature elevations reached at different locations and skull 
state for acoustical power of 30 W sonications at 0.6 MHz. 
Plastic skull 
state 
Thermometer 
Type 
Position Distance(cm) 
Temperature 
Elevation (⁰C) 
Intact 
Thermistor probe Brain phantom 
surface 
0 38 
Intact Thermistor probe Near field 2 9 
Intact Thermocouple Focus 3.5 2 
Intact Thermistor probe Far field 6 1 
Skull removed Thermocouple Focus 3.5 31 
 
Conclusions  
Exposing the intact skull with moderate acoustic power (30 W) sonications at 0.6 MHz 
(high penetration) resulted in focal temperature increments that did not exceed ambient 
by more than 2 ºC, whereas temperature at brain phantom surface was indicative of 
excessive skull heating (38 ºC). This experiment demonstrated a common problem of 
transcranial HIFU where acoustic energy is not transferred efficiently at focus while skull 
bone is heated. The small active area of the single element HIFU transducer (~20 cm2) 
focused the beam over an even smaller area on the plastic skull surface transferring 
considerably large amounts of power per unit area. The high intensity pressure wave 
propagating though the skull was converted to heat by plastic skull which possessed an 
attenuation coefficient in the range of skull bone tissue (16 dB/cm-MHz). MRgFUS 
vendors use semispherical helmet-like phased arrays to manage skull excessive heating 
by distributing acoustic energy over a larger surface area [218], [219] .  
 Acoustic wavefront dephasing occurred during propagation through the skull of 
high variability in thickness. The dephasing effect was intensified further by the high 
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propagation speed of ultrasound in ABS. The acoustic field’s dephasing limited the 
focusing gain which was observed in small focal temperature elevations. These phase 
aberrations are compensated in clinical systems by applying appropriate phase shift 
corrections calculated by computed tomography data. In the absence of skull phantom, 
temperature was elevated significantly as a result of adequate acoustic energy delivery 
and lack of significant phase aberrations. Increased temperature levels in the near field 
were possibly a result of heat conduction by the plastic skull rather than of absorption by 
the brain mimicking agar based gel phantom. 
 As expected it was not possible to transcranially focus the beam using a single 
element transducer. Excessive skull heating can be reduced by increasing the single 
element’s aperture area but compensation of skull induced phase aberrations requires an 
adaptive focusing approach that is only achievable by phased array of transducers [15], 
[220]. This functionality test demonstrated that the composite skull phantom can be a 
very useful tool for assessing the performance of transcranial HIFU instrumentation and 
the efficiency of adaptive focusing algorithm by looking in to temperature elevations and 
its profile across the treatment volume. 
6.4.1 MRI for testing composite head phantom functionality during HIFU 
thermal sonications. 
Materials and Methods  
The composite head phantom was simultaneously imaged under MRI while exposing it 
to a sonication using the 1.1 MHz (Sonic Concepts) transducer. MR thermometry was not 
available since the signal recorded in the complex data (real and imaginary) was 
erroneous. A possible cause was the large FOV (30 cm) used to cover the whole head 
phantom exceeded the sensitive range of the GPFLEX imaging coil. Instead temperature 
elevations were observed qualitatively using a SPGR pulse sequence. Since SPGR was a 
T1-weighted pulse sequence, it was expected to detect regions with increased temperature 
regions as hypointense since heat induced T1 increments progressively relax smaller 
amounts of longitudinal magnetization. 
 The composite head phantom was positioned on the treatment platform of an MR 
compatible positioning device for treating brain diseases with HIFU [221] as shown in 
Figure 6.9. The phantom was placed laterally on to the platform with the craniotomy 
section facing down. The platform was immersed a few millimeters deep in a tank filled 
with degassed water. This configuration ensured a coupling between the phantom and the   
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transducer also immersed in the water tank and underneath the treatment platform.  The 
front face of the transducer was positioned for a bottom to top sonication. The positioning 
device was capable of moving the transducer in all three orthogonal directions (xyz) for 
precise beam targeting.  
 
Figure 6.9 - Experimental configuration used during sonications of the composite head 
phantom under MR imaging. 
 
 The positioning device consisted only by MR compatible materials such as ABS 
plastic for the main body, brass screws, racks and pinions. Brass is a non-ferromagnetic 
material and does not induce serious safety or image artifacts in the vicinity of the MRI. 
The device employed three MR compatible piezoelectric ultrasonic motors (PUM) 
(Shinsei USR60E3N, Shinsei Corp., Kasuya-Setagaya-ku Tokyo, Japan) for moving the 
transducer independently in the three linear orthogonal directions. The positioning device 
and sonication parameters were controlled via a custom made interface. The latest version 
of the control software was developed in C# and was capable of moving the transducer in 
all 3 directions by controlling the PUM drivers (Shinsei USR60 Series). A computer 
communicated via an interface with a Digital Acquisition (DAQ) devices (National 
Instruments Corp.). The DAQ was responsible for translating digital inputs from the 
interface to the motor drivers which executed the displacement of the robot in the three 
Head Composite Phantom 
GPFLEX imaging coil 
MR compatible positioning 
device with 3 axes 
 MR compatible HIFU transducer 
MRI bore 
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axes. Additionally the DAQ was returning feedback from linear encoders from each axes 
for its current position. The robot’s motor drivers and encoder wires were passed in the 
MRI room through a waveguide of the Faraday’s cage. The transducer was driven by the 
power generator (JJ&A Instruments), which was equipped with a built-in-frequency 
generator operating in the range of 700 kHz to 5 MHz, an adjustable power level between 
1 and 750 W output and was capable of working both in continuous and pulse mode.  The 
generator was controlled by a series of string commands sent via a standard USB 
interface. The power line of the transducer was filtered by a low pass filter and was fed 
via an impedance matching circuit. The complete control station of the MR compatible 
positioning device, RF power generator and HIFU transducer is illustrated in Figure 6.10. 
 
Figure 6.10:  Control station of positioning device and RF power for driving the HIFU 
transducer under MRI guidance. 
 
 The transducer’s power line was passed inside the MRI room via a BNC connector 
on both sides of the Faraday’s cage penetration panel. Any cables going in and out of the 
MRI room were passed through the penetration panel to prevent interference from 
external RF signals.  The transducer’s power line through the panel’s BNC connection is 
shown in Figure 6.11. The head phantom was sonicated with the craniotomy section 
detached with two different protocols (50 W-60 s and 90 W-90 s) at 1.1 MHz in order to 
observe changes over the T1 weighted image. Using the same configuration, but this time 
with the craniotomy section attached to simulate a non-invasive transcranial approach, 
the phantom was exposed to similar acoustic energy levels (50 W-60 s). Temperature 
increment induced changes were monitored with a T1 weighted SPGR sequence (TR: 38.5 
DAQ devices Computer with interface RF generator 
Motor drivers and encoders 
unit 
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ms, TE: 2.7 ms, slice thickness: 10 mm, ETL: 1, NEX: 1, matrix size: 128 × 128, DFOV: 
30 × 30 cm). TE was set to minimum in order to minimize T2 contrast. Imaging slices 
were prescribed along the central beam axis of the axial and sagittal plane. Images in time 
series for each sonication protocol were acquired every 12 s and covered both heating and 
cooling phase. 
 
Figure 6.11: RF transmission connection through the MRI’s Faraday cage penetration 
panel. 
 
Results  
In the absence of skull, sonications induced a local increase of the temperature dependent 
T1 relaxation time. For the 50 W acoustical power and 60 s sonication, regions of 
increased temperature appeared with hypointense signal in the T1 weighted images 
(Figure 6.12A and Figure 6.12B). 
  
Figure 6.12: T1 weighted image at maximum heat deposition (60 s) in the absence of 
craniotomy section for a 50 W-60 s sonication in the A) sagittal and B) axial plane. 
RF power 
transmission 
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Hot spot 
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The slice in the sagittal plane was perpendicular to the beam axis and the heated region 
appeared as a circular-like hot spot (Figure 6.12A). Figure 6.12B illustrates the axial slice 
set parallel to the beam’s long axis where a cigar-shaped region of hypointense signal was 
observed. Observations in both planes were indicative of the temperature gradients 
developed across the focused field. The temperature increment for the 50 W-60 s and the 
90 W-90 s sonications were compared qualitatively by observing the contrast of the 
formed hot spot to its background in the T1 weighted images (Figure 6.13A and Figure 
6.13B). The window level and width were kept the same for both images to avoid contrast 
saturation. The hot spot in the 90 W-90 s was significantly darker as a result of the higher 
HIFU induced temperature. 
 
Figure 6.13: Sagittal T1 weighted images at peak temperature in the absence of 
craniotomy section for A) 50 W-60 s and B) 90 W-90 s sonication. 
 
The equivalent images of 50 W-60 s sonications with intact skull in the axial and sagittal 
plane showed no observable formation of hot regions (Figure 6.14A and Figure 6.14B). 
 
Figure 6.14: T1 weighted image at maximum heat deposition (60 s) in the presence of 
skull phantom for a 50 W-60 s sonication in the A) sagittal and B) axial plane. 
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 A careful observation of the images revealed a diffuse grey band of hypointense 
signal on brain phantom adjacent to the skull (Figure 6.14B). Temperature increase in 
that area was a result of conduction from the hot skull phantom. These results were in 
agreement with thermocouple measurements (30 W-60 s) where temperature rise at focus 
did not exceed 2 ºC whilst adjacent to the skull phantom a temperature rise of 38 ºC was 
reached. Skull thickness in the craniotomy section ranged from 3 to 12 mm which resulted 
in deleterious phase aberrations and uneven attenuation across the acoustic wavefront that 
could not be corrected using a single element transducer. Hot spots hypointense signal 
diffused during the cooling phase since heat conducted in the colder background. The full 
time series for each sonication protocol tested using the composite head phantom are 
illustrated in Appendix C. 
Conclusions 
Although temperature measurements via MR Thermometry were not available during 
HIFU sonications, results were presented through invasive thermocouple measurements 
and observations in T1 changes. In the absence of the craniotomy section, the brain 
phantom absorbed acoustic energy adequately. According to thermocouple readings the 
focal temperature reached ablative levels within seconds (54 ºC in 60 s). Observations in 
T1 weighted images in a plane perpendicular to the direction of acoustic propagation 
illustrated the formation of a fine circularly shaped region of hypointense signal. The 
contrast of the hypointense spot with its background increased for higher acoustic power 
sonications. In the transcranial configuration, the single element transducer did not focus 
the beam through the skull. The hot skull craniotomy section conducted heat to adjacent 
brain phantom whereas inadequate amounts of heat were delivered at the focus. 
Temperature increment at focus measured with the thermocouple (2 ºC after 60 s of 
sonication) was considered inadequate for ablating brain tissue in a clinical setting. 
6.5 HIFU thermal sonications of composite femur bone-muscle 
phantom under MR Thermometry monitoring. 
Materials and Methods  
This particular functionality test was designed to simulate the existing approach used in 
bone palliative treatments and assess the performance of the developed phantom under 
MR thermometry. The phantom was placed on top of the MR compatible positing 
device’s platform central square opening and immersed by a few millimeters inside a tank 
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filled with degassed water. The device was the same used for the head phantom 
functionality test. The MR compatible spherically HIFU transducer (Sonic Concepts) 
with a 40 mm diameter and 100 mm radius of curvature was also immersed underneath 
the phantom. This configuration was set for a bottom to top sonication (Figure 6.15). 
 
Figure 6.15: Experimental configuration used during sonication sonications of the 
composite femur bone-muscle phantom monitored by MR Thermometry. 
A fast gradient echo pulse sequence (FGRE) localizer was used to fine adjust the 
transducer’s position relative to the phantom (TR: 4.9 ms, TE: 1.4 ms, flip angle: 30º, 
rBW: 62 kHz, Matrix size: 256×128 and DFOV: 44 cm). Using a sagittal localizer the 
transducer was positioned 100 mm below the bone/tissue interface. This was identical to 
the clinical setup for bone metastases palliation treatments where the transducer focuses 
the acoustic beam at the bone/tissue interface. The phantom was treated with several 
sonication protocols shown in Table 6-3. 
Table 6-3: Maximum temperature (Tmax) for all the tested sonication protocols monitored 
by MR Thermometry in the axial plane 
Sonication protocol Monitoring Period (s) 
No. of thermal 
maps 
30 W-30 s (axial) 144 12 
60 W-30 s (axial) 144 12 
90 W-30 s (axial) 144 12 
30 W-60 s (axial) 216 18 
60 W-60 s (axial) 216 18 
60 W-60 (sagittal) 216 18 
Femur bone/muscle 
phantom 
Transducer 
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 Temperature elevation was monitored using PRFS thermometry. A SPGR pulse 
sequence (TR: 32ms, TE: 20 ms, Flip angle: 30º, rBW=15 kHz, slice thickness: 10 mm, 
matrix size: 128×128 and DFOV: 19 cm) was used to acquire complex data needed to 
construct the thermal maps in the axial plane as described in previous chapters. The actual 
temporal resolution of the MR thermometry sequence was 12 s per map. The phantom 
was monitored with a single MR thermometry slice orientated in a plane parallel to the 
beam’s propagation central axis (axial) for sonications of 30 W - 30 s, 30 W - 60 s, 60 W 
- 30 s, 60 W - 60 s and 90 W - 30 s (Figure 6.16). Thermometry was also conducted for a 
60 W - 60 s sonication in a plane perpendicular (sagittal) to the beam’s axis and 5mm 
away from the interface. 
 
Figure 6.16:  FGRE image of the phantom transducer setup cross section demonstrating 
the prescribed sagittal and axial thermometry slices. 
 All sonications lasting 30 s were monitored with MR Thermometry for 144 s (12 
thermal maps) and 60 s sonications for 216 s (18 thermal maps). This was done to record 
phantom thermal performance in the cooling stage. The distance of the transducer to the 
muscle/bone interface was set to 10 cm which was approximately equal to the focal 
length. This way the thermal focus was expected to form on the interface. Since no MR 
signal was expected to be produced by the plastic bone model, temperature increment was 
assessed in regions adjacent to the sonicated bone model layer. This is exactly what is 
done in all in vivo experiments where the MR signal of bones is short lived because of 
their extremely short T2 relaxation time. Thus, the efficacy of treatment was assessed on 
Axial slice 
Sagittal slice 
Transducer 
ABS plastic 
(mimicking bone) 
Gel phantom 
(mimicking muscle) 
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the basis of an apparent temperature of the muscle phantom adjacent to the treated bone 
phantom. Thermometry data were analyzed using the TempMap1 GUI.  
 
Results  
 A magnitude image of the exact prescribed axial thermometry slice is displayed in Figure 
6.17 for reference purposes.  
 
Figure 6.17: Magnitude image of the axial slice used in PRFS thermometry. 
 
 The maximum temperature rise from background developed in the phantom 
during sonication 30W - 30s was approximately 18.6 ºC (thermal map 3). The maximum 
temperature rise was determined by identifying the pixel with highest reading within 5 
pixels from the interface corresponding to a distance of 7.5 mm. Temperature kept 
increasing even after the ultrasound was switched off since bone phantom absorbed 
acoustic energy efficiently and transferred heat via thermal conduction to the surrounding 
muscle phantom. The maximum temperature rise was 22.9 ºC in thermal map 8. Thermal 
map 8 was recorded approximately 66 s after sonication was switched off and temperature 
increment was attributed to heat conducting from adjacent bone phantom. This rather 
delayed heating effect was attributed to the low thermal diffusivity of the ABS bone 
phantom. The maximum temperature in the last map during the cooling phase (108 s post 
sonication) was 18.4 ºC. The same analysis was followed for all sonication protocols and 
the max temperature rise (Tmax) at the end of each sonication protocol is shown in Table 
6-4. 
Muscle Phantom 
Bone Phantom 
Transducer 
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Table 6-4: Max temperature rise (Tmax) at the end of each sonication protocol 
Sonication protocol Tmax at the end of sonication (ºC) 
30 W - 30 s (axial) 18.6 
60 W - 30 s (axial) 27.3 
90 W - 30 s (axial) 49.7 
30 W - 60 s (axial) 30.8 
60 W - 60 s (axial) 85.6 
60 W - 60 (sagittal) 35.7 
 
Typical thermal maps (Tmax) for axial sonications at 30W - 30s, 60W - 30s and 90W - 30s 
are shown in Figure 6.18 A-C respectively. 
 
Figure 6.18: Typical thermal maps at (Tmax) for A) 30W - 30s, B) 60W - 30s and C) 90W 
- 30s. 
  
 
 
Axial thermal map for 30W-30s 
 
 
Axial thermal map for 60W-30s 
 
 
Axial thermal map for 90W-30s 
 
 
Axial thermal map for 30W-30s 
 
 
Axial thermal map for 60W-30s 
 
 
Axial thermal map for 90W-30s 
 
 
Axial thermal map for 30W-30s 
 
 
Axial thermal map for 60W-30s 
 
 
Axial thermal map for 90W-30s 
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Cooling rate was faster for sonications where higher maximum temperature were reached 
due to higher temperature gradients. The calculated SNR for the bone/muscle phantom 
was 18.5 which corresponded according to equation 5.13 to a pixel temperature error 
equal to 0.7 ºC. Pixel statistics were calculated using ImageJ (National Institutes of 
Health, USA), which is a Java open source image analysis software. The heating profile 
of the hot region formed adjacent to the bone phantom during the sonication period was 
similar to what was seen in patients [91]. Some temperature increment was also observed 
in the agar-based phantom residing in the middle of the bone. This was indicative of heat 
transferring to the gel via conduction from the hot bone phantom. For some of the tested 
sonication protocols ablative temperatures were reached. HIFU induced measured 
temperatures were consistent with HIFU dosage which was directly proportional to the 
product of acoustic power with sonication time. The 60 W- 60 s induced the maximum 
temperature and the 30 W-30 s the minimum. With 30 s sonication, the 90 W was the 
only exposure reaching ablative temperature levels (>60 ºC).  The full time series for each 
axial sonication protocol are illustrated in Appendix C. 
 The sagittal thermometry slice was set approximately 5 mm in front of the 
bone/tissue interface (Figure 6.26), to monitor a 60 W- 60 s sonication in a plane 
perpendicular to the direction of propagation. The acquisition parameters of the SPGR 
pulse sequence used for calculating the sagittal thermal maps were the same with the ones 
used in the axial plane, except slice thickness and DFOV which were 5 mm and 18 cm 
respectively. The maximum temperature elevation was 35.7 ºC with an error equal to 1.2 
ºC. Increased temperature error was a result of signal reduction since voxel volume in the 
sagittal slice was approximately 47 % of voxel volume used in the axial slice. 
Thermometry demonstrated a Gaussian temperature distribution which is typical when 
monitoring the formed focus in a plane perpendicular to the propagation direction 
(sagittal). During cooling period the Gaussian profile spread as heat diffused in the 
surrounding agar phantom. The SNR in the region of the muscle phantom adjacent to the 
treated bone is governing up to date apparent temperature in surrounding muscle is the 
index used for controlling ablation of bone lesions. The estimated SNR levels (18.5 for 
axial slice and 10.9 for sagittal slice) were found to be in the range of clinical studies 
conducted to assess the quality of MR thermometry during palliative HIFU treatment of 
bone metastases [222]. In this study the average SNR of surrounding muscle retrieved 
from 13 treatments ranged from 8.7 to 39. The good quality of temperature monitoring 
using this phantom was reflected by the estimated temperature errors (0.7 ºC-1.2 ºC), 
which were close to accuracy required (1 ºC) for closed-loop control of energy deposition Cooling Phase 
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in commercial MRgFUS systems. Typical thermal maps demonstrating the thermal lesion 
formed at peak temperature and at maximum cooling are demonstrated in Figure 6.19 A 
and Figure 6.19B respectively. 
 
Figure 6.19: Thermal maps at (A) Tmax, (B) at maximum cooling in the sagittal plane for 
a 60 W-60 s sonication using a SPGR pulse sequence.  
 
The full time series for the sagittal sonication protocol is illustrated in Appendix C. 
  
Conclusions 
This work demonstrated the functionality of the developed bone/muscle phantom for 
assessing MRgFUS protocols. The phantom was made out of MRI compatible materials 
and introduced no image artifacts, whist image quality in MR thermometry produced 
readings with similar accuracy obtained in clinical systems. The phantom’s materials 
possessed acoustic properties close to the replicated biological tissues, therefore the 
developed temperature levels were similar to HIFU clinical treatments. Phantom heating 
profiles corresponded as expected to HIFU dosage and ablative temperatures were 
reached for some of the protocols.  
 The proposed design avoided the use of biological tissue in the form of cadavers 
which unless used fresh they require formalin fixation for preservation. In vivo studies 
that use small animal models differ significantly in geometry and size and their results 
cannot be translated reliably to the clinical setting with humans. Therefore this phantom 
is not only a step forward in replacing animal models but can also improve the 
transferability of research findings in human applications. This phantom can be developed 
further in the future and serve as reference phantom of thermal dosimetry in MRgFUS 
exposures and can be used to calibrate such systems or to provide intercomparison 
between similar systems of different vendors. It is literally customizable to individual 
patient’s bone geometry and has the potential of becoming a valuable treatment planning 
or educational tool. The muscle mimicking agar-based phantom was doped with 
A B 
5 cm 5 cm 
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appropriate concentrations of silica dioxide and evaporated milk for controlling acoustic 
scatter and absorption independently. The cumulative effect of these additives was to 
approximate the attenuation coefficient of muscle tissue while simultaneously retaining 
the relative contributions of scatter and absorption.   
6.6 HIFU thermal sonications of Composite breast-rib phantom under 
MR Thermometry monitoring. 
Materials and Methods 
The phantom was placed with the breast phantom pointing downwards for a bottom to 
top HIFU sonication. The phantom was resting on top of the tissue holder of the MR 
robotic positioning device used to drive the HIFU transducer. The phantom weight was 
supported with a thin Mylar film. The breast phantom was partially sunk in the water tank 
which was later filled with degassed water to provide the necessary coupling. Lateral and 
top views of the phantom’s setup are illustrated in Figure 6.20. 
 
Figure 6.20: (A) Lateral and (B) top view of the composite breast-rib phantom resting on 
the treatment platform, with breast phantom partially sunk inside the water tank. 
 
The robotic positioning device used for this set of experiments was different from the one 
used for the bone/muscle phantom. A motorized angular axis was added that allowed the 
A 
B 
water tank breast phantom 
breast phantom Entrance of 
Transducer arm 
rib phantom 
rib phantom 
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transducer to rotate around the subject. The purpose of this modification was to 
demonstrate the effect of avoiding structures like bone by changing the acoustic beam’s 
angle of incidence. The upgraded positioning device was originally developed for 
isocentric bone HIFU applications [223]. Details of the upgraded design are given in the 
following chapter.  
 The plastic arm with the attached MR compatible 1.1 MHz transducer (Sonic 
Concepts) were immersed inside the water tank. Care was taken to remove any air bubbles 
from the transducer’s and the breast’s surface that could attenuate the beam. The position 
of the transducer relative to the phantom was set centrally underneath the breast phantom 
via the robotic system. The robotic system along with the phantom were positioned and 
centered on the MRI table. The phantom was wrapped around by the GPFLEX imaging 
coil.  A SPGR pulse sequence was used for PRFS thermometry with the following 
acquisition parameters: TR: 38.5 ms, TE: 20 ms, rBW: 15 kHz, matrix size: 128 × 128, 
slice thickness: 10 mm, NEX: 1, DFOV: 25 x 25 cm.  Figure 6.21 shows an axial SPGR 
magnitude image with the transducer positioned in the central axis of propagation. 
 
Figure 6.21: Axial magnitude image of the transducer’s position relative to the breast-
rib phantom. 
 
 The focus of the acoustic field was expected to form approximately 9 mm in front 
of the breast/rib interface at a distance equal to the focal length of the transducer (10 cm). 
Coronal thermometry slices were positioned at a distance equal to the transducer’s focal 
length (10 cm). A second coronal thermometry slice was also prescribed 5 mm from the 
ribs 
breast phantom 
transducer 
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rib/breast phantom interface in order to assess the adverse heating from rib phantom 
residing in the far field. Thermometry maps were also calculated in the axial and sagittal 
plane. Figure 6.22 illustrates the various thermometry slice planes used while monitoring 
various sonication protocols. The sonication protocols used are shown in Table 6-5.  
 
Figure 6.22: Illustration of thermometry slices prescribed in different planes for 
assessing sonication protocols in composite rib cage/breast phantom. 
 
Table 6-5: Sonication protocols used during functionality tests of the composite breast-
rib phantom 
No. 
Acoustic 
Power (W) 
Sonication 
Duration (s) 
Propagation 
Direction 
Thermometry plane 
1 45 60 Bottom to top Axial 
2 45 60 Bottom to top Coronal (near ribs) 
3 45 60 Bottom to top Coronal (on focus) 
4 45 60 Lateral Axial 
 
The transducer was activated for the first 5 maps (60 s for 12 s/map temporal resolution). 
All protocols were monitored using PRFS technique and temperature elevations were 
calculated using the TempMap1 GUI. Total temperature monitoring period lasted for 108 
s (9 thermometry maps). 
 
 
Axial plane 
Coronal 
plane 
(Near ribs) 
Coronal 
plane 
(On Focus) 
Ribs 
Transducer 
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Results  
Thermometry maps in the axial plane for a bottom to top sonication and with the rib bone 
positioned in the far field simulated a very common problem that clinicians face when 
applying HIFU (Figure 6.23A). Excessive heating well above 100 ºC was observed in 
some pixels adjacent to rib/breast interface whereas temperature raised in the focal area 
exceeding 90 ºC. These temperature levels were beyond agar’s melting point and possibly 
the artifacts observed (distribution of signal discontinuities in front of the interface) can 
be attributed to this effect. Once the transducer was rotated in the theta axis, a lateral 
sonication using the same power and duration (45 W - 60 s) the maximum temperature 
elevation decreased dramatically down to 32.5 ºC (Figure 6.23B). The presence of an 
acoustically reflective and absorptive material like the bone phantom in the line of 
propagation perturbed the distribution and magnitude of temperatures in the thermometry 
plane.  It was speculated that thermometry in the beam’s long axis was not precise since 
slice thickness (10 mm) was large compared to focal width (3.48 mm) and temperature 
measurements suffered from partial volume averaging. 
 
 
Figure 6.23: Typical axial thermal maps at Tmax for (A) 45 W-60 s sonication for a bottom 
to top approach and with the rib bone phantom residing in the far field and (B) 45W-60s 
sonication for a lateral approach while avoiding the rib bone in the far field. 
 
 Coronal thermal maps were prescribed in a plane perpendicular to the beam’s 
propagating direction were expected to produce more realistic temperatures. Voxels of 
the slice were filled with spins that their PRF has shifted by approximately the same 
degree as a result of temperature increment. Thermal maps acquired 5 mm in front of the 
rib phantom demonstrated a maximum temperature elevation equal to 60.3 ºC (Figure 
6.24A). The estimated error in temperature measurements based on SNR measurements 
was calculated to be 0.7 ºC. The equivalent measurement for the thermal at a distance 
from the transducer equal to its focal length was 63.4 ºC with an estimated temperature 
5 cm 
B A 
5 cm 
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error equal to 0.8 ºC (Figure 6.24B). The high temperature developed distally to the focus 
and near the ribs was attributed to the combined effect of the acoustic focus length 
dimension, which according to manufacturer datasheet the focus -6 dB contour was 58.25 
mm and strong reflections at the rib/breast interface. This effect was demonstrated by 
Nell et al  [224], where their experiments using bone phantoms showed that at sufficiently 
high acoustic power, reflection of the HIFU beam from bone introduced temperature 
fluctuations as much as +/-15 %.  
 
Figure 6.24: Typical coronal thermal maps at Tmax for A) 45 W-60 s sonication for a 
bottom to top approach and the thermometry slice prescribed 5 mm in front of the rib 
phantom and (B) 45 W-60 s sonication for a bottom to top approach and the thermometry 
slice prescribed at the focus. 
 
 Cooling in the focal plane took place in a faster rate due to the steep temperature 
gradient with the surroundings reaching 24.4 ºC at 48 s after the transducer was 
deactivated. The decay of maximum temperature during the cooling phase near ribs for 
the same time post sonication was 33.2 ºC indicating a slower cooling rate. A possible 
explanation for the slower heat dissipation rate was that this plane was at the proximity 
of the heat conducting bone phantom. 
 
Conclusions 
The functionality of this phantom was evaluated initially with a protocol applied using a 
bottom to top penetration and later using a lateral approach that avoided rib heating. The 
proposed phantom involved a model with the target (tissue mimicking breast phantom) 
intervening between the transducer and the ribs. It was shown using MRI thermometry, 
that when the ribs were exposed to the focused ultrasound beam (far-field), excessive 
heating was created. When the ribs were avoided, the estimated temperature using the 
same exposure was much lower, indicating that lateral ablation has clear benefits in breast 
ablation. 
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 Planning of thermometry slices played an important role in the accuracy of 
thermometry results. Although one would expect the same maximum temperature shifts 
for the same power and different slice orientations, it was concluded observed that this 
was not strictly true. Slices along the long axis of the beam are prone to positioning and 
partial volume errors. The presence of other materials near the isocentre (positioning 
device motors, transducer) can give rise to a field inhomogeneity associated with phase 
errors. These errors present a directional predominance depending on the spatial 
distribution of such materials in the vicinity of the static magnetic field. Another 
speculation was that in areas of high magnetic susceptibility difference like the rib/breast 
phantom interface, the field was distorted resulting in local phase errors when using 
sequences of the GRE family. 
 The proposed phantom combined into a single phantom both breast tissue 
equivalent (agar/silica/evaporated milk) and bone equivalent (ABS plastic). The main 
acoustic parameter contributing to energy loss during FUS exposure (attenuation) was 
carefully adjusted in the replicated soft tissue phantom to match the values found in 
humans. The cost of manufacturing the proposed phantom was low and therefore it can 
be easily offered to users in order to evaluate the performance of FUS protocols, new 
hardware, new adaptive focusing and beam steering algorithms. Since the proposed 
phantom was designed based on information extracted from human CT images, the 
dimensions involved in the phantom were considered realistic.  
 
6.7 Summary 
 The agar-based soft tissue mimicking phantoms were assessed for their thermal 
repeatability and attenuation capability at different depths. Functionality tests of the 
developed tissue mimicking composite phantoms were performed using MR 
thermometry. This involved observing the spatial distribution of temperature elevations 
induced by a single element focused ultrasound transducer operating at 1 MHz across the 
thermometry slice.  The destructive interaction of the skull phantom with ultrasound 
resulting in the absence of a thermal focus, the high efficiency of the femur bone phantom 
in absorbing acoustic energy and the strong reflections from ribcage residing in the far 
field during breast tissue ablative sonications were demonstrated. These results were 
similar to treatment safety and efficiency related observations made in relevant preclinical 
studies and prove the usefulness of these phantoms in replacing animal models for testing 
focused ultrasound thermal applications.
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7 Functionality and MR compatibility assessment of a robotic 
device designed for HIFU thermal bone treatments. 
7.1 Introduction  
 The purpose of this study was to test the functionality of a new robotic device 
developed and assess its MR compatibility. Using three linear and one angular stage, the 
positioning device navigates the transducer to easily access any target. The advantage of 
using the proposed system over conformal bone systems is that the focus is steered 
mechanically instead of electronically making it less complex, affordable and compact.  
 Transcranial HIFU applications make the use of a phased array mandatory to 
overcome skull induced aberrations. In applications where only transmission through soft 
tissue is involved, treatment using a single element transducer is feasible. The possibility 
of using single-element transducer HIFU systems was supported by results of the 
bone/muscle and rib/breast phantoms. Functionality tests showed sufficient heat at the 
targeted site. The developed device was used in synergy with the rib-breast phantom to 
demonstrate the effect of avoiding the ribs in the far field through lateral sonications. 
7.2 Short description of the system 
 The aforementioned device was a continuation of several other technologies 
designed for various applications by our group. Knowledge and experience was gained 
during the development and design of its predecessors like the brain ablation prototype 
by Mylonas et al [221], the first [225]  and upgraded [226] version of the endorectal 
MRgFUS prostate ablation system by Yiallouras et al and the recent endovaginal 
treatment system by Epaminonda et al [227]. The proposed system was produced with 
four directional degrees of freedom. These included linear motion in three orthogonal 
axes (xyz) and a rotation around the z-axis for acoustic propagations in the xy plane. 
7.2.1 Mechanical parts 
 The main body of the robotic system made out of ABS was prototyped using the 
FDM 400 3D printer (FDM400, Stratasys). The system was equipped with four 
piezoelectric ultrasonic motors (USR60-S3N, Shinsei Kogyo Corp.) for driving the HIFU 
transducer linearly in one of the three orthogonal axes and for angular rotation. The device 
has maximum dimensions (height: 25 cm, length: 38 cm and width: 22.5 cm) and can 
easily be used without space restrictions inside the cylindrical bore of any conventional 
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high-field MRI system. The range of motion of the robotic system was set to x: 8 cm, y: 
8 cm, z: 8 cm and to an azimuthal angle (θ) in xy plane spanning between 0 and 180 
degrees in a clockwise rotation. The total weight of the device was approximately 2 kg. 
Figure 7.1 illustrates the setup of the positioning device for a top to bottom bone 
treatment. 
 
Figure 7.1: Setup of HIFU bone treatment positioning device on the MRI table with 
notations pointing the PUM motors that control motion in the xyz axes and theta (θ) 
rotation.. 
 
7.2.2 Device control interface. 
 The device was controlled via a custom made user-friendly interface developed in 
C#. Motion in the four directions was controlled by the software in user-defined steps or 
in grid sequence patterns. Drivers for controlling the PUM motors and powered by a 24 
V- 2 A DC supply, were controlled via a USB 6251 data acquisition (DAQ) interface card 
(National instruments) that included timing and digital output modules. Control and 
monitoring of secondary functions was also available via the interface. 
7.2.3 Motion encoding and angular axis. 
 Optical encoders (EM1, US Digital Corporation, Vancouver, WA, USA) installed 
on the stationary parts of the device’s body returned back to the interface a digital 
feedback of the device’s displacement. The displacement was encoded by installing 
reflective linear strips on sliding racks which were displaced by each of the xyz PUM 
motors. Rotation of the angular axis was controlled by an optical encoder monitoring a 
x z 
y 
θ 
x-axis motor 
θ motor 
y-axis motor 
z-axis motor 
bone phantom 
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linear strip wrapped around a coupling frame between the PUM motor and the upper 
section of an axle. The lower end of the axle was equipped with threads which were 
coupled with a gear responsible for rotating the transducer’s arm. A CAD of the angular 
axis is shown in Figure 7.2. 
 
Figure 7.2:  CAD drawing of the angular axis complete assembly. 
 
7.2.4 HIFU system used for conducting the functionality tests. 
 The HIFU system consists of a signal generator (Agilent technologies), an RF 
amplifier (AR), and a spherical transducer made from piezoelectric ceramic (Etalon, 
Lebanon, IN, USA). The spherically focused transducer operates at 1 MHz, with a focal 
length of 10 cm and a diameter of 3 cm. 
7.2.5 Functionality test of the newly developed angular axis. 
 The functionality of the robotic device was evaluated by creating discrete and 
overlapping thermal lesions using HIFU in gel phantoms (ONDA Corporation) using the 
newly developed angular axis, that did not exist in any of the previous robotic systems 
developed by our group. The gel by ONDA Corporation under evaluation was placed in 
a degassed water tank. The transducer was attached to the arm of the positioning device 
and was immersed in the water tank to establish adequate acoustic coupling between the 
gel and transducer. During the first set of sonications two thermal lesions were created 2 
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cm deep inside the gel phantom by rotating 20 º the arm holding the transducer. The 
ultrasound intensity used was 1500 W/cm2 (spatial average in situ) for 60 s. The second 
set of sonications produced overlapping thermal lesions using 9 steps of 5 º. The intensity 
used was 1500 W/cm2 (spatial average in situ) for 60 s. Figure 7.3 demonstrates the 
formed thermal lesions for the 20 º and 5 º angular steps. 
 
Figure 7.3: A)Two thermal lesions in the gel phantom created by moving the angular axis 
of the robotic system using a discrete step of 20º and B) Overlapping thermal lesions 
created in the gel phantom by moving the angular axis of the robotic system using 9 steps 
of 5 º. 
 
7.3 MR compatibility assessment of the robotic device. 
 The American Society of Testing and Materials (ASTM) standard F2503-05 
[228], indicates the conditions for which it has been determined that a medical device or 
other item may be safely placed and used in the MR environment. HIFU positioning 
devices are no exemption and they must be tested prior to using them with humans. The 
standard makes the distinction between “MR safe” and “MR conditional” devices. “MR 
safe” corresponds to a device which poses no hazard to the patient when used in the MR 
environment but without guaranteeing of image quality degradation and loss of diagnostic 
information. The “MR conditional” classification is usually assigned to a device that 
poses no known hazards in the MR environment but with specified conditions of use. 
 The MR compatibility of the positioning device in terms of induced image 
artefacts and signal degradation in the vicinity of the piezoelectric motors, transducers 
and encoders was assessed. The robotic HIFU system was tested in a 1.5 T MR system 
A B 
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(General Electric) using the abdominal imaging coil (USA instruments, Cleveland, OH, 
USA). The DQA phantom (NiCl2-H2O, GE-Dielectric Corporation, Menomonee Falls, 
WI, USA) was used to measure the SNR was under various conditions (Motor/encoder 
activation, and transducer activation). A FSPGR pulse sequence was used to assess the 
SNR (TR: 32 ms, TE: 4.4 ms, FOV: 30 cm, matrix size: 128×128, flip angle: 30 º, rBW: 
15 kHz and NEX: 1). Being a fast gradient echo sequence FSPGR was considered 
particularly sensitive in any external interferences that could perturb the homogeneity of 
the static field and the linearity of the encoding gradients. 
  The SNR of the DQA liquid phantom was calculated for different states (ON, 
OFF) for each of the robotic system’s component that required electricity for activation 
(piezoelectric motor, optical encoder and transducer). The results are presented as a 
percentage of the maximum SNR in  
Figure 7.4. 
 
 
Figure 7.4: SNR calculations of the DQA phantom magnitude image for different 
scenarios: (ALL OUT) all the components removed from the bore, motor/ encoder (M/E 
OFF) added to the system and deactivated, motor/ encoder (M/E ON) added to the system 
and activated, transducer (TRX OFF) added to the system and deactivated, transducer 
(TRX ON) added to the system and activated, (ALL ON) all components added and 
activated. 
 
 The piezoelectric motor and optical encoder of the angular axis were the two most 
proximal components to the imaging plane. The motor/encoder pair was activated and 
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deactivated simultaneously.   As expected the maximum SNR was measured when all the 
components were removed from the bore of the magnet. There was some decrease in the 
SNR in the presence of the motor/encoder pair. Although these components did not 
contain metallic materials possibly the presence of solder contributed in to signal 
degradation by distorting the homogeneity of the static magnetic field. A further decrease 
in SNR was observed when the motor/encoder were activated. The motor was powered 
by a DC current which itself induced a secondary magnetic field around the power 
carrying wire that interacted with the MRI static field. The presence of the transducer also 
caused an SNR drop but smaller compared to the motor/encoder pair. No measureable 
change in the SNR was observed after the transducer was activated. The transducer was 
powered by an AC current which induced an alternating magnetic field. Possibly the 
nature and magnitude of the alternating magnetic field was inadequate to produce any 
measurable SNR drop. When all the component were activated the cumulative effect was 
to decrease the SNR to its minimum. The SNR drop in the worst case scenario was 
approximately 30%. No severe image geometric distortion or signal inhomogeneity was 
observed when all components were present and activated.   
 By comparing the phantom’s magnitude images for the best and worst case 
scenario it was easy to visually observe the drop in the SNR in the vicinity of all activated 
components inside the bore of the magnet (Figure 7.5).  
 
Figure 7.5: Magnitude image of the DQA phantom using the MRI sequence FSPGR when 
the motor/encoder and transducer were deactivated, and B) Corresponding image when 
the motor/encoder and transducer were all activated. 
 
A “zipper” artifact appearing as a dashed line extending perpendicular to the frequency’s 
encoding direction was observed. The artifact was attributed to RF interference signal 
produced by the motors, encoders and transducer. Additionally unshielded transmitting 
wires were possible carriers of the interfering signal, which was picked by the receiver 
chain of the imaging sub-systems.  
RF interference 
artifact 
A B 
  
 144 
7.4 Summary 
 The work described in this chapter demonstrated the functionality test for the 
updated version of a HIFU positioning device that is capable of performing sonications 
at different angles of incidence in the subject. The formation of the thermal lesions inside 
the ONDA gel indicating the line of propagation of the focused field was an index for the 
beam’s angle of incidence. Angular steps of the device for wide and narrow angle were 
completed successfully. This was a confirmation that this device can avoid obstructing 
structures like bone and air. The mechanically steered system offers a cheaper and less 
complex solution compared to other system that employ a phased array. A mechanically 
steered device that employs a single element transducer can be used for any soft tissue 
applications that do not require adaptive focusing. 
 The conditional testing was completed in a 1.5 T MRI system operating at 
standard operating conditions and the SNR measurements indicated a 30% loss when all 
current carrying components were activated with no severe image quality degradation. 
RF interference can be isolated in the future by shielding and low pass filtering all 
components. 
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8 Discussion and Future Work 
8.1 Discussion 
 The aim of the thesis was to design and develop MR compatible phantoms for 
research in the area of focused ultrasound. The basic prerequisites set at the beginning of 
the project was to use materials that mimic at least the attenuation coefficient and the 
geometry of the replicated tissue and to be MR compatible. The approach was to create a 
set of composite phantoms representing human anatomies that combined soft and bone 
tissue mimicking parts. Upon following relevant literature, it was evident that safety and 
efficacy studies of HIFU applications often report adverse effects when a bone tissue is 
within the acoustic field. Additionally the efficacy of HIFU applications targeting a soft 
tissue lesion are often limited when the acoustic beam transmits through a bone. 
 Bone tissue was mimicked using ABS. ABS seemed to be a possible bone 
mimicking candidate, since it is a popular thermoplastic polymer used in rapid 
prototyping machines for producing true size 3D models. Testing ABS as a bone replica 
was attractive since it combined strength and rigidity with good chemical resistance and 
dimensional stability which were essential for building a long lasting and inert phantom.  
Being a plastic it was expected to have a very low magnetic permeability, thus making it 
ideal for safe use inside the MRI environment while inducing minimum susceptibility 
image artefacts. Using a set of 3.5 MHz planar transducers and samples of ABS, the 
polymer’s acoustic properties were characterized using pulse echo and transmission 
through techniques. The attenuation coefficient of ABS was extrapolated from 3.5 MHz 
at 1 MHz in dB/cm assuming a linear dependence with frequency. The derived coefficient 
of 16.01 ± 6.18 dB/cm at 1 MHz was within the broad range of the reported values found 
in literature for multi-layered bones (diploe) [173], [229], [230]. The result was in 
agreement even for studies that reported BUA of cortical bone[231], [232] separately 
from trabecular bone layers[231], [233], [234], spanned over orders of magnitude due to 
great biological variability. Trabecular bone has a higher BUA due to increasing 
contribution of scatter from trabeculae especially in high frequencies. Attenuation in 
cortical bone is primarily a result of acoustic absorption with values in the lower end of 
the range.  The large error in ABS attenuation measurement was due to significant signal 
drop. The small transmitting signal’s amplitude approached the minimum Volts per 
division setting on the oscilloscope which induced high uncertainty on the reading. The 
speed of sound in the ABS specimen was estimated at 2048 ± 79 m/s which was in the 
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low end of the range of values found in literature [16], [17]. The combination of the 
measured speed of sound in ABS with its low mass density (1.04 g/cm3) given by the 
manufacturer (Stratasys) produced an acoustic impedance equal to 2.14 MRayls. 
Comparing with values reported for the acoustic impedance of human bones (3.75-7.38 
MRayls) by Goss et al [16], it was deduced that the ABS phantom would reflect 
ultrasound less than most human bones. Using a dedicated software bone models were 
created by segmenting bony tissue from medical CT images. The dimensional accuracy 
of the segmented 3D model was dependent on the user defined mask. The bone mask was 
relatively easy to define manually by observing CT images with appropriate windowing. 
Bone is a dense tissue which appears as hyper intense signal in grayscale images with 
high contrast relative to background tissue.  
 The suitability of agar based gel phantoms was investigated for creating the soft 
tissue phantom parts. The novel approach for building these agar based phantoms was the 
introduction of both absorption and scatter agents. Phantoms presented in literature have 
used different concentrations of either scattering agents or absorption agents to control 
and match the attenuation coefficient of the replicated tissue. This was considered an 
important difference compared with our approach since the main purpose of an 
acoustically tissue mimicking phantom is to reproduce the whole spectrum of acoustic 
interactions as realistically as possible. A phantom doped only with a scattering agent will 
result in significant loss of acoustic energy along the beam’s path between the transducer 
and the focus. Scattering events that redistribute acoustic energy out of the plane of 
propagation will result in a lower heating rate and lower apparent absorption in the focal 
plane compared to real tissue. Similarly a phantom doped only with an absorbing agent 
will convert acoustic energy more efficiently to heat and therefore exaggerate the heating 
rate at focal plane compared to a real tissue with the same total attenuation coefficient.  
 Silica dioxide in powdered form with particle size ranging between 0.5 -10 μm 
was used as a scattering agent whereas absorption was controlled with the addition of 
evaporated milk. The attenuation coefficient of agar based gels (2 % w/v) was assessed 
for different concentrations of either silica or evaporated milk once again using the pulse 
echo immersion technique. Although data in literature reporting the relative contributions 
of scatter and absorption to attenuation for different tissue types are rare, it was made 
possible to extract typical values for brain and muscle tissue. These data were used to 
linearly combine the required agents’ concentrations to achieve the desired relative 
contributions of scatter and absorption to total attenuation coefficient for mimicking the 
brain and muscle tissue. The finalised gel samples for brain (2 % w/v agar, 1.2 % w/v 
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silica dioxide, 25 % evaporated milk) and muscle (2 % w/v agar, 2 % w/v silica dioxide, 
40 % evaporated milk) were characterized for speed of sound, mass density , acoustic 
impedance, thermal conductivity and diffusivity.  
 The choice of the agar as a gelling agent was due to its preservation of structural 
integrity up to 85 ºC, which covers HIFU applications requiring ablative temperature 
levels. Additionally agar is not toxic unlike similar studies that used polyacrylamide 
which is a known neurotoxin that can be passed to human by either oral or even inhalation 
exposure. Preparation of agar gels does not require specialised equipment and duration of 
the whole process does not last more than 2 hours. The low cost of preparation that did 
not exceed €1 per 100 ml was the main reason for not adding preservatives to the gels. 
Fresh gels were made for every experiment and were refrigerated for up to one week after 
which they were disposed. The most important disadvantages of agar gels were the 
opaque texture and brittleness upon exertion of strain or stress. The opaqueness of the 
gels was not a real problem since the phantoms were designed for monitoring HIFU 
thermal exposures with MRI. 
 Three composite phantoms were fabricated following the selection of the 
candidate mimicking materials for bone and soft tissue. First a head phantom which was 
composed from an ABS skull part with an agar based brain mimicking gel moulded inside 
it. The second phantom was a partial ABS model of a femur bone embedded in a 
cylindrically shaped agar based muscle mimicking gel and the third one was a unilateral 
composite ABS ribs-breast phantom. A simplified approach was used for building the 
breast phantom which was mimicked using the muscle recipe. In reality the average breast 
of an adult female consists mainly from layers of adipose tissue (fat), dense fibro-
glandular tissue and pectoral muscle which variability in their acoustic properties. On the 
other hand the acoustic properties of brain and muscle tissue are usually reported in 
literature as a homogeneous media. 
 All phantoms were tested for their functionality under MRI monitoring. 
Conventional MRI monitoring in HIFU thermal treatments involves the implementation 
of MR thermometry techniques in order to non-invasively assess in quasi real time the 
evolution of the temperature distribution across the treatment envelope. The functionality 
of the composite head phantom was assessed in a transcranial treatment configuration 
where an extracorporeal 1.1 MHz single element HIFU transducer targeting a region 
inside the brain phantom. Sonications were conducted with and without intact skull while 
temperature was monitored using an implanted thermistor probe in different positions of 
the focal plane. The results of this study demonstrated inadequate focal heating due to 
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complete defocussing of the beam when the skull phantom intervened with excessive 
temperature increment near brain surface. Similar qualitative results were drawn when 
the head phantom was monitored with a SPGR T1w weighted pulse sequence.  
 A custom made GUI designed in Matlab for employing PRFS thermometry was 
developed, since the MRI system used was not equipped with integrated thermometry 
capabilities. PRFS Thermometry is up to date the only temperature monitoring technique 
employed in commercial systems since the precession frequency shifts linearly for a range 
of temperatures that covers HIFU hyperthermia and ablation applications. Another 
advantage is that the PRFS sensitivity coefficient measured in ppm/ºC is independent of 
tissue type. The GUI retrieved complex image data from the MRI, calculated the phase 
wrapped images and applied on the fly a non-continuous pathway unwrapping algorithm 
based on pixel reliability. The advantage of using this algorithm was that noise in the 
image was unwrapped last and therefore phase unwrapping errors did not propagate 
across the final image. Internal and external references in the form of tubes filled with oil 
and surrounding the phantoms were used to correct for an intermittent phase background 
offset. The unwrapped reference and post treatment images were combined to calculate 
their complex difference image. The final temperature elevation map was calculated by 
applying the PRFS equation pixel by pixel on the complex difference image. The thermal 
repeatability of the soft tissue phantoms was assessed with the TempMap1 GUI by 
calculating the coefficient of variation in temperature readings recorder at different 
locations of the phantom. Temperature readings for the same sonication protocol and 
setup were independent of phantom location. 
The femur bone/muscle phantom functionality was demonstrated by targeting the focus 
on the bone/muscle interface. This configuration replicated palliative sonications 
conducted to ablate the periosteum in patients suffering from bone metastases. The 
apparent temperatures measured by the TempMap1 GUI in the muscle tissue adjacent to 
the bone phantom reached ablative temperature even at moderate acoustic power settings. 
A frequent adverse effect that occurs when a bone resides in the far field was 
demonstrated during the ribs/breast phantom functionality test. The MR compatible 
transducer was set for a bottom to top sonication of patient laying in prone position. The 
rib cage was positioned distally to the focus and high temperatures were developed at the 
interface. Adverse bone heating was avoided using an MR compatible positioning device 
that mechanically steered the transducer for lateral sonication. The temperature level 
developed inside the breast phantom was significantly lower for the same power setting. 
Maximum temperature elevation was confined within the focal region. The positioning 
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device was assessed for its functionality and MR compatibility and showed that it could 
be a possible replacement at a lower cost and complexity compared to the phased array 
transducer systems for applications that no adaptive focusing is required. 
8.2 Future work 
This following section describes a series of improvements or additions to the existing 
work that upon completion are expected to improve the performance of the designed 
phantoms. 
 An important limitation of this study was the complete absence of perfusion in the 
designed tissue mimicking phantoms. Highly perfused tissues might be more resistant to 
thermal ablation than poorly perfused areas owing to the heat-sink effect of their blood 
supply [235]. Early studies indicated that for short pulse lengths (less than or equal to 2 
s) and small focal diameters (approximately 3 mm) produced temperature elevation and 
thermal dose which was nearly perfusion independent [236]. Nevertheless the majority 
of clinical applications would exceed this time threshold and therefore perfusion needs to 
be simulated in a tissue mimicking phantom designed for assessing reliably HIFU thermal 
applications. A possible improvement would be to introduce vessels in the agar-based 
phantoms.  Water sustained at body temperature (36 ºC) pumped by a peristaltic pump to 
simulate blood flow in a wall-less vessel around the targeted lesion to approximate 
isotropic perfusion. This would be particularly useful for the brain phantom which 
represents one of the most highly perfused human organs. 
  Breasts consist of adipose, glandular and muscle tissue that all possess slightly 
different acoustic properties. Fabricating a breast tissue phantom in a multilayer format 
with agar-based gels of different attenuation coefficient according to the replicated tissue 
layer would be more realistic than the homogeneous phantom built during this project. 
 Regions of enhanced contrast can be added to the phantom in order to test the 
spatial accuracy of the HIFU treatment. Gadolinium and agar are T1 and T2 relaxation 
time modifiers and can be used to create targets that differentiate from the background in 
T1 and T2 weighted images respectively. These images can be fused with the thermometry 
maps to quantify the displacement of the thermal focus relative to the target. 
 Many studies in literature use physical phantoms to compare with numerical 
models. The nonlinear parabolic Khokhlov-Zabolotskaya-Kuznetsov equation which 
accounts for nonlinearity, diffraction, and absorption has been applied to calculate the 
pressure field produced by HIFU source in a medium [237]. The Pennes Bioheat Equation 
has also been used in numerical models to predict the temperature distribution across a 
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perfused medium sonicated by a HIFU source [238]. The implementation of these models 
requires declaration of certain boundary conditions and characterization of medium 
specific parameters. The majority of the soft tissue mimicking gels parameters has been 
characterized (absorption coefficient, speed of sound, mass density, thermal conductivity 
and diffusivity and specific heat) in this study except the nonlinearity coefficient (B/A). 
This coefficient determines the rate of acoustic energy loss from the fundamental 
frequency to higher harmonics as a result of nonlinear propagation in high pressure fields. 
The B/A coefficient for both recipes should be measured in order to compensate the 
accumulation of nonlinear effects along the propagation direction. 
 A coating of high acoustic impedance like acrylic resin can applied to the 
surface of ABS bone phantoms to introduce reflections closer to the ones produced in 
human bone interfaces. A coating of submillimetre thickness is not expected to alter 
significantly the attenuation characteristic of the bone phantoms.  
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Appendix B 
 
Example of pixel reliability index calculation 
This example demonstrates the calculation of the reliability index for a central pixel in a 
3 x 3 pixel matrix. Second difference is defined as the difference of the first differences*.  
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
Resultant Second Difference of central pixel (RSD) = √𝐻2 + 𝑉2 + 𝐷1
2 + 𝐷2
2 = 12.04 
Reliability Index (R) = 
1
𝑅𝑆𝐷
 =  0.083 
 
*Note: During first differences calculation a simple unwrapping operation is applied were 
±2π jumps are removed.  
 
 
 
 
3 2 -1 
2 3 0 
-4 2 1 
Horizontal original sequence 2  3  0 
1st Difference  -1  3  
2nd Difference (H)   -4   
3 2 -1 
2 3 0 
-4 2 1 
Vertical original sequence 2  3  2 
1st Difference  -1  1  
2nd Difference (V)   -2   
3 2 -1 
2 3 0 
-4 2 1 
1st Diagonal original sequence 3  3  1 
1st Difference  0  2  
2nd Difference (D1)   -2   
3 2 -1 
2 3 0 
-4 2 1 
2nd Diagonal original sequence -1  3  -4 
1st Difference  -4  7  
2nd Difference (D2)   -11   
  
 154 
Appendix C 
 
Figure 1: Time series of coronal thermometry maps (1-9) in deep phantom during 25W - 
60 s sonication. 
 
Figure 2: Time series of axial thermometry maps (1-9) in deep phantom during 25W - 60 
s sonication. 
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Figure 3: Time series of coronal thermometry maps (1-9) in medium phantom during 
25W - 60 s sonication. 
 
Figure 4: Time series of axial thermometry maps (1-9) in medium phantom during 25W 
- 60 s sonication. 
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Figure 5: Time series of coronal thermometry maps (1-9) in shallow phantom during 25W 
- 60 s sonication. 
 
Figure 6: Time series of axial thermometry maps (1-9) in shallow  phantom during 25W 
- 60 s sonication. 
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Figure 7: Sagittal T1w images for 50W-60 s sonication in the absence of plastic skull. 
 
 
Figure 8: Axial T1w images for 50 W-60 s sonication in the absence of plastic skull.  
 
 
Figure 9: Sagittal T1w images for 50 W-60 s sonication with intact plastic skull. 
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Figure 10: Axial T1w images for 50 W-60 s sonication with intact plastic skull. 
 
 
Figure 11: Sagittal T1w images for 90 W-60 s sonication in the absence of plastic skull. 
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Figure 12: Thermal maps (1-12) of the bone/muscle phantom in the axial plane for 30 W-
30 s sonication using a SPGR pulse sequence. 
 
Figure 13: Thermal maps (1-12) of the bone/muscle phantom in the axial plane for 60 W-
30 s sonication using a SPGR pulse sequence. 
 
Figure 14: Thermal maps (1-12) of the bone/muscle phantom in the axial plane for 90 
W-30 s sonication using a SPGR pulse sequence. 
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Figure 15: Thermal maps (1-18) of the bone/muscle phantom in the axial plane for 30 W-
60 s sonication using a SPGR pulse sequence. 
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Figure 16: Thermal maps (1-18) of the bone/muscle phantom in the axial plane for 60 W-
60 s sonication using a SPGR pulse sequence. 
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Figure 17: Thermal maps (1-18) of the bone/muscle phantom in the sagittal plane for 
30 W-60 s sonication using a SPGR pulse sequence.  
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Figure 18: Axial thermal maps for a 45 W-60 s of the breast/rib phantom sonication for 
a bottom to top approach and with the rib bone residing in the far acoustic field. 
 
Figure 19: Axial thermal maps for a 90W-60s sonication of the breast/rib phantom  for a 
lateral approach while avoiding the rib bone in the far field 
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Figure 20: Coronal thermal maps for a 45 W-60 s sonication of the breast/rib phantom 
for a bottom to top approach and the thermometry slice prescribed 5 mm in front of the 
rib phantom. 
 
 
Figure 21: Coronal thermal map for a 45 W-60 s sonication of the breast/rib phantom 
for a bottom to top approach and the thermometry slice prescribed at the focus. 
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Appendix D 
TempMap1 GUI Matlab code 
% TEMPMAP1 MATLAB code for TempMap1.fig 
function varargout = TempMap1(varargin) 
% Initialization of GUI 
gui_Singleton = 1; 
gui_State = struct('gui_Name',       mfilename, ... 
                   'gui_Singleton',  gui_Singleton, ... 
                   'gui_OpeningFcn', @TempMap1_OpeningFcn, ... 
                   'gui_OutputFcn',  @TempMap1_OutputFcn, ... 
                   'gui_LayoutFcn',  [] , ... 
                   'gui_Callback',   []); 
if nargin && ischar(varargin{1}) 
    gui_State.gui_Callback = str2func(varargin{1}); 
end 
if nargout 
    [varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:}); 
else 
    gui_mainfcn(gui_State, varargin{:}); 
end 
% End initialization code  
% Executes just before TempMap1 is made visible. 
function TempMap1_OpeningFcn(hObject, eventdata, handles, varargin) 
% Choose default command line output for TempMap1 and set default user defined values for 
alpha and waiting time. 
set(handles.alpha, 'String', -0.01); 
set (handles.WaitingTime, 'String', 60); 
handles.output = hObject; 
% Update handles structure 
guidata(hObject, handles); 
% TempMap1 waits for user response  
% uiwait(handles.figure1); 
% Outputs from this function are returned to the command line. 
function varargout = TempMap1_OutputFcn(hObject, eventdata, handles)  
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% varargout  cell array for returning output args (see VARARGOUT); 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
% Get default command line output from handles structure 
varargout{1} = handles.output; 
 
% Executes on button press in pushbutton1. 
function pushbutton1_Callback(hObject, eventdata, handles) 
% Browse and load magnitude (reference) image DICOM file. 
[filename, pathname] = uigetfile('*.*', 'Select a Magnitude Image'); 
% Check if file is empty and give warning for cancellation. 
if ~isequal(filename,0) 
% Create array MG1 and set equal to matrix of read pixel data. 
    MG1= dicomread (fullfile(pathname,filename)) 
% Create struct with fields MG1info and set equal to DICOM file metadata. 
    MG1info= dicominfo (fullfile(pathname,filename)) 
 % Show magnitude image MG1 in figure (1) with in grayscale in full dynamic range 
    figure(1); 
    imshow (MG1, []); 
% Create handles of 6 elliptical ROI with radii of (10 x 10 pixels) and center at (0, 0).  The use 
drags and drops by double clicking the ROI at each external oil reference. Position and size of 
ROI can be adjusted. 
    h1 = imellipse(gca, [0 0 10 10]); 
    wait(h1); 
    h2 = imellipse(gca, [0 0 10 10]); 
    wait(h2); 
    h3 = imellipse(gca, [0 0 10 10]); 
    wait (h3); 
    h4 = imellipse(gca, [0 0 10 10]); 
    wait (h4); 
    h5 = imellipse(gca, [0 0 10 10]); 
    wait (h5); 
    h6 = imellipse(gca, [0 0 10 10]); 
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    wait (h6); 
    fig=gcf; 
else 
% Error message if user cancels reference magnitude image selection. 
    msgbox ('User cancelled image selection', 'Error','Error');         
end 
%Carry useful handles to other pushbutton within GUI 
handles.MG1 = MG1; 
handles.h1=h1; 
handles.h2=h2; 
handles.h3=h3; 
handles.h4=h4; 
handles.h5=h5; 
handles.h6=h6; 
handles.fig=fig; 
handles.MG1info = MG1info; 
guidata(hObject, handles); 
 
% --- Executes on button press in pushbutton2. 
function pushbutton2_Callback(hObject, eventdata, handles) 
% Browse and load Real (reference) image from DICOM file. 
 [filename, pathname] = uigetfile('*.*', 'Select a Real Image'); 
% Check if file is empty and give warning for cancellation 
if ~isequal(filename,0) 
% Create array RE1 and set equal to matrix of Real image read pixel data. 
    RE1= dicomread (fullfile(pathname,filename)); 
else 
    msgbox ('User cancelled image selection', 'Error','Error');         
end 
%Carry useful handles to other pushbutton within GUI 
handles.RE1 = RE1; 
guidata(hObject, handles); 
% Executes on button press in pushbutton3. 
function pushbutton3_Callback(hObject, eventdata, handles) 
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% Browse and load Imaginary (reference) image from DICOM file. 
 [filename, pathname] = uigetfile('*.*', 'Select an Imaginary Image'); 
% Check if file is empty and give warning for cancellation 
if ~isequal(filename,0) 
    IM1= dicomread (fullfile(pathname,filename)); 
else 
    msgbox ('User cancelled image selection', 'Error','Error');         
end 
%Carry useful handles to other pushbutton within GUI 
handles.IM1 = IM1; 
guidata(hObject, handles); 
 
% If the user selects to follow the Single Pair Analysis then he must run all three pushbuttons 4, 
5 and 6. These pushbuttons are used to browse and load pixel data of the Ablation Image to matrix 
arrays in the code (MG2, RE2, and IM2). Comments for this part of the code are omitted. 
 
% Executes on button press in pushbutton4 
 [filename, pathname] = uigetfile('*.*', 'Select a Magnitude Image'); 
if ~isequal(filename,0) 
    MG2= dicomread (fullfile(pathname,filename)); 
    MG2info = dicominfo (fullfile(pathname,filename)) 
else 
    msgbox ('User cancelled image selection', 'Error','Error');         
end  
handles.MG2 = MG2; 
handles.MG2info = MG2info; 
guidata(hObject, handles); 
 
% --- Executes on button press in pushbutton5. 
function pushbutton5_Callback(hObject, eventdata, handles) 
 [filename, pathname] = uigetfile('*.*', 'Select a Real Image'); 
if ~isequal(filename,0) 
    RE2= dicomread (fullfile(pathname,filename)); 
else 
  
 169 
    msgbox ('User cancelled image selection', 'Error','Error');         
end     
handles.RE2 = RE2; 
guidata(hObject, handles); 
 
% --- Executes on button press in pushbutton6. 
function pushbutton6_Callback(hObject, eventdata, handles) 
 [filename, pathname] = uigetfile('*.*', 'Select an Imaginary Image'); 
if ~isequal(filename,0) 
    IM2= dicomread (fullfile(pathname,filename)); 
else 
    msgbox ('User cancelled image selection', 'Error','Error');         
end    
handles.IM2 = IM2; 
guidata(hObject, handles); 
 
 
% --- Executes on button press in pushbutton7. 
function pushbutton7_Callback(hObject, eventdata, handles) 
% Retrieves from GUI handles the RE1 and IM1 to calculate reference wrapped phase image 
WP1 
RE1 = double (handles.RE1) 
IM1 = double (handles.IM1) 
%Check if variables are empty 
if isempty(RE1) 
        msgbox ('Select a Real Mask Image!', 'Error','Error');   
elseif isempty(IM1)        
        msgbox ('Select an Imaginary Mask Image!', 'Error','Error');   
else     
 
%Calculate reference wrapped phase image WP1 using the atan2 function from Matlab Library    
WP1=atan2(IM1,RE1); 
end 
%Carry useful handles to other pushbutton within GUI 
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handles.WP1 = WP1; 
guidata(hObject, handles); 
 
% --- Executes on button press in pushbutton8. 
function pushbutton8_Callback(hObject, eventdata, handles) 
% Retrieves from GUI handles the RE2 and IM2 to calculate ablation wrapped phase image WP2 
RE2 = double (handles.RE2); 
IM2 = double (handles.IM2); 
% Check if variables are empty 
if isempty(RE2) 
        msgbox ('Select a Real Mask Image!', 'Error','Error');   
elseif isempty(IM2)        
        msgbox ('Select an Imaginary Mask Image!', 'Error','Error');   
else    
%Calculate ablation wrapped phase image WP2 using the atan2 function from Matlab Library    
        WP2=atan2(IM2,RE2); 
end 
%Carry useful handles to other pushbutton within GUI 
handles.WP2 = WP2; 
guidata(hObject, handles); 
 
% --- Executes on button press in pushbutton9. 
function pushbutton9_Callback(hObject, eventdata, handles) 
%Retrieve handles of external variables 
RE1=handles.RE1; 
IM1=handles.IM1; 
MG1 = double (handles.MG1); 
WP1 = double (handles.WP1); 
 
% Calculate complex reference image IC1 
IC1=MG1.* exp(1i *(WP1)); 
%Carry useful handles to other pushbutton within GUI 
handles.IC1 = IC1; 
guidata(hObject, handles); 
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% --- Executes on button press in pushbutton10. 
function pushbutton10_Callback(hObject, eventdata, handles) 
%Retrieve handles of external variables 
RE2=handles.RE2; 
IM2=handles.IM2; 
MG2 = double (handles.MG2); 
WP2 = double (handles.WP2); 
%Calculate complex ablation image IC2 
IC2=MG2.* exp(1i *(WP2)); 
%Carry useful handles to other pushbutton within GUI 
handles.IC2 = IC2; 
guidata(hObject, handles); 
 
% --- Executes on button press in pushbutton11. 
function pushbutton11_Callback(hObject, eventdata, handles) 
%Retrieve handles of external variables 
RE1=double(handles.RE1); 
IM1=double(handles.IM1); 
MG1=handles.MG1; 
WP1=handles.WP1; 
IC1=handles.IC1; 
RE2=double(handles.RE2); 
IM2=double(handles.IM2); 
MG2=handles.MG2; 
WP2=handles.WP2; 
IC2=handles.IC2; 
fig=handles.fig; 
h1=handles.h1; 
h2=handles.h2; 
h3=handles.h3; 
h4=handles.h4; 
h5=handles.h5; 
h6=handles.h6; 
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%Calculate complex difference CD by multiplying IC1 with complex conjugate of IC2. 
CD = double(IC1) .* conj(double(IC2)); % complex 
%Calculate phase difference angle PDa matrix array from complex difference data CD. 
PDa = angle(CD);  
%Unwrap PDa using Miguel Herrraez unwrapping algorithm 
PDb=Miguel_2D_unwrapper(single(PDa)); 
%Show PDb in axes1 on grayscale with min and max equal to –pi to +pi 
axes(handles.axes1); 
imshow(PDb,[-3.14 3.14]);colormap(jet(264)); colorbar; 
title ('Mask phase(rad)') 
%Create array with mean pixel values of predefined ROI handles for each external oil reference 
roi=[mean(PDb(createMask(h1)));mean(PDb(createMask(h2)));mean(PDb(createMask(h3)));m
ean(PDb(createMask(h4)));mean(PDb(createMask(h5)));mean(PDb(createMask(h6)));]; 
%Get position of each ROI 
a1=getPosition(h1); 
a2=getPosition(h2); 
a3=getPosition(h3); 
a4=getPosition(h4); 
a5=getPosition(h5); 
a6=getPosition(h6); 
%Contsruct X and Y vectors where the xy coordinates of ROI are saved. 
X=[a1(1)+a1(3)/2;a2(1)+a2(3)/2;a3(1)+a3(3)/2;a4(1)+a4(3)/2;a5(1)+a5(3)/2;a6(1)+a6(3)/2]; 
Y=[a1(2)+a1(4)/2;a2(2)+a2(4)/2;a3(2)+a3(4)/2;a4(2)+a4(4)/2;a5(2)+a5(4)/2;a6(2)+a6(4)/2]; 
 
 
% Mean pixel values are used to fit a 1st degree polynomial using least absolute residuals criterion 
f1=fit([X Y],roi,'poly11','Robust','LAR'); 
figure(3); 
plot(f1, [X Y], roi); 
coef=coeffvalues(f1); 
M=zeros(256); 
for i=1:256; 
  for  j=1:256; 
%A 256 by 256 correction matrix with fitted data is created to correct for pseudophase offset  
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M(i,j)=coef(1)+coef(2)*i+coef(3)*j; 
  end 
end 
% Final phase difference matrix array is created by subtracting the phase correction matrix M 
PD=PDb-M; 
% Show WP2 
axes(handles.axes3); 
imshow(WP2,[-3.14 3.14]);colormap(jet(264)); colorbar; 
title ('Ablation phase(rad)') 
%Carry useful handles to other pushbutton within GUI 
handles.CD=CD; 
handles.PD = PD; 
handles.PDb=PDb; 
handles.roi=roi; 
handles.M=M; 
guidata(hObject, handles); 
 
% --- Executes on button press in pushbutton13. 
function pushbutton13_Callback(hObject, eventdata, handles) 
%Retrieve handles of external variables 
alpha = str2num(get(handles.alpha, 'String')); 
CD=handles.CD; 
PD=handles.PD; 
PDb=handles.PDb; 
MG2info=handles.MG2info; 
%PRFS equation for calculating temperature shift     
dT = PD./(gamma*alpha*TE*B0); 
axes(handles.axes4); 
% Show Temperature map 
imagesc(dT,[-3 25]); axis off; colormap(jet(264)); colorbar; 
title('Temperature Change(^{o}C)'); 
datacursormode on; 
 
% --- Executes on button press in pushbutton14. 
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The user selects to follow the Multiple Pair Analysis. The preloaded data of the reference image 
are used. The GUI waits for incoming new files to automatically analyze for  a period equal to 
Waiting Time. 
function pushbutton14_Callback(hObject, eventdata, handles) 
%Import alpha and waiting time (time for checking new images during Quick TempMap) 
%settings from GUI 
alpha = str2num(get(handles.alpha, 'String')); 
WaitingTime= str2num(get(handles.WaitingTime, 'String')); 
% Set counting 
counting=1; 
fig=handles.fig; 
h1=handles.h1; 
h2=handles.h2; 
h3=handles.h3; 
h4=handles.h4; 
h5=handles.h5; 
h6=handles.h6; 
%Retrieve handle of reference complex image 
IC1 = handles.IC1; 
WP1 = handles.WP1; 
% Initialize image folders 
previousfolder = ''; 
%Start Timer 
tic; 
% While loop checking parsed time less than set WaitingTime 
while (toc<=WaitingTime) 
 % Set image current folder. The string of current folder is updated by 3rd party application which 
sends the new address of the an incoming folder of DICOM files. 
 currentfolder=fileread('C:\Users\xbmc\Desktop\currentfolder.txt');  
 %Check if current folder is same with previous folder (new incoming images) 
 test=strcmp(currentfolder,previousfolder); 
 %Dir current folder for later use (image counting) 
DirChecker= dir ([currentfolder, '\*.*']); 
%If new images arrived ,currentfolder not empty and with at least 3 images 
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 if (test==0 && isempty(currentfolder)~=1 && 
length(DirChecker(not([DirChecker.isdir])))>=3) 
pathway =  strcat(currentfolder,'\**\*'); 
% DIR to current folder 
 d=rdir(pathway); 
% Sort images chronologically (last modified) and pick last three which correspond to last 
magnitude, real and imaginary.  
dates = [d.datenum]; 
[~, Index] = sort (dates); 
first = d(Index(end-2)); 
MG2=double(dicomread(first.name)); 
MG2info=dicominfo(first.name); 
second = d(Index(end-1)); 
RE2 = double(dicomread(second.name)); 
third = d(Index(end)); 
IM2 = double(dicomread(third.name)); 
WP2=atan2(IM2,RE2);  
% Create ablation complex data image IC2 
IC2=MG2.* exp(1i *(WP2));    
% Calculate complex difference by multiplying with conjugate 
CD = double(IC1) .* conj(double(IC2));  
% Calculate phase angle difference matrix 
PDa = angle(CD); 
%Unwrap phase angle difference matrix using Miguel Herraez unwrapping algorithm. 
PDb= Miguel_2D_unwrapper(single(PDa));   
% Display PDb 
figure(2); 
imshow(PDb,[]); 
% Calculate mean pixel values at each predefined ROI for pseudophase offset correction. 
roi=[mean(PDb(createMask(h1)));mean(PDb(createMask(h2)));mean(PDb(createMask(h3)));m
ean(PDb(createMask(h4)));mean(PDb(createMask(h5)));mean(PDb(createMask(h6)));]; 
 a1=getPosition(h1); 
 a2=getPosition(h2); 
 a3=getPosition(h3); 
 a4=getPosition(h4); 
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 a5=getPosition(h5); 
 a6=getPosition(h6); 
% Create X Y vectors based on ROI x,y coordinates. 
X=[a1(1)+a1(3)/2;a2(1)+a2(3)/2;a3(1)+a3(3)/2;a4(1)+a4(3)/2;a5(1)+a5(3)/2;a6(1)+a6(3)/2]; 
Y=[a1(2)+a1(4)/2;a2(2)+a2(4)/2;a3(2)+a3(4)/2;a4(2)+a4(4)/2;a5(2)+a5(4)/2;a6(2)+a6(4)/2]; 
% 1st degree polynomial fit of ROI mean pixel values with and X, Y vectors to a 2D surface. 
f1=fit([X Y],roi,'poly11'); 
coef=coeffvalues(f1); 
% Create correction matrix using the coefficients of the fit 
M=zeros(256); 
for i=1:256; 
  for  j=1:256; 
   M(i,j)=coef(1)+coef(2)*i+coef(3)*j; 
  end 
end 
% Apply correction to current unwrapped phase image. 
PD=PDb-M; 
% Get alpha value set by user in GUI  
alpha = str2num(get(handles.alpha, 'String')); 
 %Declare parameters for PRFS equation 
 gamma=2.675*10^8; % in rad/s*T 
 alpha= alpha*10^(-6); % in 1/degree_celcius 
B0=1.5; % in T 
TE = MG2info.EchoTime * 10^(-3); % in s 
%Declare PRFS equation 
dT = PD./(gamma*alpha*TE*B0); 
% Use of subtightplot function to display maps in a predefined 3 x 3 multi-frame format. 
figure (3); 
subtightplot(3,3,counting); 
imshow (dT,[0 105]); axis off; colormap(jet(264));colorbar 
title(counting); 
% Changes previousfolder value and  counter value; 
previousfolder=currentfolder; 
counting=counting+1; 
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    else 
    end 
% End of loop of the Multiple pair analysis. The loop returns at the beginning for as long as the 
Waiting Time is not expired. 
end 
 
% --- Executes on button press in pushbutton15. 
function pushbutton15_Callback(hObject, eventdata, handles) 
% Delete all handles and close GUI. 
close all;
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